<SEC-DOCUMENT>0001493152-22-018458.txt : 20220705
<SEC-HEADER>0001493152-22-018458.hdr.sgml : 20220705
<ACCEPTANCE-DATETIME>20220705092028
ACCESSION NUMBER:		0001493152-22-018458
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220701
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220705
DATE AS OF CHANGE:		20220705

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		221063352

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:SMTI="http://sanaramedtech.com/20220701">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_SMTI_sanaramedtech.com_20220701 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220701_20220701 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20220701.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-01to2022-07-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_905_edei--DocumentType_c20220701__20220701_zfxSUujvfBt9"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_901_edei--DocumentPeriodEndDate_c20220701__20220701_zPexNXB5KXn3"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 1, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20220701__20220701_ztjS2Q2rIbIh"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityRegistrantName">SANARA
    MEDTECH INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20220701__20220701_zqHqrmncfhUa"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20220701__20220701_zQMXmnQLH5zk"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20220701__20220701_zKb1kZfMhdg6"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
                                                                                <p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                            incorporation)</span></p></td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                                <p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
                                            Number)</span></p></td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
                                                                                <p style="text-align: center; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
                                            No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20220701__20220701_zjT43eKBbtSl"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityAddressAddressLine1">1200
                                            Summit Avenue</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20220701__20220701_zOcrJVXNldp7"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20220701__20220701_zhIUPobXgDS3"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20220701__20220701_zkjhyXi2uEk9"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressPostalZipCode_c20220701__20220701_zntEOi0UgMA9"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_903_edei--CityAreaCode_c20220701__20220701_z3DFzgq6gfe6"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20220701__20220701_zBU6Zl1S45vk"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--WrittenCommunications_c20220701__20220701_zRzzyh97mXu5"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--SolicitingMaterial_c20220701__20220701_zCBYhMi02t08"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--PreCommencementTenderOffer_c20220701__20220701_z1RzIpcVzfK6"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20220701__20220701_z0eGjOgX31ia"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 18%"><b>Trading
    Symbol(s)</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20220701__20220701_zE7pOyYrhyFb"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:Security12bTitle">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20220701__20220701_zfClAU2yUMN3"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90D_edei--SecurityExchangeName_c20220701__20220701_zwIEekjvluK2"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20220701__20220701_zTJnpOogfqte"><ix:nonNumeric contextRef="From2022-07-01to2022-07-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2022, Sanara MedTech Inc., a Texas corporation (the &#8220;Company&#8221;), entered into a Membership Interest Purchase Agreement
(the &#8220;Purchase Agreement&#8221;) by and among the Company, Scendia Biologics, LLC, a Delaware limited liability company (&#8220;Scendia&#8221;),
and Ryan Phillips (the &#8220;Seller&#8221;) pursuant to which, and in accordance with</span> the terms and conditions set forth therein,
the Company acquired 100% of the issued and outstanding membership interests in Scendia (including all rights and benefits associated
with such membership interests, the &#8220;Membership Interests&#8221;) from the Seller (the &#8220;Acquisition&#8221;). On July 1,
2022, the parties to the Purchase Agreement completed the Acquisition (the &#8220;Closing&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scendia
provides clinicians and surgeons with a full line of the regenerative and orthobiologic technologies for their patients through certain
customer accounts. Beginning in early 2022, the Company began co-promoting certain products with Scendia, including: (i) TEXAGEN Amniotic
Membrane Allograft, (ii) BiFORM Bioactive Moldable Matrix, (iii) AMPLIFY Verified Inductive Bone Matrix and (iv) ALLOCYTE Advanced Cellular
Bone Matrix. Prior to the Acquisition, Scendia owned 50% of the issued and outstanding membership interests in Sanara Biologics, LLC
(&#8220;Sanara Biologics&#8221;), and the Company owned the remaining 50% of the membership interests. As a result of the Acquisition,
the Company indirectly acquired all of the interests in Sanara Biologics, such that the Company now holds 100% of the issued and outstanding
equity interests in Sanara Biologics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the aggregate purchase price for the Acquisition was $7.36 million, which consists of (i) a $1.36 million
cash payment, subject to certain adjustments (the &#8220;Cash Consideration&#8221;), and (ii) 291,686 shares of common stock,
par value $0.001 per share, of the Company (the &#8220;Common Stock&#8221;) with an agreed upon value of $6.0 million (the &#8220;Stock
Consideration&#8221;). Pursuant to the Purchase Agreement, at Closing, the Company withheld 94,798 shares of Common Stock with
an agreed upon value of $1.95 million (the &#8220;Indemnity Holdback Shares&#8221; and the portion of the Stock Consideration issued
at Closing plus the Indemnity Holdback Shares, the &#8220;Stock Consideration Shares&#8221;), which such Indemnity Holdback Shares shall
be withheld, issued, and released to the Seller after Closing as and to the extent provided in Purchase Agreement to satisfy the Seller&#8217;s
indemnification obligations, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Cash Consideration and the Stock Consideration, the Purchase Agreement provides that the Seller is entitled to receive
two potential earnout payments, payable on an annual basis, not to exceed $10.0 million in the aggregate (the &#8220;Earnout
Consideration). The Earnout Consideration is payable to the Seller in cash or, at the Company&#8217;s election, in up to 486,145
shares of Common Stock (the &#8220;Earnout Shares&#8221;), upon the achievement of certain performance thresholds relating to Net
Revenue (as such term is defined in the Purchase Agreement) attributable to Scendia&#8217;s existing customers and to sales
of Scendia products during the two-year period following the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations, warranties and obligations of the parties, including, among others, certain confidentiality,
non-competition and non-solicitation covenants. The parties each have customary indemnification obligations and rights under the terms
of the Purchase Agreement, including with respect to breaches of certain representations and warranties and failure to observe and perform
certain covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety to the complete text
of the Purchase Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K (this &#8220;Current Report&#8221;)
and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement attached as Exhibit 2.1 hereto is included to provide investors and security holders with information regarding its
terms, and it is not intended to provide any other factual information about the Company, the Seller, Scendia or their respective subsidiaries
and affiliates. The representations, warranties and covenants contained in the Purchase Agreement were made only for the purposes of
the Purchase Agreement and only as of the date of the Purchase Agreement or such other date as is specified in the Purchase Agreement
and are qualified by information in confidential disclosure schedules provided by the Company and Scendia in connection with the signing
of the Purchase Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions
to the representations and warranties and certain covenants set forth in the Purchase Agreement. Moreover, certain representations and
warranties in the Purchase Agreement were used for the purpose of allocating risk between the Company, the Seller and Scendia rather
than establishing matters as facts. Information concerning the subject matter of the representations and warranties may change after
the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures.
Accordingly, the representations and warranties in the Purchase Agreement should not be relied upon as characterizations of the actual
state of facts about the Company, the Seller or Scendia, and the Purchase Agreement should be read in conjunction with the Company&#8217;s
Forms 10-K, Forms 10-Q and other documents that are filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.01 Completion of Acquisition or Disposition of Assets.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 regarding the Acquisition is incorporated by reference into this Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth under Item 1.01 with respect to the issuance of the Stock Consideration Shares and Earnout Shares to the Seller
pursuant to the Purchase Agreement is incorporated herein by reference. The issuance of the Stock Consideration Shares and the Earnout
Shares was or will be undertaken, respectively, in reliance upon the exemption from the registration requirements of the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 5, 2022, the Company issued a press release announcing the Acquisition. A copy of the press release is furnished as Exhibit
99.1 to this Current Report and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information included under Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise be subject to
the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the
Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Financial Statements of Business Acquired.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to file the financial statements required by Item 9.01(a), with respect to the Acquisition described in Item 2.01 herein,
by amendment to this Current Report as soon as practicable and in any event not later than 71 days after the date on which this Current
Report is required to be filed pursuant to Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Pro Forma Financial Information.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to file the pro forma financial information required by Item 9.01(b), with respect to the Acquisition described in Item
2.01 herein, by amendment to this Current Report as soon as practicable and in any event not later than 71 days after the date on which
this Current Report is required to be filed pursuant to Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="text-align: justify; font-family: Times New Roman, Times, Serif; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex2-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Interest Purchase Agreement, dated July 1, 2022, by and among Sanara MedTech Inc., Scendia Biologics, LLC and Ryan Phillips. </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1
    </span></td>
    <td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Sanara MedTech Inc., dated July 5, 2022 (furnished pursuant to Item 7.01). </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted
exhibit or schedule will be furnished supplementally to the SEC or its staff upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    5, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Wkq3DPIyqYgsQiK6XXKMJd2R2e3HR+ot25RoGBiGc75zhAjFmla6RobzosjhiE1bK4dQYIWM5oLekW22Kfhb4FVbx8q4/v2BGXkGPZOM4qnyQm99aItlCtFsLOdjKSGWaTKBw04EXz0jU+kSjdOqBmVKODC1rNEp7oaEo3qRoabrq07IVpNJIR5Fg/wGGcUS9vRQT+KbhTzPRBD2E4g107391tytowaWNTa+yw7of4MPHKhJUQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
2.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEMBERSHIP
INTEREST PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
MEMBERSHIP INTEREST PURCHASE AGREEMENT (this &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into as of July 1, 2022 (the &ldquo;<B><I>Closing
Date</I></B>&rdquo;), by and among Sanara MedTech Inc., a Texas corporation (&ldquo;<B><I>Purchaser</I></B>&rdquo;), Scendia Biologics,
LLC, a Delaware limited liability company (the &ldquo;<B><I>Company</I></B>&rdquo;), and Ryan Phillips (&ldquo;<B><I>Seller</I></B>&rdquo;).
The Company, Seller and Purchaser are sometimes collectively referred to herein as the &ldquo;<B><I>Parties</I></B>&rdquo; and individually
as a &ldquo;<B><I>Party</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company provides clinicians and surgeons with a full line of the highest quality regenerative and orthobiologic technologies (the
&ldquo;<B><I>Business</I></B>&rdquo;) for their patients through the Existing Customer Accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Company owns 50% of the issued and outstanding membership interests (the &ldquo;<B><I>JV Interests</I></B>&rdquo;) in Sanara Biologics,
LLC (the &ldquo;<B><I>JV</I></B>&rdquo;), and Purchaser owns the remaining 50% of the issued and outstanding membership interests in
the JV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Seller holds 100% of the issued and outstanding membership interests in the Company (including all rights and benefits associated with
such membership interests, the &ldquo;<B><I>Membership Interests</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Upon the terms set forth in this Agreement (a) Seller is selling all of the Membership Interests to Purchaser, and (b) Purchaser is (i)
acquiring all of the Membership Interests from Seller and (ii) indirectly acquiring all of the JV Interests from Seller such that Purchaser
will, directly or indirectly, hold 100% of the issued and outstanding equity interests in the JV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises, representations, warranties, covenants and agreements contained herein, and certain
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
I.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PURCHASE
AND SALE OF THE MEMBERSHIP INTERESTS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Purchase and Sale of the Membership Interests</U>.
Upon the terms contained herein, Seller hereby sells, transfers and assigns to Purchaser, free and clear of any Liens, and Purchaser
hereby purchases or otherwise accepts from Seller, the Membership Interests, together with all rights and advantages attaching thereto
(the &ldquo;<B><I>Sale Transaction</I></B>&rdquo;); <U>provided</U> that for the avoidance of doubt, Purchaser is indirectly acquiring
the JV Interests held by the Company at the time of the Closing such that Purchaser and the Company, collectively, will hold 100% of
issued and outstanding equity interests in the JV immediately following the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consideration.</U> The aggregate consideration for
the purchase of the Membership Interests and the covenants and agreements of Seller and the Company set forth in this Agreement, will
be (a) $7,000,000 (the &ldquo;<B><I>Purchase Price</I></B>&rdquo;), which shall consist of (i) an amount in cash equal to $1,000,000
(the &ldquo;<B><I>Cash Consideration</I></B>&rdquo;), and (ii) the Stock Consideration, <U>plus</U> (b) the earnout payments, if any,
in each case as adjusted pursuant to <U>Section 1.03</U> and <U>Section 6.05</U>. The &ldquo;<B><I>Stock Consideration</I></B>&rdquo;
shall equal 291,686 shares of Purchaser Common Stock with an approximate value of $6,000,000 based on the Purchaser Common Stock Price
as of the Closing Date; <U>provided</U> that any fractional shares of Purchaser Common Stock resulting from calculating the Stock Consideration
shall be accounted for by an increase in the Cash Consideration payable to Seller such that only an integral number of Purchaser Common
Stock will be issued to any given Seller. The portion of the Stock Consideration to be issued at Closing shall be reduced by the Indemnity
Holdback Shares (the Stock Consideration less the Indemnity Holdback Shares, the &ldquo;<B><I>Closing Stock Consideration</I></B>&rdquo;).
The portion of the Cash Consideration payable at Closing shall be calculated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000,000, <U>plus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$360,517 (50% of the average Specified Inventory working
capital contribution), <U>plus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Estimated Closing Cash Amount, <U>minus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Target Working Capital exceeds the Estimated
Closing Working Capital, then the amount by which the Target Working Capital exceeds the Estimated Closing Working Capital, <U>plus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Estimated Closing Working Capital exceeds the
Target Working Capital, then the amount by which the Estimated Closing Working Capital exceeds the Target Working Capital, <U>minus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Estimated Closing Debt Amount, which shall be paid
directly to the holder of the Indebtedness by the Purchaser in accordance with <U>Section 1.05(b)</U>, <U>minus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate amount of all Estimated Unpaid Transaction
Expenses, <U>minus</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(h)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Working Capital Escrow Amount, which shall be paid
directly by Purchaser to the Escrow Agent in accordance with <U>Section 1.05(b)</U> (the amount resulting from such calculation, the
&ldquo;<B><I>Closing Cash Payment</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Purchase Price Adjustment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the Closing Date, the Company has delivered
to Purchaser a written statement (the &ldquo;<B><I>Estimated Closing Statement</I></B>&rdquo;) setting forth in reasonable detail and
accompanied by reasonably detailed backup documentation, the Company&rsquo;s good faith estimate of (i) the balance sheet of the Company
as of the Effective Time, (ii) the Closing Cash Amount (the &ldquo;<B><I>Estimated Closing Cash Amount</I></B>&rdquo;), (iii) the Closing
Working Capital (&ldquo;<B><I>Estimated Closing Working Capital</I></B>&rdquo;), (iv) the Closing Debt Amount (the &ldquo;<B><I>Estimated
Closing Debt Amount</I></B>&rdquo;), and (v) the Unpaid Transaction Expenses (the &ldquo;<B><I>Estimated Unpaid Transaction Expenses</I></B>&rdquo;),
which amounts are set forth on <U>Schedule 1.03(a)</U>. The Company hereby certifies that the Estimated Closing Statement and the calculations
and determinations related thereto (including reasonable supporting documentation related to such calculations and determinations) have
been prepared by the Company in good faith from the Company&rsquo;s books and records and calculated in accordance with the Accounting
Principles (and with respect to the Closing Working Capital, the methodologies set forth in the sample calculation of Closing Working
Capital attached hereto as <U>Exhibit B</U>). Notwithstanding any input Purchaser may have with respect to the amounts reflected in the
Estimated Closing Statement, no position or agreement made or taken by any of the Parties with respect to the amounts reflected in the
Estimated Closing Statement and/or such accompanying calculations shall preclude Purchaser from taking any other position or making any
other argument with respect to the amounts reflected on the Adjustment Statement and/or accompanying calculations, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within 120 days after the Closing Date, Purchaser shall
cause to be prepared and delivered to Seller a written statement (the &ldquo;<B><I>Adjustment Statement</I></B>&rdquo;) setting forth
in reasonable detail and accompanied by reasonably detailed backup documentation, Purchaser&rsquo;s determination of (i) the Closing
Cash Amount, (ii) the Closing Working Capital, (iii) the Closing Debt Amount, and (iv) the Unpaid Transaction Expenses (collectively,
the &ldquo;<B><I>Proposed Amounts</I></B>&rdquo;). Each of the Adjustment Statement and the Proposed Amounts shall be calculated in good
faith by Purchaser in accordance with the terms and conditions hereof (including, with respect to the Closing Working Capital, the methodologies
set forth in the sample calculation of Closing Working Capital attached hereto as <U>Exhibit B</U>), and Purchaser shall make its and
its Affiliates&rsquo; work papers, back-up materials and books and records used in preparing the Adjustment Statement and the Proposed
Amounts available to Seller and its accountants at reasonable times and upon reasonable notice following the delivery of the Adjustment
Statement and the Proposed Amounts. If Purchaser fails to deliver any of the Proposed Amounts, then the Estimated Closing Working Capital,
Estimated Closing Debt Amount and Estimated Unpaid Transaction Expenses, as applicable, delivered by Seller shall be conclusive and binding
upon the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Adjustment Statement (and the computations of the
Proposed Amounts indicated thereon) delivered by Purchaser to Seller shall be deemed to be conclusive and binding upon the parties unless
Seller, within 30 days after delivery to Seller of the Adjustment Statement, notifies Purchaser in writing that Seller disputes in good
faith the calculation of specific line items set forth therein, specifying the nature of each individual disputed line item calculation
and the basis therefor in reasonable detail. Purchaser and Seller shall in good faith attempt to resolve any dispute and, if Purchaser
and Seller so resolve all disputes, the Adjustment Statement (and the computations of Proposed Amounts indicated thereon), as amended
to the extent necessary to reflect the resolution of the dispute, shall be deemed to be conclusive and binding on the Parties. If Purchaser
and Seller do not reach agreement in resolving the dispute within 30 days after notice is given by Seller to Purchaser pursuant to this
<U>Section 1.03(c)</U>, either Seller or Purchaser may cause the Parties to submit the dispute to a nationally recognized independent
accounting firm which is mutually agreeable to Purchaser and Seller (the &ldquo;<B><I>Independent Accountant</I></B>&rdquo;) for resolution;
<U>provided</U>, that if Purchaser and Seller are unable to agree on the selection of the Independent Accountant, then the Independent
Accountant will be chosen by the American Arbitration Association, with the expenses of the American Arbitration Association to be borne
50% by Purchaser and 50% by Seller, and such appointment shall be final, conclusive and binding on the Parties. Promptly, but no later
than 30 days after acceptance of its appointment as Independent Accountant, the Independent Accountant shall determine (it being understood
that in making such determination, the Independent Accountant shall be functioning as an expert and not as an arbitrator), based solely
on written submissions by Purchaser and Seller and the terms of this Agreement, and not by independent review, only those issues in dispute
and shall render a written report as to the resolution of the dispute and the resulting computation of the Closing Cash Amount, Closing
Working Capital, the Closing Debt Amount and/or Unpaid Transaction Expenses, as applicable, which shall be final, conclusive and binding
on the Parties (except in the case of manifest error, in which case, the determination shall be sent back to the Independent Accountant
for correction of such manifest error, and such corrected determination shall be final, conclusive and binding). In resolving any disputed
item, the Independent Accountant (x) shall be bound by the provisions of this <U>Section 1.03</U> and (y) may not assign a value to any
item greater than the greatest value for such items claimed by either Purchaser, on the one hand, or Seller, on the other hand, or less
than the smallest value for such items claimed by either Purchaser, on the one hand, or Seller, on the other hand. The fees, costs and
expenses of the Independent Accountant shall be allocated to and borne by Purchaser, on the one hand, and Seller, on the other hand,
based on the inverse of the percentage that the Independent Accountant&rsquo;s determination (before such allocation) bears to the total
amount of the total items in dispute as originally submitted to the Independent Accountant. For example, should the items in dispute
total in amount to $1,000 and the Independent Accountant awards $600 in favor of Seller&rsquo;s position, 60% of the costs of its review
would be borne by Purchaser and 40% of the costs would be borne by Seller. Subject to <U>Section 6.02(a)(iii)</U>, the final, binding
and conclusive calculation of the Closing Cash Amount, Closing Working Capital, the Closing Debt Amount and Unpaid Transaction Expenses,
based either upon agreement or deemed agreement by Purchaser and Seller or the written report delivered by the Independent Accountant,
in each case, in accordance with this <U>Section 1.03(c)</U>, will be the &ldquo;<B><I>Final Closing Cash Amount</I></B><I>,</I>&rdquo;
&ldquo;<B><I>Final Closing Working Capital</I></B>,&rdquo; &ldquo;<B><I>Final Closing Debt Amount</I></B>&rdquo; or &ldquo;<B><I>Final
Unpaid Transaction Expenses</I></B>,&rdquo; as the case may be (collectively, the &ldquo;<B><I>Final Amounts</I></B>&rdquo;), for all
purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within three (3) Business Days after the determination
of the Final Amounts in accordance with <U>Section 1.03(c)</U>, Seller and Purchaser shall jointly determine the amount by which the
Closing Cash Payment would have been calculated pursuant to <U>Section 1.02</U> if the Final Closing Cash Amount, Final Closing Working
Capital, Final Closing Debt Amount and Final Unpaid Transaction Expenses were substituted for the Estimated Closing Cash Amount, Estimated
Closing Working Capital, Estimated Closing Debt Amount and Estimated Unpaid Transaction Expenses, respectively, in the Estimated Closing
Statement as of the Effective Time (such adjusted amount, the &ldquo;<B><I>Adjusted Cash Payment</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Adjusted Cash Payment is less than the Closing
Cash Payment (any such deficit, the &ldquo;<B><I>Deficit Amount</I></B>&rdquo;), the amount in dollars equal to the absolute value of
the Deficit Amount shall be satisfied (A) first, by Purchaser and Seller delivering a joint written authorization to the Escrow Agent
within three Business Days after the determination of the Final Amounts in accordance with <U>Section 1.03(c)</U>, instructing the Escrow
Agent to release (1) an amount of cash equal to the lesser of the Deficit Amount and the Working Capital Escrow Amount from the Working
Capital Escrow Account to Purchaser, by wire transfer of immediately available funds and (2) the remaining portion of the Working Capital
Escrow Amount, if any, to Seller, by wire transfer of immediately available funds, and (B) second, to the extent the Deficit Amount exceeds
the Working Capital Escrow Amount, directly by Seller by wire transfer of immediately available funds to an account designated by Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Adjusted Cash Payment is greater than the Closing
Cash Payment (any such surplus, the &ldquo;<B><I>Surplus Amount</I></B>&rdquo;), then (A) Purchaser shall pay, or cause to be paid, an
amount in dollars equal to such Surplus Amount to Seller by wire transfer of immediately available funds to such account or accounts
designated by Seller, and (B) Purchaser and Seller shall deliver a joint written authorization to the Escrow Agent within three Business
Days after the determination of the Final Amounts in accordance with <U>Section 1.03(c)</U>, instructing the Escrow Agent to release
the entire Working Capital Escrow Amount to Seller, by wire transfer of immediately available funds; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Adjusted Cash Payment is equal to the Closing
Cash Payment, then (A) no adjustment shall be made to the Closing Cash Payment pursuant to this <U>Section 1.03</U>, and (B) Purchaser
and Seller shall deliver a joint written authorization to the Escrow Agent within three Business Days after the determination of the
Final Amounts in accordance with <U>Section 1.03(c)</U>, instructing the Escrow Agent to release the entire Working Capital Escrow Amount
to Seller, by wire transfer of immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing</U>. The closing and consummation of the
transactions contemplated hereby (the &ldquo;<B><I>Closing</I></B>&rdquo;) shall take place by electronic communications and transmission
of PDF documents on the Closing Date and the payment of the Closing Cash Payment by federal wire transfer to one or more accounts as
directed by Seller, and the Closing shall be deemed to be effective as of 12:01 a.m. (Eastern time) on the Closing Date (the &ldquo;<B><I>Effective
Time</I></B>&rdquo;). Except as otherwise expressly provided herein, all proceedings to be taken and all documents to be executed and
delivered by all Parties at the Closing shall be deemed to have been taken and executed simultaneously as of the Effective Time, and
no proceedings shall be deemed to have been taken nor documents executed or delivered until all have been taken, executed and delivered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hereby deliver, or are causing to be delivered,
to Purchaser, in each case in a form reasonably satisfactory to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a membership interest assignment, duly executed by Seller,
free and clear of all Liens;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) invoices or similar expense statements respecting
all Estimated Unpaid Transaction Expenses to be paid as of the Closing (the &ldquo;<B><I>Transaction Expense Statements</I></B>&rdquo;);
(B) customary payoff letters respecting the Closing Debt Amount (the &ldquo;<B><I>Payoff Letters</I></B>&rdquo;); and (C) evidence of
the satisfaction, termination and discharge in full of all Indebtedness of the Company as of the Effective Time and the release of any
Liens related thereto, to the assets of the Company or to the Membership Interests, including UCC-3 termination statements or similar
documents;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certificates of good standing and certificates of existence
issued by each jurisdiction set forth on <U>Schedule 3.01</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a certificate from an authorized officer of the Company
certifying (A) the appropriate resolutions as to the due authorization of this Agreement and the Ancillary Agreements executed by the
Company, (B) the Certificate of Formation and Operating Agreement or comparable governing documents (&ldquo;<B><I>Organizational Documents</I></B>&rdquo;)
of the Company, and (C) the incumbency and signatures of the officers of the Company executing this Agreement and any Ancillary Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an IRS Form W-9, duly executed by Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an Escrow Agreement in a form reasonably satisfactory
to Purchaser and Seller (the &ldquo;<B><I>Escrow Agreement</I></B>&rdquo;), duly executed by Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a written resignation, duly executed by Seller as the
sole officer and manager of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(viii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidence reasonably satisfactory to Purchaser that Novasol
Medical distribution of Company products has been converted to a house account of the Company on or prior to the Closing Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ix)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evidence reasonably satisfactory to Purchaser that the
Company&rsquo;s monthly guarantees with respect to Shelley Houde have been eliminated or otherwise terminated on or prior to the Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser hereby delivers, or is causing to be delivered:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to Seller, the Closing Cash Payment, by wire transfer
of immediately available funds to one or more accounts designated by Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to Seller, the Closing Stock Consideration;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the Escrow Agent, the Working Capital Escrow Amount,
to be held in accordance with the terms of the Escrow Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on behalf of the Company, to each payee identified in
each Payoff Letter and Transaction Expense Statement, the amount payable to such payee as set forth in such Payoff Letter or Transaction
Expense Statement and reflected in the Estimated Closing Statement, in each case, by wire transfer of immediately available funds to
an account designated by the applicable payee; <U>provided</U><I>, </I><U>however</U>, that in the case of Estimated Unpaid Transaction
Expenses owed to employees of the Company, Purchaser shall contribute such amounts to the Company upon the Closing and cause the Company
to pay such amounts (less applicable withholding and any Taxes required to be paid by the Company with respect thereto) to the applicable
employees within two pay periods following the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the individuals party thereto, the Offer Letters,
duly executed by Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to Seller, counterparts duly executed by Purchaser (or
its applicable Affiliate, as the case may be) to the membership interest assignment and the Escrow Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Earnout</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Earnout Amounts</U>. In addition to the other consideration
payable to Seller pursuant to the other Sections of this <U>Article 1</U>, Seller shall be entitled to the Earnout Amounts, if any, subject
to the terms of this <U>Section 1.06</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Certain Definitions</U>. Each of the terms below
has the meaning set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Annual Net Revenue Increase</I></B>&rdquo;
means, with respect to a particular Yearly Earnout Period, an amount equal to (1) the Net Revenue earned from the Existing Customer Accounts
during such Yearly Earnout Period, <U>less</U> (2) $9,054,767.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Extra-Territorial Net Revenue</I></B>&rdquo;
means, with respect to a particular Yearly Earnout Period, an amount equal to (1) the Net Revenue attributable to Scendia Products earned
from any hospital, surgery center, doctors office or any other customer, other than any Existing Customer Accounts during such Yearly
Earnout Period, <U>less</U> (2) (x) $1,000,000 with respect to the First Earnout Period or (y) $2,000,000 with respect to the Second
Earnout Period; <U>provided</U> that in no event shall Extra-Territorial Net Revenue include any net revenue used in the calculation
of Annual Net Revenue Increase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Earnout Amount</I></B>&rdquo; means, with
respect to a Yearly Earnout Period, the sum of (1) the Annual Net Revenue Increase for such Yearly Earnout Period, multiplied by 17%;
<U>plus</U> (2) the Extra-Territorial Net Revenue for such Yearly Earnout Period, multiplied by 10%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Earnout Period</I></B>&rdquo; means the
two-year period commencing on the Closing Date and ending on the second anniversary of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>First Earnout Period</I></B>&rdquo; means
the one-year period commencing on the Closing Date and ending on the first anniversary of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Net Revenue</B></I>&rdquo; means gross
invoiced sales by Purchaser and the Company from sales to third parties (excluding pilots and/or marketing assessments to the extent
they are complimentary as opposed to being sold) after the Effective Time, less sales taxes, excise duties, import and export duties,
shipping costs if separately invoiced to the customer, chargebacks, trade and early payment discounts, refunds, rebates, and returns,
in each case as determined from the financial statements of Purchaser maintained and prepared in the ordinary course of business according
to GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Scendia Products</I></B>&rdquo; means the
products licensed and sold by the Company as of the Closing Date, which for the avoidance of doubt shall not include any CellerateRX&reg;
products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(viii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Second Earnout Period</I></B>&rdquo; means
the one-year period commencing on the first anniversary of the Closing Date and ending on the second anniversary of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ix)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Yearly Earnout Period</I></B>&rdquo; means
the First Earnout Period or Second Earnout Period, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery and Review of Earnout Statements by Purchaser</U>.
No later than ninety (90) days after each Yearly Earnout Period, Purchaser shall (i) prepare a written statement (each, an &ldquo;<B><I>Earnout
Statement</I></B>&rdquo;) setting forth Purchaser&rsquo;s calculation of the Earnout Amount, if any, and (ii) deliver such statement
to the Seller for review. The Seller shall have thirty (30) days after receipt of an Earnout Statement from Purchaser to review such
Earnout Statement (the each, an &ldquo;<B><I>Earnout Statement Review Period</I></B>&rdquo;). If requested by the Seller, Purchaser shall
provide the Seller with reasonable access to the books and records and accounting personnel of the Company during normal business hours
for the purpose of enabling the Seller to review Purchaser&rsquo;s determinations in the Earnout Statement. Purchaser&rsquo;s calculation
of an Earnout Amount as set forth in an Earnout Statement shall be final and binding on the parties for purposes of this <U>Section 1.06
</U>unless, within thirty (30) days after the Seller&rsquo;s receipt of the Earnout Statement, the Seller shall notify Purchaser of any
objections to such Earnout Statement and specify in reasonable details the items in dispute (the &ldquo;<B><I>Earnout Notice of Objection</I></B>&rdquo;).
If the Seller notifies Purchaser of any such objections, such objections will be resolved according to the dispute resolution set forth
in <U>Section 1.03(c)</U>, mutatis mutandis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Final Earnout Amounts</U>. Within five (5) Business
Days of the final determination of an applicable Earnout Amount, if any, in accordance with <U>Section 1.06(c)</U>, Purchaser shall pay
the applicable Earnout Amount, if any, with a combination of cash and/or Purchaser Common Stock, at Purchaser&rsquo;s sole discretion.
Any cash shall be paid to Seller via wire transfer of immediately available funds to an account designated in writing by the Seller,
and any Purchaser Common Stock shall be promptly issued to Seller and valued based on the Purchaser Common Stock Price as of the Closing
Date. For the avoidance of doubt and notwithstanding anything to the contrary, the aggregate Earnout Amount payable to Seller shall in
no event exceed $10,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acknowledgements and Agreements Concerning Earnout</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller acknowledges and agrees that the rights of Seller
to the Earnout Amounts, if any, are not transferable, shall not be represented by a certificate or other instrument, shall not represent
an ownership interest in Purchaser or any of its Affiliates, shall not entitle Seller to any rights common to any holder of equity interests
in Purchaser or any of its Affiliates, and shall not bear any interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller acknowledges and agrees that, from and after
the Closing, Purchaser has the right to make all determinations concerning its businesses (including the business of the Company) in
its sole and absolute discretion, subject only to the express obligations set forth in this Agreement and that Purchaser shall not, and
hereby agrees not to, take any action, or omit to take action in bad faith the primary intent of which is to reduce or eliminate the
achievement of thresholds that would result in Earnout Amounts becoming payable; <U>provided</U>, <U>however</U>, that during the Earnout
Period, Purchaser agrees that it will not (except as a result of any pricing reduction at a commissionable end user facility or as required
to bring any such relationship in line with the Company&rsquo;s existing relationship with such distributor) materially decrease or otherwise
materially and adversely modify the commission and profit-sharing amounts paid under existing distributor relationships of the Company
without providing Seller with at least ten Business Days&rsquo; prior written notice of and before any such decrease or modification
takes effect and giving Seller, if Seller so desires, a reasonable opportunity to discuss such decrease during such ten Business Day
period. Without limiting the foregoing, Seller acknowledges and agrees that Purchaser shall have no implied obligation to operate its
businesses (or any business of the Company) in a manner (A) designed to achieve the thresholds that would result in Earnout Amounts becoming
payable, or (B) consistent with the manner in which the Company was operated before the Closing, it being understood and intended by
the parties hereto that that express provisions of this Agreement shall govern the parties&rsquo; rights and obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.07
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnity Holdback</U>. At Closing, Purchaser shall
withhold and not issue 94,798 shares of Purchaser Common Stock with an agreed upon value of $1,950,000 based on the Purchaser Common
Stock Price as of the Closing Date from, and without duplication to, the Stock Consideration to be issued by Purchaser at the Closing
(the &ldquo;<B><I>Indemnity Holdback Shares</I></B>&rdquo;). The Indemnity Holdback Shares shall be withheld, issued, and released to
Seller after Closing as and to the extent provided in this <U>Section 1.07</U> to satisfy Seller&rsquo;s indemnification obligations
under <U>Section 6.02(a)</U>, if any. The Parties agree that the Purchaser shall issue the Indemnity Holdback Shares only in accordance
with the following procedures:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within two (2) Business Days following the final resolution
of any claim for indemnification under <U>Article VI</U> in favor of the Purchaser Indemnified Parties, Purchaser shall reduce the Indemnity
Holdback Shares by a number of shares equal to (i) the amount of the Losses finally determined to be owed to the Purchaser Indemnified
Parties in respect of such claim for indemnification, divided by (ii) the Purchaser Common Stock Price as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly after the twelve (12)-month anniversary of
the Closing Date (such date, the &ldquo;<B><I>Initial Indemnity Holdback Release Time</I></B>&rdquo;), Purchaser shall issue to Seller
the balance of the then remaining Indemnity Holdback Shares (if any), <U>less</U> a number of shares equal to (i) (A) $450,000, <U>plus
</U>(B) the amount of Losses asserted to be owed to the Purchaser Indemnified Parties in respect of any claims for indemnification that
remain in dispute as of the Indemnity Holdback Release Time, <U>divided by</U> (ii) the Purchaser Common Stock Price. If such amount
is a negative number, then no issuance of any Indemnity Holdback Shares will be made as of the Initial Indemnity Holdback Release Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly after the final resolution and full release
of any liabilities of the Purchaser and the Company with respect to the Special Indemnity Matters (such date, the &ldquo;<B><I>Final
Indemnity Holdback Release Time</I></B>&rdquo;), Purchaser shall issue to Seller the balance of the then remaining Indemnity Holdback
Shares (if any), <U>less</U> a number of shares a number of shares equal to (i) the amount of Losses asserted to be owed to the Purchaser
Indemnified Parties in respect of any claims for indemnification that remain in dispute as of the Final Indemnity Holdback Release Time,
<U>divided by</U> (ii) the Purchaser Common Stock Price. With respect to the balance of the Indemnity Holdback Shares (if any) withheld
by Purchaser following the Final Indemnity Holdback Release Time, if, following final resolution (and reduction, if applicable, for any
amounts owed to the Purchaser Indemnified Parties pursuant) of all outstanding claims for indemnification under <U>Article VI</U> in
favor of the Purchaser Indemnified Parties prior to the Final Indemnity Holdback Release Time, any Indemnity Holdback Shares remain,
then within three (3) Business Days thereafter, Purchaser shall issue to Seller such remaining Indemnity Holdback Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">1.08
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Withholding</U>. Purchaser, the Company (or their
payroll provider), and any agent of Purchaser (including the Escrow Agent) shall be entitled to deduct and withhold from the consideration
otherwise payable any amounts that Purchaser determines are required to be deducted and withheld with respect to the making of payments
pursuant to this Agreement as required by the Code, or under any provision of state, local or foreign Law relating to Taxes. To the extent
amounts are lawfully withheld and properly paid over to the Taxing Authority, the withheld amounts shall be treated for all purposes
of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
II.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES OF SELLER</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a material inducement to Purchaser entering into this Agreement and completing the transactions contemplated by this Agreement and acknowledging
that Purchaser is entering into this Agreement in reliance upon the representations and warranties of Seller set forth in this <U>Article
II</U>, Seller hereby represents and warrants to Purchaser, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization of Agreement</U>. Seller is a natural
person and has all requisite capacity and authority to execute and deliver this Agreement and each other agreement, document, instrument,
or certificate contemplated by this Agreement to be executed by Seller in connection with the consummation of the transactions contemplated
by this Agreement (collectively, the &ldquo;<B><I>Seller Documents</I></B>&rdquo;), and to consummate the transactions contemplated hereby
and thereby, including the sale and transfer of the Membership Interests to Purchaser. The execution, delivery, and performance of this
Agreement and each of the Seller Documents, and the consummation of the transactions contemplated hereby and thereby, have been duly
authorized and approved by all required action on the part of Seller. This Agreement and each of the Seller Documents to which Seller
is a party have been duly and validly executed and delivered by Seller, and (assuming due authorization, execution, and delivery by the
other parties hereto and thereto) this Agreement and each of the Seller Documents to which Seller is a party constitute legal, valid,
and binding obligations of Seller, enforceable against Seller in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conflicts; Consents of Third Parties</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None of the execution and delivery by Seller of this
Agreement or the Seller Documents, the consummation of the transactions contemplated hereby or thereby, or compliance by Seller with
any of the provisions hereof or thereof will conflict with, or result in any violation of or default (with or without notice or lapse
of time, or both) under, or give rise to a right of termination or cancellation under any provision of (i) any Contract or Permit to
which Seller is a party or by which any of the properties or assets of Seller are bound, (ii) any Order of any Governmental Authority
applicable to Seller or by which any of the properties or assets of Seller are bound, or (iii) any applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 2.02(b)</U>, no consent,
waiver, approval, Order, Permit or authorization of, or registration, declaration or filing with, or notification to, any Person (including
any Governmental Authority) is required on the part of Seller in connection with the execution and delivery of this Agreement, the Seller
Documents, the compliance by Seller with any of the provisions hereof or thereof, or the consummation of the transactions contemplated
hereby or thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Ownership and Transfer of the Membership Interests</U>.
Seller is the record and beneficial owner of the Membership Interests described on <U>Schedule 3.04(a)</U>, in each case, free and clear
of any and all Liens. Seller has the power, authority and legal capacity to sell, transfer, assign, and deliver the Membership Interests
as provided in this Agreement and such delivery will convey to Purchaser good, valid and marketable title to the Membership Interests,
free and clear of any and all Liens. Seller is not a party to any voting trust, proxy, or other agreement or understanding between or
among any Persons that affects or relates to the voting or giving of written consent with respect to the Membership Interests. There
are no preemptive rights, co-sale rights, rights of first refusal, management equity holder transfer restrictions, or similar rights
with respect to the Membership Interests to which Seller may be entitled, or that Seller has granted to any other Person, in relation
to the sale and purchase of the Membership Interests hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Litigation</U>. There is no Legal Proceeding pending
or, to the Knowledge of Seller, threatened against Seller or to which Seller is otherwise a party relating to this Agreement, the Seller
Documents or the transactions contemplated hereby or thereby. Seller is not subject to any outstanding Order that affects or could reasonably
be expected to affect Seller&rsquo;s direct or indirect ownership of the Membership Interests or right or ability to perform his obligations
under this Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Brokers&rsquo; Fees and Commissions</U>. Except as
set forth on <U>Schedule 2.05</U>, no Person has acted, directly or indirectly, as an investment banker, broker, financial advisor or
finder for Seller in connection with the transactions contemplated by this Agreement, and no Person is or will be entitled to any fee
or commission or like payment in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">2.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities Matters; Investigation; Non-Reliance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller acknowledges that the information supplied by
Seller in the warranties contained herein will be relied upon by Purchaser in concluding that the Stock Consideration has been issued
pursuant to Section 4(a)(2) of the Securities Act or another exemption from the registration requirements of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an &ldquo;accredited investor&rdquo; as defined in Rule
501(a) of Regulation D;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not receiving the Stock Consideration as a result of
any &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as those terms are defined in Regulation D); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">receiving the Stock Consideration for his own account
with no intention of distributing the Stock Consideration or an amount thereof, or any arrangement or understanding with any other Persons
regarding the distribution of such Stock Consideration or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller is sufficiently aware of Purchaser&rsquo;s business
affairs and financial condition to reach an informed and knowledgeable decision to receive the Stock Consideration. Seller acknowledges
that information regarding Purchaser is publicly available via the SEC&rsquo;s website (www.sec.gov). Seller has made its own investment
decision to receive the Stock Consideration based on its own knowledge and information which is publicly available, including Purchaser
SEC Documents, with respect to the Stock Consideration of Purchaser, as well as the written warranties of Purchaser pursuant to <U>Article
4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
III.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES RELATING TO THE COMPANY</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a material inducement to Purchaser&rsquo;s entering into this Agreement and completing the transactions contemplated by this Agreement
and as an acknowledgment that Purchaser is entering into this Agreement in reliance upon the representations and warranties set forth
in this <U>Article III</U>, Seller represents and warrants to Purchaser that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Organization and Good Standing</U>. The Company is
a limited liability company, duly organized, validly existing, and in good standing under the Laws of the State of Delaware. The Company
has all requisite corporate power and capacity and is duly qualified to own, operate and lease its properties in each jurisdiction in
which it owns, operates or leases property, to carry on the business as it is presently being conducted and as currently proposed to
be conducted, and is qualified or licensed to do business and is in good standing in every jurisdiction where the business, as it is
presently being conducted, requires such qualification or license (and such jurisdictions are set forth on <U>Schedule 3.01</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization and Agreement</U>. The Company has
all requisite limited liability company power and authority and has taken all limited liability company action required to execute and
deliver this Agreement and each other agreement, document, instrument, or certificate contemplated by this Agreement or to be executed
by the Company in connection with the transactions contemplated by this Agreement (collectively, the &ldquo;<B><I>Company Documents</I></B>&rdquo;),
to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution,
delivery, and performance of this Agreement and each of the Company Documents, and the consummation of the transactions contemplated
hereby and thereby, have been duly authorized and approved by all requisite action on the part of the Company. This Agreement and each
of the Company Documents has been duly and validly executed and delivered by the Company, and (assuming the due authorization, execution,
and delivery by the other parties hereto and thereto) this Agreement and each of the Company Documents constitute legal, valid, and binding
obligations of the Company, enforceable against the Company in accordance with their respective terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conflicts; Consents of Third Parties</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 3.03(a)</U>, none
of the execution and delivery by the Company of this Agreement or the Company Documents, the consummation of the transactions contemplated
hereby or thereby, or compliance by the Company with any of the provisions hereof or thereof will: (i) conflict with, or result in any
violation or breach of, or default (with or without notice or lapse of time, or both) under, (ii) give rise to a right of termination,
cancellation, or acceleration of any obligation or the loss of a material benefit under, (iii) give rise to any obligation of the Company
to make any payment under, or to increase, accelerate, or guarantee any rights or entitlements of any Person under, or (iv) result in
the creation of any Liens upon any of the properties or assets of the Company, in each case, under or pursuant to, as applicable, any
provision of (A) the articles of formation and limited liability company agreement or comparable organizational documents of the Company,
(B) any Material Contract or Permit to which the Company is a party or by which any of the properties or assets of the Company are bound,
(C) any approval or certification of the Company by any prime contractor, higher tier subcontractor or reseller to any Governmental Authority,
(D) any Order applicable to the Company or any of the properties or assets of the Company, or (E) any applicable Law, except, in the
case of clauses (B), (D) and (E), as would not and would not reasonably be expected to, individually or in the aggregate, (x) adversely
impact the business of the Company as presently conducted in any material respect, or (y) prevent or materially impair or delay (1) the
Company&rsquo;s ability to consummate the transactions contemplated by this Agreement or any of the Company Documents or (2) the Company&rsquo;s
performance of its obligations hereunder or thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 3.03(b)</U>, no consent,
waiver, approval, Order, Permit or authorization of, or registration, declaration or filing with, or notification to, any Person (including
any Governmental Authority) is required on the part of the Company in connection with (i) the execution and delivery of this Agreement
or the Company Documents, the compliance by the Company with any of the provisions hereof and thereof, or the consummation of the transactions
contemplated hereby or thereby, or (ii) the continuing validity and effectiveness immediately following the Closing of any Permit or
Contract of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capitalization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.04(a)</U> sets forth the authorized, issued,
and outstanding equity interests of the Company. The Membership Interests have been duly authorized for issuance and are validly issued
in accordance with applicable Law, fully paid and non-assessable and were not issued in violation of any purchase or call option, right
of first refusal, subscription right, preemptive right, applicable Law, Contract, the organizational documents of the Company, or any
similar rights. The Membership Interests represent the only issued and outstanding membership interests or other equity interests, including
securities convertible or exercisable into capital stock or other equity interests, of the Company, and all such Membership Interests
have been offered, sold and delivered by the Company in compliance with all applicable federal and state securities Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 3.04(b)</U>, there
are no outstanding subscriptions, options, warrants, rights (including preemptive rights), calls, convertible securities or other agreements
or commitments of any character obligating the Company to issue, redeem, sell, transfer, vote or otherwise dispose of any equity securities
of any kind. There are no obligations, contingent or otherwise, of the Company to (i) repurchase, redeem, or otherwise acquire any shares,
membership interests, capital stock or other securities of any Person, (ii) provide material funds to, or make any material investment
in (in the form of a loan, capital contribution or otherwise), or provide any guarantee with respect to the obligations of, any Person,
or (iii) form any legal entity. There are no outstanding equity appreciation, phantom equity, profit participation, or similar rights
with respect to the Company. There are no bonds, debentures, notes, or other Indebtedness of the Company having the right to vote or
consent (or, convertible into, or exchangeable for, securities having the right to vote or consent) on any matters on which members (or
other equity holders) of the Company may vote. There are no voting trusts, irrevocable proxies, or other Contracts or understandings
to which the Company or Seller is a party or is bound with respect to the voting or consent of any of the Membership Interests or any
other equity interests of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not made an assignment in favor of its
creditors or a proposal in bankruptcy to its creditors or any class thereof nor had any petition for a receiving order presented in respect
of it. No receiver has been appointed in respect of the Company or any of its property or assets, and no execution or distress has been
levied upon any of the property or assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.04(d)</U> contains a complete and accurate
list of: (i) all Indebtedness of the Company and separately indicates all such Indebtedness that is owed by the Company to Seller or
a Related Person, and (ii) all obligations of the Company for the reimbursement of any obligor under any letter of credit, banker&rsquo;s
acceptance, surety bond or similar credit transaction, contingent or otherwise. The Company is not insolvent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Subsidiaries</U>. The Company is the record and
beneficial owner of the JV Interests free and clear of any and all Liens. Except for the Company&rsquo;s ownership of the JV Interests,
the Company has no Subsidiaries, nor does the Company own, directly or indirectly, any equity, partnership, membership interest in, or
other equity, voting or economic interest in, or any interest convertible into, exercisable for the purchase of, or exchangeable for
any such equity, partnership, membership interest, other equity, voting or economic interest, or is under any current or prospective
obligation to form or participate in, provide funds to, make any loan, capital contribution or other investment in, any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial Statements; No Undisclosed Liabilities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has Made Available copies of (i) the unaudited
balance sheets of the Company as of December 31, 2020 and 2021 and the related unaudited statements of income and cash flows of the Company
for the twelve (12)-month fiscal periods then ended, and (ii) the unaudited balance sheet of the Company as of February 28, 2022 and
the related unaudited statements of income and cash flows of the Company for the two (2)-month period then ended (such balance sheets
and statements referred to in subsections (i) and (ii) immediately above, including the related notes and schedules thereto, are referred
to herein as the &ldquo;<B><I>Financial Statements</I></B>&rdquo;). Each of the Financial Statements is complete and correct in all material
respects and has been prepared in accordance with the Accounting Principles and consistent with past practice, and fairly presents the
financial position, results of operations, and cash flows, as applicable, of the Company as at the dates and for the periods indicated
therein. The unaudited balance sheet and financial statements described in clause (ii) of the first sentence of this <U>Section 3.06(a)
</U>is referred to herein as the &ldquo;<B><I>Interim Financial Statements</I></B>&rdquo; and February 28, 2022 is referred to herein
as the &ldquo;<B><I>Balance Sheet Date</I></B>.&rdquo; The Company does not have any Indebtedness or Liabilities (whether or not required
under GAAP to be reflected on a balance sheet or in the notes thereto) other than those (a) specifically reflected on and fully reserved
against in the Interim Financial Statements; or (b) incurred in the Ordinary Course of Business since the Balance Sheet Date that are
not material, individually or in the aggregate, to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.07
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Absence of Certain Developments</U>. Except as expressly
contemplated by this Agreement or as set forth on <U>Schedule 3.07</U>, since the Balance Sheet Date, (a) the Company has conducted its
business only in the Ordinary Course of Business, (b) there has not been any Material Adverse Effect, and (c) the Company has not suffered
any material loss, damage, destruction or other casualty affecting any of its material properties or assets, whether or not covered by
insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.08
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Legal Proceedings</U>. Except as set forth on <U>Schedule
3.08(1)</U>, there is no Legal Proceeding pending or, to the Knowledge of the Company, threatened against the Company or the Company&rsquo;s
assets, Plans, properties or business (or to the Knowledge of the Company, pending or threatened, against any of the officers, managers,
directors, or Employees of the Company with respect to their business activities on behalf of the Company), or to which the Company is
otherwise a party; nor to the Knowledge of the Company is there any reasonable basis for any such material Legal Proceeding. Except as
set forth on <U>Schedule 3.08(2)</U>, the Company is not subject to any Order, and the Company is not in breach or violation of any Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.09
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Title to Assets; Tangible Personal Property</U>.
The Company has good, valid and marketable legal and beneficial title, or a valid leasehold interest in, all material assets and property
owned or purported to be owned (or, as applicable, leased or licensed or purported to be leased or licensed) by the Company or used in
its business, in each case, free and clear of all Liens. All inventory and all items of tangible personal property used in the business
of the Company (i) are in good operating condition, free from material defects, and in a state of good maintenance and repair (ordinary
wear and tear excepted) and (ii) are adequate and suitable for the purposes used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.10
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Real Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not own and has never owned any real
property. <U>Schedule 3.10(a)</U> sets forth a complete list of all real property and interests in real property leased, subleased or
licensed by the Company (individually, a &ldquo;<B><I>Company Property</I></B>&rdquo; and collectively, the &ldquo;<B><I>Company Properties</I></B>&rdquo;),
including a description of each lease, sublease or license applicable to each of the Company Properties (individually, a &ldquo;<B><I>Real
Property Lease</I></B>&rdquo; and collectively, the &ldquo;<B><I>Real Property Leases</I></B>&rdquo;). Except as to that certain lease
wherein HT Medical, LLC and Seller are co-lessees, there are no parties in possession at the Company Properties other than the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a valid, binding and enforceable leasehold
interest under each of the Real Property Leases under which it is a lessee, free and clear of all Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the Company Properties is (i) in material compliance
with all applicable legal requirements, covenants, conditions and restrictions affecting the applicable portion of such Company Property,
and (ii) benefited by all easements and rights necessary to conduct the business thereon consistent with the Ordinary Course of Business,
including easements for utilities, services, roadway and other means of ingress and egress. Each of the Company Properties is zoned for
a classification that permits the continued use of such property in the manner of its current use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.11
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Material Contracts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Schedule 3.11(a)</U> sets forth, by reference to the applicable subsection of this <U>Section 3.11(a)</U>, all of the following Contracts
to which the Company is a party or by which the Company or its respective assets or properties are bound (collectively, including all
such Contracts required to be disclosed on <U>Schedule 3.11(a)</U> (whether or not disclosed), the &ldquo;<B><I>Material Contracts</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Contracts with Seller, any of his Affiliates or any current or former Related Person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Intellectual Property Licenses, except licenses of commercial off-the-shelf Software or Technology available on reasonable terms for
a license fee of no more than $10,000;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Contracts containing (A) covenants of the Company not to compete with any Person in any line of business, industry or geographical area
or restricting the solicitation, engagement or hiring of any Person or otherwise materially restricting the operation of the Company,
or (B) covenants of any other Person not to compete with the Company in any line of business, industry, or in any geographical area or
restricting the solicitation, engagement or hiring of any Person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Contracts relating to (A) Indebtedness, (B) the acquisition (by merger, purchase of equity, or assets or otherwise) of any operating
business, material assets, capital stock or equity securities of any other Person, or (C) the sale of any of the assets of the Company
other than in the Ordinary Course of Business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Contracts (or group of related Contracts) which (A) involve the expenditure of more than $50,000 annually or $100,000 in the aggregate,
or (B) require the Company to purchase or sell a stated portion of its requirements or outputs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Contracts involving the licensing of any products from third-parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
Contracts (A) providing any preferential rights to purchase assets of the Company, right of first negotiation, right of first refusal,
or similar right to any other Person, or (B) providing any exclusivity rights, that any term of such Contract will be no less favorable
to any other Person either individually or in the aggregate than similar provisions in any other Contract, or any other similar &ldquo;most
favored nation&rdquo; or &ldquo;most favored customer&rdquo; provision in favor of any other Person; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Real Property Leases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the Material Contracts is in full force and effect and is the legal, valid and binding obligation of the Company and of the other
parties thereto enforceable against each of them in accordance with its terms and, will be enforceable upon consummation of the transactions
contemplated by this Agreement. The Company is not in material default under any Material Contract, nor, to the Knowledge of the Company,
is any other party to any Material Contract in material breach of or default thereunder. No party to any of the Material Contracts has
exercised any termination rights with respect thereto, and no party has given notice of any significant dispute with respect to any Material
Contract. The Company has Made Available all of the Material Contracts, together with all amendments, modifications or supplements thereto.
The Company has complied in all material respects with all material terms and conditions of each Material Contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.12
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 3.12(a)</U>, (i)
all Tax Returns required to be filed by or on behalf of Seller and the Company and any affiliated group of which the Company is or was
a member have been duly and timely filed with the appropriate Taxing Authority in all jurisdictions in which such Tax Returns are required
to be filed, and all such Tax Returns are true, complete, and correct, and (ii) all Taxes payable by or on behalf of each Seller and
the Company and any affiliated group of which the Company is or was a member have been fully and timely paid. With respect to any period
for which Tax Returns have not yet been filed or for which Taxes are not yet due or owing, the Company has made due and sufficient accruals
for such Taxes in the Financial Statements and its books and records. All required estimated Tax payments sufficient to avoid any underpayment
penalties or interest have been timely made by or on behalf of the Company. The Company has properly collected and paid all sales Taxes
and similar Taxes required to be collected and paid in any jurisdictions where the Company&rsquo;s products and services are sold or
used and has timely filed all Tax Returns with respect thereto. The Company has complied in all material respects with applicable Laws
relating to Taxes, including the payment and withholding of Taxes (including in connection with amounts paid or owing to any Employee,
Independent Contractor, creditor or other Person) and has timely withheld and paid over to the appropriate Taxing Authority all amounts
required to be withheld and paid under the applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has Made Available complete copies of any
audit report issued by a Taxing Authority within the last six (6) years relating to any Taxes due from or with respect to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any other Person on their behalf
has (i) agreed to or is required to make any adjustments pursuant to Section 481(a) of the Code or any similar provision of Law or has
any Knowledge that any Taxing Authority has proposed any such adjustment, or has any application pending with any Taxing Authority requesting
permission for any changes in accounting methods that relate to the Company, (ii) executed or entered into a closing agreement pursuant
to Section 7121 of the Code or any similar provision of Law with respect to the Company, (iii) requested any extension of time within
which to file any Tax Return, which Tax Return has since not been filed, (iv) granted any extension for the assessment or collection
of Taxes, which remains in effect, or (v) granted to any Person any power of attorney that is currently in force with respect to any
Tax matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not a party to any tax sharing, allocation,
indemnity or similar agreement or arrangement (whether or not written) pursuant to which it will have any obligation to make any payments
for Taxes of another Person after the Closing other than pursuant to commercial agreements entered into in the Ordinary Course of Business
no principal purpose of which relates to taxation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no Contract, agreement, plan, or arrangement
covering any Person that, individually or collectively, could reasonably be expected to give rise to the payment of any amount that would
not be deductible by Purchaser, the Company or any of their respective Affiliates by reason of Section 280G of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not received an any private letter ruling
of the IRS or comparable rulings of any Taxing Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has never been a member of any consolidated,
combined, affiliated or unitary group of corporations for any Tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(h)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no taxable income of the Company that will
be required under applicable Tax Law to be reported by Purchaser or any of its Affiliates, including the Company, for a taxable period
beginning after the Closing Date which taxable income was realized (and reflects economic income) arising prior to the Closing Date as
a result of (i) any &ldquo;intercompany transaction&rdquo; or &ldquo;excess loss account&rdquo; within the meaning of the Treasury Regulations
issued under Section 1502 of the Code (or any corresponding or similar provision of state, local or foreign tax law) with respect to
a transaction occurring on or before the Closing Date, (ii) any installment sale or open transaction disposition made by the Company
on or before the Closing Date; (iii) any deferred revenue or prepaid amount received by the Company on or before the Closing Date or
(iv) the application of Section 965 of the Code. The Company is in compliance with Section 482 of the Code (or any corresponding or similar
provision of applicable state, local or foreign tax law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has disclosed on its federal income Tax
Returns all positions taken therein that could give rise to substantial understatement of federal income tax within the meaning of Section
6662 of the Code. The Company has not participated in any &ldquo;reportable transaction&rdquo; within the meaning of Treasury Regulation
Section 1.6011-4(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(j)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not deferred any payroll or employment
Taxes of the Company to a period following the Closing Date pursuant to the CARES Act or other legislation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.13
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compliance with Laws; Permits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in compliance, and has been in compliance
for the past six (6) years, in all material respects with all Laws applicable to its business, operations, assets, properties, employees
or independent contractors, including all Laws relating to the employment of labor, the CARES Act, the Foreign Corrupt Practices Act,
the Laws promulgated, monitored or enforced by the U.S. Office of Foreign Assets, any other applicable anti-bribery, anti-money laundering,
or Anti-Corruption Laws and Environmental Laws. To the Knowledge of the Company, the Company is not under investigation with respect
to the violation of any Laws and there are no facts or circumstances which could form the basis for any such violation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has all certificates of occupancy, Permits,
and/or approvals which are required for the operation of, or otherwise material to, its business (&ldquo;<B><I>Company Permits</I></B>&rdquo;),
other than those the failure of which to possess is immaterial. All Company Permits are in full force and effect, and the Company is
not in default or violation, and no event has occurred which, with or without notice or the lapse of time or both, would reasonably be
expected to constitute a default or violation, in any material respect of any term, condition or provision of any Company Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.14
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial Advisors</U>. Except as set forth on <U>Schedule
3.14</U>, no Person has acted, directly or indirectly, as a broker, finder, or financial advisor for the Company in connection with the
transactions contemplated by this Agreement and no Person is or will be entitled to any fee or commission or like payment in respect
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.15
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intellectual Property; Data Security; Privacy</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.15(a)</U> sets forth an accurate and complete
list of all Internet domain names, Patents, registered Marks, pending applications for registration of Marks, material unregistered Marks,
registered Copyrights, pending applications for registration of Copyrights, Software, and material unregistered copyrightable works that
are Company Intellectual Property. <U>Schedule 3.15(a)</U> lists (i) the jurisdictions, as applicable, in which each such item of Company
Intellectual Property has been issued, registered, otherwise arises or in which any such application for such issuance and registration
has been filed and (ii) the registration or application number and date, as applicable. All Company Intellectual Property is valid, subsisting
and enforceable. No interference, opposition, reissue, re-examination, post-grant review, or other Legal Proceeding is pending or, to
the Knowledge of the Company, threatened, in which the scope, validity, or enforceability of any Company Intellectual Property is being,
has been, or could reasonably be expected to be contested or challenged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth on <U>Schedule 3.15(b)</U> or as
licensed to the Company pursuant to an Intellectual Property License, the Company is the sole and exclusive owner of the Intellectual
Property used in the conduct of the business of the Company as presently conducted. The Company has a right to use any Technology or
Intellectual Property used by the Company in the business of the Company as presently conducted. The Company owns each of the inventions
and works of authorship, conceived, reduced to practice, created, or prepared by or for the Company that resulted from or arose out of
any work performed by or on behalf of the Company by Seller, any Employee, former Employee, officer, or any consultant or contractor
of the Company, in each case, free and clear of all Liens or obligations to others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company Intellectual Property, the Company Technology,
and the design, development, manufacturing, licensing, marketing, distribution, offer for sale, sale or use or maintenance of any products
and services in connection with the business of the Company as previously, presently and as currently proposed to be conducted, and the
past, present and currently proposed business practices, methods, and operations of the Company have not and do not infringe (directly,
contributorily, by inducement or otherwise), constitute an unauthorized use of, misappropriate, dilute or violate any Intellectual Property
right or other right of any Person (including, pursuant to any non-disclosure agreements or obligations to which the Company or any of
its Employees or former Employees is a party). To the Knowledge of the Company, no Person has infringed, misappropriated or otherwise
violated, and no Person is currently infringing, misappropriating or otherwise violating, any Company Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except with respect to licenses of commercial off-the-shelf
Software or as set forth on <U>Schedule 3.15(d)</U>, the Company is not required, obligated, or under any Liability whatsoever, to make
any payments by way of royalties, fees, or otherwise to any owner, licensor of, or other claimant to, any Intellectual Property, or any
other Person, with respect to the use thereof or in connection with the conduct of their respective businesses as currently conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has taken adequate security measures to
protect the secrecy, confidentiality, and value of all the Trade Secrets included in the Company Intellectual Property and any other
non-public, proprietary information included in the Company Technology, which measures are reasonable in the industry in which the Company
operates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.16
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounts and Notes Receivable and Payable</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A complete and accurate list of the accounts receivable
of the Company as of the date that is two (2) Business Days preceding the Closing Date, showing the aging thereof, is included on <U>Schedule
3.16(a)</U>. All accounts and notes receivable of the Company have arisen from bona fide transactions in the Ordinary Course of Business
and are payable on ordinary trade terms. None of the accounts or the notes receivable of the Company (i) are subject to any setoffs or
counterclaims or (ii) represent obligations for goods sold on consignment, on approval or on sale or return basis or subject to any other
repurchase or return arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A complete and accurate list of the accounts payable
of the Company as of the date that is two (2) Business Days preceding the Closing Date, showing the aging thereof, is included on <U>Schedule
3.16(b)</U>. There are no accounts payable of the Company (i) that did not arise in the Ordinary Course of Business, or (ii) that are
materially past due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.17
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Related Persons Transactions</U>. None of Seller
or any Employee, former Employee, current or former officer, director, manager, member or equity holder of the Company, any member of
his or her immediate family, any trust of which any such Person is the grantor, trustee or beneficiary, or any Affiliate of any of the
foregoing (each, a &ldquo;<B><I>Related Person</I></B>,&rdquo; and, collectively, the &ldquo;<B><I>Related Persons</I></B>&rdquo;) (i)
owes any amount to the Company nor does the Company owe any amount to, or has the Company committed to make any loan or extend or guarantee
credit to or for the benefit of, any Related Person, (ii) is involved in any business arrangement or other relationship with the Company
(whether written or oral), (iii) owns any property or right, tangible or intangible, that is used by the Company, (iv) has any claim
or cause of action against the Company, or (v) owns any direct or indirect interest of any kind in, or controls or is a manager, director,
officer, employee or partner of, or consultant to, or lender to, or borrower from, or has the right to participate in, the profits of,
any Person which is a competitor, supplier, service provider, customer, client, landlord, tenant, creditor or debtor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.18
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Environmental Matters</U>. Except as set forth on
<U>Schedule 3.18</U>, there has been no Release or threatened Release of any Hazardous Materials on, at, under, to or about (a) any Company
Property or any property currently operated by the Company, (b) any property formerly owned, operated or leased by the Company, during
the time of such ownership, operation or lease, or (c) any location where Hazardous Materials from the operations or activities of the
Company have come to be located. The Company and its assets and properties (including the Company Property) are, and for the past five
years have been, in compliance with all applicable Environmental Laws. There are no actual, pending, outstanding or threatened Environmental
Claims against the Company or, to the Knowledge of the Seller, any other Person with respect to the Company Property or the other assets
or properties of the Company, and neither Seller nor the Company has received any notice from a Government Authority or other Person
relating to any actual, threatened, outstanding or potential violation of or default under any Environmental Laws or alleging any Environmental
Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.19
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Customers and Suppliers</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set forth on <U>Schedule 3.19(a)(i)</U> are the fifteen
(15) largest customers, by dollar volume, for the Company, during the 2021 calendar year and the period beginning on January 1, 2022
and ending on May 31, 2022 and set forth opposite the name of each such customer is the dollar amount of sales attributable to such customer
for such periods. The Company is not engaged in any material dispute or controversy with any customer. Except as set forth on <U>Schedule
3.19(a)(ii)</U>, no customer has terminated, canceled, or substantially reduced the quantity of products or services it purchases from
the Company or materially modified the commercial terms of its relationship (whether related to payment, price, or otherwise) with the
Company, and to the Knowledge of the Company, no customer intends to take any such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set forth on <U>Schedule 3.19(b)</U> are the fifteen
(15) largest suppliers, by dollar volume, for the Company, during the 2021 calendar year and the period beginning on January 1, 2022
and ending on May 31, 2022 and set forth opposite the name of each such supplier is the dollar amount of purchases attributable to such
supplier for such periods. The Company is not engaged in any material dispute or controversy with any current supplier. No supplier has
terminated, canceled or substantially reduced the quantity of products or services it provides to the Company or materially modified
the commercial terms of its relationship (whether related to payment, price or otherwise) with the Company, and to the Knowledge of the
Company, no supplier intends to take any such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.20
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employee Benefit Plans</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.20(a)</U> contains a true and complete
list of all Plans. The Company has Made Available true and complete copies of all documents that set forth the terms of each Plan and
all Contracts and reports related thereto. Neither the Company nor any ERISA Affiliate maintains or is obligated to provide benefits
under any life, medical or health plan (other than as an incidental benefit under a Plan intended to be &ldquo;qualified&rdquo; within
the meaning of Section 401(a) of the Code (&ldquo;<B><I>Qualified Plan</I></B>&rdquo;)) which provides benefits to retirees or other
terminated employees other than benefit continuation rights under COBRA or any similar state Law. Neither the Company nor any ERISA Affiliate
has at any time contributed to or had any obligation to contribute to or has any Liability, contingent or otherwise, with respect to
any (i) &ldquo;multiemployer plan,&rdquo; as that term is defined in Section 4001 of ERISA, or (ii) &ldquo;employee benefit plan&rdquo;
subject to Title IV of ERISA or Section 412 of the Code. No Plan is a &ldquo;multiple employer welfare arrangement&rdquo; within the
meaning of Section 3(40) of ERISA. No Plan is or has been funded by, associated with or related to (A) a &ldquo;voluntary employee&rsquo;s
beneficiary association&rdquo; within the meaning of Section 501(c)(9) of the Code, or (B) a &ldquo;qualified asset account&rdquo; within
the meaning of Section 419A of the Code. Except as set forth on <U>Schedule 3.20(a)</U>, the Company and its ERISA Affiliates have performed,
in all material respects, all of their obligations under all Plans, and all contributions and other payments required to be made to any
Plan with respect to any period ending before or at or including the Closing Date have been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No transaction contemplated by this Agreement will result
in any Liability to the PBGC under Section 302(c)(ii), 4062, 4063, 4064 or 4069 of ERISA, or otherwise, with respect to the Company or
any ERISA Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for any formal written qualification requirement
with respect to which the remedial amendment period set forth in Section 401(b) of the Code, and any regulations, rulings or other IRS
releases thereunder, has not expired, (i) each Plan that is intended to be a Qualified Plan has received a favorable determination letter
or, in the case of prototype or volume submitter plans, is subject to an opinion or advisory letter, from the IRS and is qualified in
form and operation under Section 401(a) of the Code, and each trust for each such Plan is exempt from federal income tax under Section
501(a) of the Code, and (ii) no event has occurred or circumstance exists that could reasonably be expected to give rise to disqualification
or loss of tax-exempt status of any such Plan or trust.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the execution of this Agreement nor the consummation
of the transactions contemplated hereby will result in &ldquo;excess parachute payments&rdquo; within the meaning of Section 280G(b)
of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">3.21
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Labor Relations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 3.21(a)(1)</U> lists all Employees by name,
position, full-time or part-time status, date of hire, seniority or service credit date if different from initial date of hire, location
of employment, exempt or non-exempt status under the Fair Labor Standards Act, exempt or non-exempt status under any applicable state
Law relating to the payment of daily or weekly overtime, employment status (whether active or on leave of absence), compensation (listing
Employees paid by the hour at the Employee&rsquo;s hourly rate and Employees paid by salary at the Employee&rsquo;s annual salary rate),
bonuses or commissions, benefits, and accrued but unused vacation, sick or other paid leave and the rate at which such vacation, sick
or other paid leave is accrued. <U>Schedule 3.21(a)(2)</U> lists Independent Contractors by name and the terms on which each Independent
Contractor is engaged. No Employee is on long-term disability leave or otherwise an inactive Employee, all Employees are employees at-will,
and no Former Employee has any right to recall or reemployment. To the Knowledge of the Company, no executive or key Employee or group
of Employees plans to terminate employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Employees are represented by any labor organization
or union, and the Company is not a party to, or bound by, any labor, collective bargaining, or similar agreement. No labor organization,
union, or group of Employees has made a pending demand for recognition, and there are no organizational campaigns, representation proceedings,
petitions, or other unionization activities seeking recognition of a collective bargaining unit or seeking a representation proceeding
and no such proceeding or petition is presently pending or threatened to be brought or filed with the National Labor Relations Board
or other labor relations tribunal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has paid or accrued for as of the Closing
Date all salaries and wages, including vacation, bonuses, incentives, break times, differentials, etc. owed to its Employees and former
Employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
IV.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES OF PURCHASER</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser
hereby represents and warrants to Seller as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Organization of Purchaser</U>. Purchaser is a corporation
duly organized, validly existing and in good standing under the Laws of the State of Texas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization</U>. Purchaser has full power and authority
to execute and deliver this Agreement and each other agreement, document, instrument, or certificate contemplated by this Agreement or
to be executed by Purchaser in connection with the consummation of the transactions contemplated hereby and thereby (the &ldquo;<B><U>Purchaser
Documents</U></B>&rdquo;), and to consummate the transactions contemplated hereby and thereby. The execution, delivery, and performance
by Purchaser of this Agreement and each Purchaser Document have been duly authorized by all necessary limited liability company action
on behalf of Purchaser. This Agreement and each Purchaser Document has been duly executed and delivered by Purchaser and (assuming the
due authorization, execution, and delivery by the other parties hereto and thereto) this Agreement and each Purchaser Document constitutes
legal, valid, and binding obligations of Purchaser, enforceable against Purchaser in accordance with their respective terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conflicts; Consents of Third Parties</U>. The execution
and delivery of this Agreement and the Purchaser Documents by Purchaser, the performance by Purchaser of its obligations hereunder and
thereunder, and the consummation by Purchaser of the transactions contemplated hereby and thereby will not <FONT STYLE="color: windowtext">(a)
</FONT>violate or result in any breach of any provision of its Organizational Documents or <FONT STYLE="color: windowtext">(b)</FONT>
conflict with or violate any Law, writ, judgment, injunction or decree, of any court or Governmental Authority applicable to Purchaser
or any of its properties or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Purchaser SEC Documents</U>. Purchaser has filed
all forms, reports, statements, schedules and other documents required to be filed by it with the SEC since December 31, 2021. The Purchaser
SEC Documents (i) at the time they were filed and, if amended, as of the date of such amendment, complied in all material respects with
all applicable requirements of the Securities Act or the Exchange Act or the Sarbanes-Oxley Act of 2002, as amended, as the case may
be, and the rules and regulations promulgated thereunder, and (ii) did not, at the time they were filed, and, if amended, as of the date
of such amendment, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Litigation</U>. There are no Legal Proceedings pending
or, to the Knowledge of Purchaser, threatened that are reasonably likely to prohibit or restrain the ability of Purchaser to enter into
this Agreement or consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial Advisors</U>. Except as set forth on <U>Schedule
4.06</U>, no Person has acted, directly or indirectly, as a broker, finder or financial advisor for Purchaser in connection with the
transactions contemplated by this Agreement and no Person is entitled to any fee or commission or like payment in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">4.07
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities Laws</U>. Assuming Seller&rsquo;s representations
contained in this Agreement are true and correct, the offer and sale of the Purchaser Common Stock comprising the Stock Consideration
(a) are and will be exempt from the registration and prospectus delivery requirements of the Securities Act, (b) have been registered
or qualified (or are exempt from registration and qualification) under the registration, permit or qualification requirements of all
applicable state securities laws, and (c) are and will be accomplished in conformity with all other federal and applicable state securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
V.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>COVENANTS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Competition; Non-Solicitation; Confidentiality</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Compete</U>. Except as otherwise provided for
herein, during the period commencing at the Closing and ending on the fifth anniversary of the Closing Date (the &ldquo;<B><I>Restricted
Period</I></B>&rdquo;), Seller shall not, and shall cause his Affiliates not to, without the express written consent of Purchaser, directly
or indirectly, in any state or political subdivision anywhere in the United States, engage in or assist others in engaging in (i) the
Business or (ii) any other line of business that competes with the Business (the types of businesses described in (i) and (ii) shall
be referred to as the &ldquo;<B><I>Restricted Business</I></B>&rdquo;). For the avoidance of doubt, the covenant in the immediately preceding
sentence prohibits Seller from owning, managing, operating, rendering services to (whether as owner, part-owner, shareholder, member,
partner, director, officer, trustee, executive, employee, agent or consultant, or in any other capacity), participating or investing
in, providing financing to or providing or facilitating the provision of financing to, or assisting, any Person engaged in a Restricted
Business (other than Purchaser); <U>provided</U>, <U>however</U>, that nothing in this <U>Section 5.01(a)</U>, shall prevent or restrict
Seller from any of the following: (i) owning as a passive investment less than 2% of the outstanding securities (whether public or private)
that is engaged in a Restricted Business, provided that Seller is not otherwise associated with such corporation; (ii) owning a passive
equity interest in a private debt or equity investment fund in which Seller does not have the ability to control or exercise any managerial
influence over such fund; or (iii) owning, operating, and managing HT Medical, LLC d/b/a Xenix Medical and Novasol Medical in the ordinary
course of business consistent with past practice; <U>provided</U> that so long as Seller is an officer, owner, or otherwise actively
involved in the business of, HT Medical d/b/a Xenix Medical or Novasol Medical, as the case may be, HT Medical, LLC d/b/a Xenix Medical
and Novasol Medical, as applicable, shall not engage in the Business during the Restricted Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Solicit</U>. During the Restricted Period, Seller
shall not, and shall cause his Affiliates not to, without the express written consent of Purchaser, directly or indirectly (i) solicit
or attempt to solicit any Employees, or any employees of Purchaser or any of its Affiliates, or any former employee of any such Person
who was employed by such Person during the 90-day period immediately preceding the date of such attempt to hire or engage, (ii) encourage
any such employee to terminate his or her relationship or employment with the Company, Purchaser, or any of their respective Affiliates,
(iii) recruit or solicit any customer of the Company, Purchaser or any of their respective Affiliates, or any former customer of any
such Person who was a customer during the twelve (12)-month period immediately preceding the date of such solicitation, for purposes
of providing products or services on behalf of Restricted Business or (iv) divert to any Person any customer or business opportunity
of the Company, Purchaser, or any of their respective Affiliates, for the purpose of engaging in a Restricted Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Disparagement</U>. Seller shall not make or publish,
orally or in writing, any disparaging statements concerning the Company, Purchaser, or any of its respective Affiliates; provided, however,
that nothing in this <U>Section 5.01(d)</U> shall prevent Seller from responding to subpoenas that are valid and enforceable under the
law applicable to this Agreement as issued by a court of law or government agency having jurisdiction over the matter, nor shall anything
in this <U>Section 5.01(d)</U> prohibit Seller from responding to any inquiry initiated and made by any government agency having authority
to initiate and make an inquiry, or from making truthful and accurate statements or disclosures that are required by applicable laws
or other legal processes; <U>provided</U>, <U>however</U>, that in the event disclosure is required by law or sought by way of a government
inquiry, Seller shall provide Purchaser with prompt notice of such requirement so that Purchaser may seek an appropriate protective order
prior to any such required disclosure by Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality</U>. Seller recognize that he has
or previously had access to certain valuable, highly confidential, privileged and proprietary information related to the Business, including,
without limitation, confidential techniques, processes, recipes, formulations, know-how, financial information, Copyrights, Patents,
trademarks, trade names, slogans, logos, designs, service marks, computer software programs, databases, magnetic media, systems and programs,
Trade Secrets, business lists, customer lists, prospects lists, client lists, supplier lists, employee personnel files, engineering data,
marketing data, sales data, logs, consultants&rsquo; reports, budgets, ratings, forecasts, format strategy, financial reports and projections,
tapes and electronic data processing files, accounting journals and ledgers, accounts receivable records and sales, operating, marketing
and business plans and other information concerning the Business regarded as proprietary and confidential (collectively, the &ldquo;<B><I>Confidential
Information</I></B>&rdquo;); <U>provided that</U> &ldquo;Confidential Information&rdquo; shall not include any information or material:
(A) to the extent that such information or material is filed with any governmental agency on a non-confidential basis or is or becomes
generally available to the public or the trade other than as a result of a wrongful disclosure by Seller; (B) to the extent such information
is received in good faith by Seller after the date of this Agreement from a third party who is not under an obligation of confidentiality
or is not otherwise prohibited from transmitting such information to Seller by a contractual, legal or fiduciary obligation; or (C) to
the extent that such information or material is subject to a subpoena, summons or other legal process (provided that in such case, Seller
shall immediately give Purchaser notice of the circumstances surrounding such compelled disclosure and an opportunity to seek an appropriate
protective order with respect thereto and in no event make disclosure before the compliance date set forth in the subpoena or other request
for production). Seller covenants and agrees that he shall not, at any time, including during the Restricted Period or thereafter, directly
or indirectly, (I) communicate, divulge, disclose, furnish or make accessible to any Person, whether or not in competition with the Company
or Purchaser, or any of its respective Affiliates, and whether or not for pecuniary gain, any aspect of the Confidential Information,
or (II) reproduce, recreate or use any Confidential Information, except pursuant to a subpoena or order issued by a court of competent
jurisdiction (<U>provided</U> that in such event, Seller shall (x) immediately give Purchaser notice of the circumstances surrounding
such compelled disclosure in order to provide Purchaser an opportunity to seek an appropriate protective order with respect thereto and
(y) in no event make disclosure before the compliance date set forth in the subpoena or other request for production). For the avoidance
of doubt, nothing herein will preclude Seller from using Confidential Information in the course of and only for the purpose of providing
services to the Company, Purchaser, or their respective Affiliates. Nothing in this <U>Section 5.01(e)</U> shall prevent Seller from
disclosing Confidential Information to the extent necessary for it to enforce or exercise its rights under this <U>Section 5.01(e)</U>
or in connection with any other Legal Proceeding. Seller hereby acknowledges that the unauthorized use or disclosure of Confidential
Information will seriously damage Purchaser and the Company in its operation of the Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller hereby acknowledges and agrees that a breach
of any of the covenants as set forth in this <U>Section 5.01</U> will cause irreparable damage to Purchaser or its Affiliates, as applicable,
incapable of measurement, and that the remedy at law for such breach may be inadequate to compensate such Person for its losses. Therefore,
in the event of any such breach, in addition to any other rights and remedies available to such Person at law, in equity or otherwise,
Purchaser or its Affiliates, as applicable, shall be entitled to a temporary restraining order and other injunctive relief, including
without limitation interim, interlocutory, preliminary and permanent injunctions, without posting bond or other security, in order to
restrain Seller from breaching or continuing any breach of any of the provisions of the covenants set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No claim against Purchaser or its Affiliates by Seller
under this Agreement or otherwise shall constitute a defense to the enforcement by Purchaser of the covenants and obligations in this
<U>Section 5.01</U>. In the event of any actual or threatened violation of the covenants and obligations under this <U>Section 5.01</U>
by Seller or any other action arising from or related to this <U>Section 5.01</U>, Purchaser shall be entitled to recover its reasonable
attorneys&rsquo; and witness fees and all costs and expenses associated with the enforcement of any provision of this <U>Section 5.01
</U>or concerning such action in addition to any other available legal or equitable remedies. If any court of competent jurisdiction
finds that Seller has breached any of its covenants or obligations under this <U>Section 5.01</U>, the time period during which such
covenants and obligations are effective shall be suspended and shall not run in favor of Seller from the date of such breach until the
date when such breach is cured or remedied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(g)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Parties agree that the provisions of this <U>Section
5.01</U> are severable, and each covenant is independent and separately given. The Parties further agree that, if any court of competent
jurisdiction in a final non-appealable judgment determines that a specified time period, a specified geographical area, a specified business
limitation or any other relevant feature of this <U>Section 5.01</U> is invalid or unenforceable in any respect, such unenforceable provision
of this <U>Section 5.01</U> shall be deemed to have been modified so as to be valid and enforceable to the fullest extent permitted at
law, and any such invalidity and unenforceability shall not affect any other provisions of this Agreement, all of which shall be fully
carried out and enforced as if such invalid or unenforceable provision had not been set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(h)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller has carefully considered the covenants set forth
in this <U>Section 5.01</U> and Seller agrees that, under all circumstances, the restrictions set forth in this <U>Section 5.01</U> are
fair and reasonable and required for protection of the legitimate interests of Purchaser and are a material and necessary part of the
transactions contemplated by this Agreement. Seller further agrees that the restrictions set forth herein are reasonable in scope, area
and time, and will not prevent Seller from pursuing other noncompetitive business ventures or otherwise cause a financial hardship to
Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller acknowledges that their covenants and obligations
in this <U>Section 5.01</U> have been a material inducement for Purchaser to consummate this Agreement. Accordingly, Seller irrevocably
waives any right existing as of the Closing Date or arising in the future to (i) file any declaratory judgment or similar action seeking
to declare unenforceable any covenant or obligations under this <U>Section 5.01</U> or challenge the validity of such covenants or obligations;
(ii) otherwise contest the enforceability of any such covenants or obligations as being unreasonable or unenforceable; or (iii) assert
any defenses to any action or effort by Purchaser or its Affiliates, as applicable, to enforce any such covenants or obligations based
on their reasonableness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(j)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The rights and remedies provided by this <U>Section
5.01</U> are cumulative and in addition to any other rights and remedies which Purchaser may have hereunder or at Law or in equity. In
the event that Purchaser were to seek damages for any breach of this <U>Section 5.01</U>, the portion of the Purchase Price that is allocated
by the Parties to the foregoing covenant shall not be considered a measure of or limit on such damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Public Announcements</U>. Seller shall not issue
any press release or public announcement concerning this Agreement or the transactions contemplated hereby without obtaining the prior
written approval of Purchaser, which approval will not be unreasonably withheld, conditioned or delayed, unless, as mutually agreed to
in good faith by Purchaser and Seller, disclosure is otherwise required by applicable Law; <U>provided</U>, that, to the extent required
by applicable Law, the party intending to make such release shall use its commercially reasonable efforts consistent with such applicable
Law to consult with Purchaser with respect to the text thereof; <U>provided</U>, <U>further</U>, that Purchaser may issue any press release
or public announcement concerning this Agreement or the transactions contemplated hereby without obtaining the prior written approval
of Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Tax Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Filing of Tax Returns; Payment of Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller will file or cause to be filed (with reasonable
assistance from the Company), all Tax Returns of the Company for all taxable periods ending on or before the Closing Date, and shall
timely pay any and all Taxes due with respect to such returns. All Tax Returns described in this <U>Section 5.03(a)(i)</U> shall be prepared
in a manner consistent with prior practice. Seller shall provide Purchaser with copies of such completed Tax Returns at least 20 Business
Days prior to the due date for filing thereof, along with supporting workpapers, for Purchaser&rsquo;s review and approval. Seller and
Purchaser shall attempt in good faith to resolve any disagreements regarding such Tax Returns prior to the due date for filing. In the
event that Seller and Purchaser are unable to resolve any dispute with respect to such Tax Returns at least 10 days prior to the due
date for filing, such dispute shall be resolved pursuant to <U>Section 5.03(e)</U>, which resolution shall be binding on the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the Closing, Purchaser shall cause the Company
to timely file all Tax Returns (other than those Tax Returns described in <U>Section 5.03(a)(i)</U>) required to be filed by the Company
after the Closing Date and, subject to the right to payment from Seller under <U>Section 5.03(a)(iii)</U>, pay or cause to be paid all
Taxes shown due thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not later than 10 days prior to the due date for the
payment of Taxes on any Tax Returns which Purchaser has the responsibility to cause to be filed pursuant to <U>Section 5.03(a)(ii)</U>,
Seller shall pay to Purchaser the amount of Taxes, as reasonably determined by Purchaser, owed by Seller and/or Owners pursuant to the
provisions of this <U>Section 5.03(a)</U>. No payment pursuant to this <U>Section 5.03(a)(iii)</U> shall excuse Seller from his indemnification
obligations pursuant to <U>Article VI</U> if the amount of Taxes as ultimately determined (on audit or otherwise) for the periods covered
by such Tax Returns exceeds the amount of Seller&rsquo;s payment under this <U>Section 5.03(a)(iii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Straddle Period Tax Allocation</U>. In any case in
which a Tax is assessed with respect to a taxable period which includes the Closing Date, but does not begin or end on that day (a &ldquo;<B><I>Straddle
Period</I></B>&rdquo;), the Taxes, if any, attributable to a Straddle Period shall be allocated (i) to Seller for the period up to and
including the Effective Time, and (ii) to the Company for the period subsequent to the Effective Time; <U>provided</U>, that any Tax
liability arising on the Closing Date that arises from an action of the Company caused by Seller that is not in the Ordinary Course of
Business, shall be allocated to Seller. Any allocation of income or deductions required to determine any Taxes attributable to a Straddle
Period shall be made by means of a deemed closing of the books and records of the Company as of the Effective Time; <U>provided</U>,
that exemptions, allowances or deductions that are calculated on an annual basis (including, depreciation and amortization deductions)
shall be allocated between the period ending on the Effective Time and the period after the Effective Time in proportion to the number
of days in each such period. Notwithstanding the foregoing, property or ad valorem taxes attributable to a Straddle Period shall be allocated
to the period ending on the Closing Date and the period after the Closing Date in proportion to the number of days in each such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Tax Audits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If notice of any Legal Proceeding with respect to Taxes
of the Company (a &ldquo;<B><I>Tax Claim</I></B>&rdquo;) shall be received by the Company or Purchaser for which Seller may reasonably
be expected to be liable pursuant to <U>Section 6.02(a)</U> or this <U>Section 5.03</U>, Purchaser shall notify Seller in writing of
such Tax Claim; <U>provided</U>, that the failure of Purchaser to give Seller notice as provided herein shall not relieve Seller of his
obligations under this <U>Section 5.03</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser shall have the right, at the expense of Seller
to the extent such Tax Claim is subject to indemnification by Seller pursuant to <U>Section 6.02(a)(iv)</U>, to represent the interests
of the Company in any Tax Claim; <U>provided</U>, that with respect to a Tax Claim relating exclusively to taxable periods ending on
or before the Effective Time, Purchaser shall not settle such claim without the consent of Seller, which consent shall not be unreasonably
withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer Taxes</U>. Seller shall (a) be responsible
for and shall pay or cause to be paid any and all sales, use, stamp, documentary, filing, recording, transfer, real estate transfer,
stock transfer, gross receipts, registration, duty, securities transactions or similar fees or Taxes or governmental charges (together
with any interest or penalty, addition to tax or additional amount imposed) as levied by any taxing authority in connection with the
transactions contemplated by this Agreement (collectively, &ldquo;<B><I>Transfer Taxes</I></B>&rdquo;), regardless of the Person liable
for such Transfer Taxes under applicable Law, and (b) timely file or caused to be filed all necessary documents (including all Tax Returns)
with respect to Transfer Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disputes</U>. Any dispute as to any matter covered
in this <U>Section 5.03</U> shall be resolved by the Independent Accountant. If any dispute with respect to a Tax Return is not resolved
prior to the due date of such Tax Return, such Tax Return shall be filed in the manner which the party responsible for preparing such
Tax Return deems correct. The fees, costs, and expenses of the Independent Accountant shall be allocated to and borne by Purchaser, on
the one hand, and Seller, on the other hand, based on the inverse of the percentage that the Independent Accountant&rsquo;s determination
(before such allocation) bears to the total amount of the total items in dispute as originally submitted to the Independent Accountant.
For example, should the items in dispute total in amount to $1,000 and the Independent Accountant awards $600 in favor of Seller&rsquo;s
position, 60% of the costs of its review would be borne by Purchaser and 40% of the costs would be borne by Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use of Name</U>. Seller hereby agrees that upon the
Closing, the Company shall have the sole right to the use of the name &ldquo;Scendia Biologics, LLC&rdquo; and any service marks, trademarks,
trade names, d/b/a names, fictitious names, identifying symbols, logos, emblems, signs, or insignia related thereto or containing or
comprising the foregoing, or otherwise used in the business of the Company, and the trademarks and service marks listed on <U>Schedule
3.15(b)</U> (collectively, the &ldquo;<B><I>Company Marks</I></B>&rdquo;), in each case to the extent that Seller or the Company have
a right to use such Company Marks prior to the Closing. Following the Closing, Seller shall not, and shall not permit his respective
Affiliates to, use such names or any substantially similar variation or simulation thereof or any of the Company Marks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Customer and Other Business Relationships; Warranty
Administration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the Closing, Seller shall refer to the Company
all inquiries relating to the Business. Seller shall not take any action that would tend to diminish the value of the Business after
the Closing or that would interfere with the business of the Company to be engaged in after the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After the Closing, the Company shall administer, acting
commercially reasonably and in accordance with applicable Company warranty policies and procedures, any warranty claims arising out of
or received by it in accordance with commercially reasonable practices, policies and procedures, and may, at any time by written notice
to Seller, request reimbursement for the amounts associated with such administration of the portion (which may be all) of such warranty
claim that arise out of underlying events, actions or failures to act occurring or existing during the period prior to the Closing Date
or arise out of any breach or violation of, or default under or noncompliance with (with or without notice or lapse of time) the applicable
Contract prior to the Closing, which amounts, if so requested, shall be paid by Seller in accordance with <U>Article VI</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Insurance Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the Closing Date, Seller shall reasonably
cooperate with and assist Purchaser to cause any carrier that has underwritten any global, primary casualty, and excess liability insurance
policies that provide insurance coverage to the Company on an &ldquo;occurrence&rdquo; basis (the &ldquo;<B><I>Occurrence Policies</I></B>&rdquo;)
to continue to make coverage available to the Company following the Closing Date for claims arising out of occurrences prior to the Closing
Date. Seller acknowledges the right of Purchaser, to the extent provided pursuant to any applicable insurance policies, to access the
benefit of insurance for such pre-Closing occurrences under the historic Occurrence Policies which have provided coverage to the Company,
to issue notice of claims under any Occurrence Policies, to present such claims for payment and to collect insurance proceeds related
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.07
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Preservation of Tax Records</U>. Subject to any internal
document retention policies of Purchaser and any retention requirements relating to the preservation of Tax records, Seller and Purchaser
agree that each of them shall (and shall cause their respective Affiliates, including the Company, to) preserve and keep the records
held by them or their Affiliates relating to the Business for a period of seven years from the Closing Date and shall make such records
and personnel available to the other as may be reasonably required by such Party in connection with, among other things, any insurance
claims by, Legal Proceedings against or governmental investigations of Seller, the Company or Purchaser or any of their respective Affiliates
or in order to enable Seller, the Company or Purchaser to comply with their respective obligations under this Agreement and each other
agreement, document or instrument contemplated hereby or thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.08
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Further Assurances</U>. At or after Closing, and
without further consideration, Seller will execute and deliver to Purchaser such further instruments of conveyance and transfer as Purchaser
may reasonably request to more effectively convey and transfer the Membership Interests to Purchaser, free and clear of all Liens and
subject to no legal or equitable restrictions of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">5.09
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreements Regarding Purchaser Common Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller irrevocably agrees, in consideration of the benefit
that the transactions contemplated hereby will confer, that following the Closing, Seller shall not transfer any shares of Purchaser
Common Stock received as Stock Consideration or Earnout Amount (the &ldquo;<B><I>Lockup Securities</I></B>&rdquo;), at any time during
the period commencing on the Closing Date and ending on the one-year anniversary of the Closing Date (the &ldquo;<B><I>Lockup Period</I></B>&rdquo;)
without Purchaser&rsquo;s prior written consent. For purposes of this <B>&lrm;</B><U>Section 5.09</U>, &ldquo;transfer&rdquo; (and all
correlative terms) means, as to any Lockup Securities, a direct or indirect (including through the use of any derivative or swap instrument
or arrangement) sale, assignment, conveyance, gift, exchange, pledge, encumbrance, Contract to sell, lease or other disposition or transfer
(or offer to do any of the foregoing) of such Lockup Securities, whether effected voluntarily, involuntarily or by operation of Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller agrees and consents to the entry of stop transfer
instructions with Purchaser&rsquo;s transfer agent and registrar against the transfer of the Lockup Securities, except in compliance
with the restrictions set forth in this Agreement. In furtherance of the foregoing, any book entries evidencing shares of Purchaser Common
Stock subject to the provisions of this Agreement shall include legends legally required, including a legend to the effect that the shares
of Purchaser Common Stock have not been registered under the Securities Act and are subject to certain legal and contractual restrictions
on transfer (including lockup restrictions), and similar instructions shall be provided to Purchaser&rsquo;s transfer agent. Purchaser
shall cause the legends referenced in the foregoing sentence to be removed promptly following the expiration of the Lockup Period and
will otherwise provide reasonable cooperation to facilitate any transfer by Seller (or its Affiliates) of the Lockup Securities (in accordance
with the limitations and restrictions set forth herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
VI.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INDEMNIFICATION</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Survival of Representations, Warranties and Covenants</U>.
The representations and warranties of the Parties contained in this Agreement or any Ancillary Agreement shall survive the Closing through
and including the 12-month anniversary of the Closing Date (the &ldquo;<B><I>General Survival Period</I></B>&rdquo;); <U>provided</U>,
that (a) (i) the Fundamental Representations shall survive the Closing through and including the later to occur of: (A) the date that
is six months following the expiration of the applicable statute of limitations with respect to a particular matter that is the subject
matter thereof, and (B) the date that is six months following the completion of any administrative audit and any subsequent administrative
proceeding or Legal Proceeding respecting the Company related to any taxable period ending before the Closing Date, and (b) any claim
with respect to Fraud shall survive the Closing and can be made by a Purchaser Indemnified Party or a Seller Indemnified Party indefinitely.
The respective covenants, agreements and obligations of Seller and Purchaser made in or pursuant to this Agreement will survive for the
respective term specified in such covenant, agreement or obligation, or, if not specified, indefinitely. The period of time a representation,
warranty, covenant, agreement or obligation survives the Closing pursuant to this <U>Section 6.01</U> shall be the &ldquo;<B><I>Survival
Period</I></B>&rdquo; with respect to such representation, warranty, covenant, agreement or obligation. In the event that notice of any
claim for indemnification under this <U>Article VI</U> shall have been given in accordance with the provisions of this Agreement within
the applicable Survival Period and such claim has not been finally resolved by the expiration of such Survival Period, the representations,
warranties, covenants, agreements or obligations that are the subject of such claim shall survive for the limited purpose of resolving
such claim until such matters are finally resolved. It is the express intent of the Parties that, (1) if an applicable Survival Period
as contemplated by this <U>Section 6.01</U> is shorter than the statute of limitations that would otherwise have been applicable, then,
by Contract, the applicable statute of limitations shall be reduced to the applicable Survival Period contemplated hereby and (2) if
an applicable Survival Period as contemplated by this <U>Section 6.01</U> is longer than the statute of limitations that would otherwise
have been applicable, then, by Contract, the applicable statute of limitations shall be increased to the longer Survival Period contemplated
hereby. The Parties further acknowledge that the time periods set forth in this <U>Section 6.01</U> for the assertion of claims under
this Agreement are the result of arms&rsquo;-length negotiations among the Parties and that they intend for the time periods to be enforced
as agreed by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Closing, the Seller shall indemnify
and hold Purchaser, the Company, their respective Affiliates, and their respective current and former directors, managers, officers,
employees, equity holders, members, partners, agents, attorneys, representatives, successors and assigns (collectively, the &ldquo;<B><I>Purchaser
Indemnified Parties</I></B>&rdquo;) harmless from and against, and pay to the applicable Purchaser Indemnified Parties the amount of
any and all losses, liabilities, claims, obligations, deficiencies, demands, judgments, damages (including incidental and consequential
damages, but excluding punitive damages except to the extent actually awarded to a third party in the case of a third-party claim), interest,
fines, penalties, suits, actions, causes of action, assessments, awards, costs, and expenses (including costs of investigation, litigation
and defense and attorneys&rsquo; and other professionals&rsquo; fees and including those arising under Environmental Law and such costs
and fees incurred in connection with enforcing this <U>Article VI</U>), in each case, whether or not involving a third-party claim (individually,
a &ldquo;<B>Loss</B>&rdquo; and, collectively, &ldquo;<B>Losses</B>&rdquo;) based upon, attributable to or arising from:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any inaccuracy in or breach of the representations or
warranties of the Company or Seller contained in this Agreement or in any Ancillary Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any breach or non-performance of any covenant, agreement
or obligation of (A) Seller or (B) to the extent required to be performed at or prior to the Closing, the Company, contained in this
Agreement or in any Ancillary Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any Deficit Amount, Indebtedness of the Company or Unpaid
Transaction Expenses, in each case, to the extent Purchaser did not receive a duplicate recovery therefor pursuant to <U>Section 1.03(d)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(iv)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except to the extent taken into account in the determination
of Closing Working Capital as finally determined pursuant to <U>Section 1.03(c)</U>, (A) all Taxes of the Company (or any predecessor
thereof) (I) for any taxable period ending on or before the Effective Time, and (II) for the portion of any Straddle Period ending at
the Effective Time (determined as provided in <U>Section 5.03(b)</U>); and (B) any failure to timely pay any and all Taxes required to
be borne by Seller pursuant to <U>Section 5.03(d)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(v)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any demands or claims by holders or purported holders
of securities of the Company or any other Person related to direct or indirect economic, voting or equity interests in the Company (including
in respect of any options, warrants or other Contract rights) arising prior to the Effective Time or in connection with the consummation
of the transactions contemplated by this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any indemnification obligations owing by the Company
to any past or present managers, directors, officers or Employees of the Company with respect to claims made against such past or present
manager, director, officer or Employee to the extent related to events, omissions or activities occurring prior to the Effective Time;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(vii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the matters set forth on <U>Schedule 6.02(a)(vii)</U>
(such matters, the &ldquo;<B><I>Special Indemnity Matters</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
INDEMNITY OBLIGATION IS INTENDED TO ALLOCATE LIABILITY FOR, WITHOUT LIMITATION, (I) ANY CLAIMS RESULTING FROM THE NEGLIGENCE OR ALLEGED
NEGLIGENCE OF ANY PURCHASER INDEMNIFIED PARTY AND (II) STATUTORY AND COMMON LAW NEGLIGENCE AND STRICT LIABILITY CLAIMS AS WELL AS NEGLIGENCE,
STRICT LIABILITY, AND ALL OTHER CLAIMS ARISING UNDER ENVIRONMENTAL LAW, INCLUDING CERCLA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Closing, Purchaser shall indemnify
and hold Seller and its Affiliates, equity holders, directors, officers, employees, members, partners, agents, attorneys, representatives,
successors, and permitted assigns (collectively, the &ldquo;<B><I>Seller Indemnified Parties</I></B>&rdquo; and together with the Purchaser
Indemnified Parties, the &ldquo;<B><I>Indemnified Parties</I></B>&rdquo;) harmless from and against, and pay to the applicable Seller
Indemnified Parties the amount of, any and all Losses based upon, attributable to or arising from:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any inaccuracy in or breach of the representations or
warranties of Purchaser contained in this Agreement or in any Ancillary Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any breach or non-performance of any covenant, agreement
or obligation of (A) Purchaser or (B) to the extent required to be performed following the Closing, the Company, contained in this Agreement
or in any Ancillary Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The waiver of any condition based on the accuracy of
any representation or warranty, or on the performance of or compliance with any covenant or agreement, will not affect the right to indemnification
or any other remedy based on such representations, warranties, covenants and agreements. A Party&rsquo;s right to indemnification hereunder
or any other remedy based on representations, warranties, covenants, and agreements in this Agreement, or in any Ancillary Agreement,
shall not be affected by any investigation conducted at any time, or any Knowledge acquired (or capable of being acquired) at any time,
whether before or after the execution and delivery of this Agreement or the Closing Date, by such Party or its Affiliates or representatives
with respect to the accuracy or inaccuracy of, or compliance with, any such representation, warranty, covenant, or agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other Indemnification Provisions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller shall not be required to indemnify any Purchaser
Indemnified Party under <U>Section 6.02(a)(i)</U> unless the aggregate amount of Losses the Purchaser Indemnified Parties are entitled
to recover under this <U>Article VI</U> exceeds $50,000 (the &ldquo;<B>Deductible</B>&rdquo;) and then Seller shall be required to indemnify
the applicable Purchaser Indemnified Parties, subject to <U>Section 6.03(b)</U>, for the full amount of such Losses, irrespective of
the Deductible limitation; <U>provided</U>, that this <U>Section 6.03(a)</U> shall not limit any recovery for Losses related to (i) the
failure to be true and correct of any of the Fundamental Representations, or (ii) any claim arising out of any Fraud of Seller or the
Company. Purchaser shall not be required to indemnify any Seller Indemnified Party under <U>Section 6.02(b)(i)</U> unless the aggregate
amount of Losses the Seller Indemnified Parties are entitled to recover under this <U>Article VI</U> exceeds the Deductible and then
Purchaser shall be required to indemnify the applicable Seller Indemnified Parties, subject to <U>Section 6.03(b)</U>, for the full amount
of such Losses, irrespective of the Deductible limitation; <U>provided</U>, that this <U>Section 6.03(a)</U> shall not limit any recovery
for Losses related to (A) the failure to be true and correct of any of the Purchaser Fundamental Representations, or (B) any claim arising
out of any Fraud of Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller shall not be required to indemnify any Purchaser
Indemnified Party under <U>Section 6.02(a)(i)</U> for an aggregate amount of Losses exceeding an amount equal to $1,500,000 (the &ldquo;<B>Cap</B>&rdquo;);
<U>provided</U>, that the Cap shall not apply with respect to Losses related to (i) the failure to be true and correct of any of the
Fundamental Representations or (ii) any claim arising out of any Fraud of Seller or the Company. The aggregate amount of Losses recoverable
hereunder by the Seller Indemnified Parties for indemnification pursuant to <U>Section 6.02(b)(i)</U> shall not exceed an amount equal
to the Cap; <U>provided</U>, <U>however</U>, that such limitation shall not apply to Losses related to (A) the failure to be true and
correct of any of the Purchaser Fundamental Representations, or (B) any claim arising out of any Fraud of Purchaser. Seller shall not
be required to indemnify any Purchaser Indemnified Party under this <U>Article VI</U> for an aggregate amount of Losses exceeding an
amount equal to the Purchase Price (the &ldquo;<B><I>Overall Cap</I></B>&rdquo;); <U>provided</U> that the Overall Cap shall not apply
with respect to Losses related to any claim arising out of any Fraud of Seller or the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of determining the failure of any representations
or warranties to be true and correct, the breach of any covenants or agreements, and calculating Losses hereunder, any materiality or
Material Adverse Effect qualifications in the representations, warranties, covenants, and agreements contained herein that have the effect
of limiting such representations, warranties, covenants or agreements shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller shall not have any right of contribution, subrogation,
or other recourse against the Company or its directors, managers, officers, Employees, Affiliates, agents, attorneys, stockholders, members,
representatives, assigns, or successors for any claims asserted by Purchaser Indemnified Parties, it being acknowledged that the covenants
and agreements of Seller and the Company are solely for the benefit of the Purchaser Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(e)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of any Losses subject to indemnification
under <U>Section 6.02(a)</U> shall be reduced by the amounts actually recovered by the Purchaser Indemnified Party under applicable insurance
policies of the Company in effect as of immediately prior to the Closing with respect to such Losses (net of any Losses incurred in connection
with such recovery) and if any Purchaser Indemnified Party receives such insurance proceeds after the settlement of any claim under <U>Section
6.02(a)</U>, such Purchaser Indemnified Party shall refund to Seller the amount of such insurance proceeds that constitute a duplicate
recovery, up to the amount received in connection with such claim (net of any Losses incurred in connection with such recovery).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnity Payments; Right to Setoff</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any payment Seller is obligated to make to any Purchaser
Indemnified Parties pursuant to <U>Section 6.02(a)</U> shall be paid (i) first, to the extent there is a sufficient amount of Indemnity
Holdback Shares, by Purchaser reducing the Indemnity Holdback Shares by a number of shares equal to (i) the amount of the Losses in respect
of such claim for indemnification, divided by (ii) the Purchaser Common Stock Price as of the Closing Date, and (ii) second, to the extent
the amount of Indemnity Holdback Shares are insufficient to cover any remaining sums due, then the Seller shall pay all of such additional
sums due and owing to the Purchaser Indemnified Parties by wire transfer of immediately available funds within five Business Days after
the date of such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without limiting any other rights or remedies available
to it, Purchaser shall be entitled to offset any claim for a Loss by a Purchaser Indemnified Party pursuant to this <U>Article VI</U>
or any payments due and payable to Purchaser pursuant to this Agreement (including <U>Section 1.03(d)(i)</U>) against payments payable
by Purchaser to any Seller Indemnified Party under this Agreement (including any Earnout Amounts payable pursuant to <U>Section 1.06</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">6.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Tax Treatment of Indemnity Payments</U>. The Parties
agree to treat any indemnity payment made pursuant to this <U>Article VI</U> as an adjustment to the Purchase Price for all Tax purposes
to the extent permitted by applicable Law. If, notwithstanding the treatment required by the preceding sentence, any indemnification
payment under this <U>Article VII</U> is determined to be taxable to the party receiving such payment by any taxing authority, the paying
party shall also indemnify the party receiving such payment for any Taxes incurred by reason of the receipt of such payment and any Losses
incurred by the party receiving such payment in connection with such Taxes (or any asserted deficiency, claim, demand, action, suit,
proceeding, judgment or assessment, including the defense or settlement thereof, relating to such Taxes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Article
VII.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MISCELLANEOUS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.01
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Expenses</U>. Except as otherwise expressly provided
in this Agreement, Seller, on the one hand, and Purchaser, on the other hand, shall each bear their own expenses incurred in connection
with the negotiation and execution of this Agreement and each other agreement, document and instrument contemplated by this Agreement
and the consummation of the transactions contemplated hereby and thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.02
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Specific Performance</U>. Seller and the Company
acknowledge and agree that a breach of this Agreement would cause irreparable damage to Purchaser and that, in the event of any such
breach, Purchaser will not have an adequate remedy at Law. Therefore, the obligations of Seller under this Agreement shall be enforceable
by a decree of specific performance issued by any court of competent jurisdiction, and appropriate injunctive relief may be applied for
and granted in connection therewith. Such remedies shall, however, be cumulative and not exclusive and shall be in addition to any other
remedies which any Party may have under this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.03
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Submission to Jurisdiction and Consent to Service
of Process</U>. The Parties hereby irrevocably submit to the exclusive jurisdiction of any federal or state court located within Tarrant
County, Texas over any dispute arising out of or relating to this Agreement or any of the transactions contemplated hereby and each Party
hereby irrevocably agrees that all claims in respect of such dispute or any suit, action or proceeding related thereto may be heard and
determined in such courts. The Parties hereby irrevocably waive, to the fullest extent permitted by applicable Law, any objection which
they may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum
for the maintenance of such dispute. Each of the Parties agrees that a judgment in any such dispute may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by Law. Each of the Parties hereby consents to process being served by any Party
in any suit, action or proceeding by delivery of a copy thereof in accordance with the provisions of <U>Section 7.06</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.04
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Entire Agreement; Amendments and Waivers</U>. This
Agreement and the Ancillary Agreements represent the entire understanding and agreement between the Parties with respect to the subject
matter hereof, supersede all prior oral discussions and written agreements between the Parties with respect to the subject matter hereof
(including any term sheet or similar agreement or document relating to the transactions contemplated hereby), and can be amended, supplemented
or changed, and any provision hereof can be waived, only by written instrument making specific reference to this Agreement signed by
the Party against whom enforcement of any such amendment, supplement, modification or waiver is sought. No oral statements or prior written
material not specifically incorporated in this Agreement shall be of any force and effect. The Parties represent and acknowledge that
in executing this Agreement, the Parties did not rely, and have not relied, on any communications, promises, statements, inducements,
or representation(s), oral or written, by any other Party, except as expressly contained in this Agreement. The Parties represent that
they relied on their own judgment in entering into this Agreement. No action taken pursuant to this Agreement, including any investigation
by or on behalf of any Party, shall be deemed to constitute a waiver by the Party taking such action of compliance with any representation,
warranty, covenant or agreement contained herein. The waiver by any Party of a breach of any provision of this Agreement shall not operate
or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach. A breach of this Agreement
shall not preclude injunctive relief. No failure on the part of any Party to exercise, and no delay in exercising, any right, power or
remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such Party
preclude any other or further exercise thereof or the exercise of any other right, power or remedy, including injunctive relief. All
remedies hereunder are cumulative and are not exclusive of any other remedies provided by Law or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.05
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing Law; Waiver of Jury Trial</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement shall be governed by and construed in
accordance with the laws of the State of Texas applicable to contracts made and performed in such State, without reference to such State&rsquo;s
principles of conflict of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR (II) IN ANY WAY
CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED
HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY
AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE
PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT
OF THE PARTIES TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.06
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>. All notices and other communications
under this Agreement shall be in writing and shall be deemed given (a) when delivered personally by hand (with written confirmation of
receipt), (b) when sent by, email or (c) one Business Day following the day sent by overnight courier (with written confirmation of receipt),
in each case, at the following addresses (or to such other address as a Party may have specified by notice given to the other Party pursuant
to this provision):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    Seller:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
    MedTech Inc.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
    Summit Avenue, Suite 414</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[*****]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
    Worth, Texas 76102</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[*****]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zach
    Fleming</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
    Phillips</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zfleming@sanaramedtech.com</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rphil84@me.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    a copy to (which will not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    a copy to (which will not constitute notice):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynes
    and Boone, LLP</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Winderweedle,
    Haines, Ward &amp; Woodman, P.A.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2323
    Victory Avenue, Suite 700</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">329
    North Park Avenue, Suite 2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
    Texas 75219</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Winter
    Park, Florida 32790</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew
    L. Fry</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    Deery</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brandon
    S. McCoy</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lionel
    Rubio</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt.Fry@haynesboone.com</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jdeery@whww.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brandon.McCoy@haynesboone.com</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lerubio@whww.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.07
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Legal Counsel</U>. Each Party represents and warrants
that it has read and fully understands the terms and provisions of this Agreement, has had an opportunity to review this Agreement with
legal counsel, and has executed this Agreement based upon such Party&rsquo;s own judgment and advice of independent legal counsel (if
sought).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.08
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>. If any term or other provision
of this Agreement is invalid, illegal or incapable of being enforced by any Law or public policy, all other terms or provisions of this
Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated
hereby is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, such provision shall be modified so as to effect the original intent of the Parties as closely
as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to
the greatest extent possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.09
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Binding Effect; Assignment</U>. This Agreement shall
be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns. Nothing in this Agreement
shall create or be deemed to create any third party beneficiary rights in any Person not a Party except as provided below or as otherwise
expressly provided herein. No assignment of this Agreement or of any rights or obligations hereunder may be made by any Party (by operation
of law or otherwise) without the prior written consent of the other Parties and any attempted assignment without the required consents
shall be void; <U>provided</U>, that Purchaser may assign this Agreement and any or all rights or obligations hereunder (including Purchaser&rsquo;s
rights to purchase and receive the Membership Interests and to seek indemnification hereunder) to any Affiliate of Purchaser, any Person
from which it has borrowed money or any Person to which Purchaser or any of its Affiliates proposes to sell all or substantially all
of the equity interests or the assets of the Company. Upon any such permitted assignment, the references in this Agreement to Purchaser
shall also apply to any such assignee unless the context otherwise requires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.10
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Counterparts</U>. This Agreement may be executed
in multiple counterparts, each of which will be deemed to be an original copy of this Agreement and all of which, when taken together,
will be deemed to constitute one and the same agreement. The Parties intend to treat as an original any document signed in connection
with the transactions contemplated by this Agreement, including any counterpart to this Agreement or any related document that is delivered
by electronic transmission, including by facsimile, .PDF, photo static copy, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.11
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Interpretive Matters</U>. Unless otherwise expressly
provided in this Agreement, for purposes of this Agreement, the following rules of interpretation shall apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When calculating the period of time before which, within
which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating
such period shall be excluded. If the last day of such period is a non-Business Day, the period in question shall end on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The schedules (the &ldquo;<B><I>Schedules</I></B>&rdquo;)
and exhibits (the &ldquo;<B><I>Exhibits</I></B>&rdquo;) attached to this Agreement and referred to herein are hereby incorporated and
made a part hereof and are an integral part of this Agreement. Any capitalized terms used in any Schedule or Exhibit but not otherwise
defined therein shall be defined as set forth in this Agreement. The Schedules shall be organized in parts corresponding to the numbering
in the applicable Article with disclosures in each part specifically corresponding to or cross-referencing a particular Section and subsection
of such Article. The disclosure of information on any Schedule will not be deemed to be disclosed on any other Schedule or to relate
to any provision of the Agreement other than the particular Section or subsection to which such Schedule refers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References herein (i) to all accounting terms not otherwise
defined herein have the meanings ascribed to them in accordance with GAAP; (ii) to Sections, Schedules and Exhibits mean the Sections
of, and Schedules and Exhibits attached to, this Agreement; (iii) to an agreement, document or instrument means such agreement, document
or instrument as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof, including by
waiver or consent; (iv) to a specific Law, or to specific provisions of Laws means such Law or specific provisions of Laws as amended,
modified or supplemented from time to time and in effect on the Closing Date and includes any successor comparable Laws in effect on
the Closing Date or provisions of Laws thereto in effect on the Closing Date and any rules and regulations promulgated thereunder in
effect on the Closing Date; (v) to a list, or any like compilation, means that the item referred to is complete and correct; (vi) to
&ldquo;any&rdquo; means &ldquo;any and all&rdquo;; (vii) to the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo;
shall be deemed to be followed by the words &ldquo;without limitation&rdquo; and shall not be construed to limit any general statement
that it follows to the special or similar items or matters immediately following it; (viii) to the words &ldquo;herein,&rdquo; &ldquo;hereof,&rdquo;
&ldquo;hereby,&rdquo; &ldquo;hereto&rdquo; and &ldquo;hereunder&rdquo; refer to this Agreement as a whole (including the Schedules and
Exhibits) and not merely to a subdivision in which such words appear unless the context otherwise requires; (ix) terms defined in this
Agreement include the plural as well as the singular; (x) to &ldquo;$&rdquo; or &ldquo;dollars&rdquo; shall mean the legal tender of
the United States; (xi) to the words &ldquo;or,&rdquo; &ldquo;either&rdquo; and &ldquo;any&rdquo; shall not be exclusive, but shall be
used in the inclusive sense of &ldquo;and/or,&rdquo; and the words &ldquo;will&rdquo; and &ldquo;will not&rdquo; are expressions of command
and not merely expressions of future intent or expectation; (xii) to the phrase &ldquo;to the extent&rdquo; means &ldquo;the degree by
which&rdquo; and not &ldquo;if,&rdquo; and (xiii) to the word &ldquo;Agreement,&rdquo; means this Agreement as amended or supplemented,
together with all Schedules and Exhibits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">(d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The phrase &ldquo;Made Available&rdquo; with respect
to any information or document to be provided by the Company or Seller shall be deemed satisfied only if a true and complete copy of
such information or document (for the avoidance of doubt, including all amendments, waivers, exhibits and schedules thereto) is available
for Purchaser to download from the Scendia Biologics online data site maintained at Box.com on behalf of the Company by the close of
business on the second Business Day immediately preceding the Closing Date and remains so available through the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext">7.12
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Defined Terms</U>. The terms defined in <U>Exhibit
A</U>, whenever used herein, shall have the meanings set forth on <U>Exhibit A</U> for all purposes of this Agreement. The definitions
on <U>Exhibit A</U> are incorporated into this Agreement as if fully set forth at length herein and all references to a section in such
<U>Exhibit A</U> are references to such section of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page is intentionally left blank; signature page follows.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
    MedTech Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary B. Fleming</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    B. Fleming</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ryan Phillips</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
    Phillips, individually </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scendia
    Biologics, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ryan Phillips</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
    Phillips</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 427.5pt; text-align: center; text-indent: -427.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 427.5pt; text-align: center; text-indent: -427.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
Page to Membership Interest Purchase Agreement</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 427.5pt; text-align: center; text-indent: -427.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
A</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined
Terms</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
definitions of terms capitalized and used throughout this Agreement are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Accounting
Principles</I></B>&rdquo; means GAAP and the sample calculation set forth on <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Affiliate</I></B>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is
controlled by, or is under common control with, such Person. The term &ldquo;<B><I>control</I></B>&rdquo; (including the terms &ldquo;<B><I>controlled
by</I></B>&rdquo; and &ldquo;<B><I>under common control with</I></B>&rdquo;) means the possession, directly or indirectly, of the power
to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities, by Contract
or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Ancillary
Agreements</I></B>&rdquo; means all other agreements, certificates and instruments which a Party executed in connection with, or is otherwise
contemplated by, this Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Anti-Corruption
Laws</I></B>&rdquo; means applicable Laws related to corruption and bribery, including the U.S. Foreign Corrupt Practices Act of 1977,
as amended, and any other Law that prohibits bribery, corruption, fraud, or other improper payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Business
Day</I></B>&rdquo; means any day of the year other than a Saturday or Sunday or any day on which the Federal Reserve Bank of Dallas is
closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>CARES
Act</I></B>&rdquo; means the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 (Public Law 116-136).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Cash</I></B>&rdquo;
means all unrestricted cash and cash equivalents of the Company as of the Effective Time (without giving effect to any of the transactions
contemplated hereby and excluding restricted cash and any cash held or maintained by the Company for the benefit of a third Person),
as computed in accordance with the Accounting Principles. For the avoidance of doubt, Cash will be calculated net of issued but uncleared
checks and drafts and inclusive of deposits in transit and may be negative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>CERCLA</I></B>&rdquo;
means the Comprehensive Environmental Response Compensation and Liability Act, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Closing
Cash Amount</I></B>&rdquo; means, as of the Effective Time, the aggregate amount of all Cash of the Company; <U>provided</U>, that the
Closing Cash Amount shall (a) be calculated net of all issued but uncleared checks, wire transfers and drafts, but solely to the extent
such checks, wire transfers and drafts are not otherwise reflected in the Closing Working Capital as a current liability or included
in the Closing Debt Amount or Unpaid Transaction Expenses, and (b) include all checks, wire transfers and drafts deposited or available
for deposit for the account of the Company, but solely to the extent such checks, wire transfers and drafts are not otherwise reflected
in the Closing Working Capital as a current asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Closing
Debt Amount</I></B>&rdquo; means, as of the Effective Time (but immediately before taking into account the consummation of the transactions
contemplated hereby), the aggregate amount of all Indebtedness of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Closing
Working Capital</I></B>&rdquo; means, as of the Effective Time, (a) the current assets of the Company, including 100% of the Specified
Inventory (excluding Cash and any deferred income Tax assets), <U>less</U> (b) the current liabilities of the Company (excluding accrued
interest on Indebtedness, deferred income Tax Liabilities and any other Liabilities included in the Indebtedness and/or Transaction Expenses
of the Company), in each case, determined as of the Effective Time (without giving effect to any of the transactions contemplated hereby).
The calculation of Closing Working Capital will be determined in accordance with the Accounting Principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>COBRA</I></B>&rdquo;
means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Company
Intellectual Property</I></B>&rdquo; mean all Intellectual Property rights used in connection with the Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Company
Technology</I></B>&rdquo; means all Technology owned by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Confidential
Information</I></B>&rdquo; means any information with respect to the Business, the Company or any Affiliate of the Company, including
methods of operation, products, Technology, inventions, Trade Secrets, commercial secrets, know-how, software, marketing methods and
sales plans and strategies, suppliers, competitors, markets, market surveys, techniques, research, development, production processes,
finances, technical data, policies, strategies, designs, formulas, developmental or experimental work, improvements, discoveries, plans
for research or future developments, database schemas or tables, infrastructure, development tools or techniques, training manuals, marketing,
distribution and installation plans, processes and strategies, methodologies, business plans, budgets, financial information and data,
customer and client information, prices and pricing strategies, costs, fees, customer and client lists and profiles, employee, customer
and client nonpublic personal information, supplier lists, business records, audit processes, management methods and information, reports,
recommendations and conclusions or other specialized information or proprietary matters; <U>provided</U>, <U>however</U>, that &ldquo;<B><I>Confidential
Information</I></B>&rdquo; does not include, and there shall be no obligation hereunder with respect to, information that (a) is generally
available to the public on the Closing Date or (b) becomes generally available to the public other than as a result of a disclosure not
otherwise permissible hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Contract</I></B>&rdquo;
means any agreement, contract, lease, note, bond, mortgage, instrument, license, loan, indenture, purchase order or other arrangement,
commitment, consensual obligation, promise or undertaking whether written or oral (whether express or implied).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Employee</I></B>&rdquo;
means any individual who is an employee, whether by contract, common law or otherwise, of the Company (which for all purposes shall include
employees on a leave of absence or temporary layoff and employees leased by the Company from a third party).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Environmental
Claim</I></B>&rdquo; means any accusation, allegation, notice of violation, action, claim, suit, litigation, application, hearing, investigation,
audit, citation, complaint, summons, writ, prosecution, proceeding, request for information, environmental Lien, demand, abatement, Order,
direction (conditional or otherwise), or other proceeding (whether in contract, tort, or otherwise, whether at law, including common
law, or in equity and whether civil, criminal, administrative, regulatory or investigative) by or before any Governmental Authority or
any other Person relating to or arising from (a) any past or present environmental matter, including any non-compliance with or breach
of any Environmental Laws or any Release of any Hazardous Material in, on, at, onto or under the Company Property, (b) any personal injury
(including sickness, disease or death), damage to tangible or intangible property, damage to the Environment, nuisance, pollution, contamination,
trespass or adverse effects on property, the Environment or Persons under any Environmental Laws or involving or in connection with any
Hazardous Material, (c) any Environmental Costs and Liabilities, or (d) any legal obligations to undertake any Remedial Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Environmental
Costs and Liabilities</I></B>&rdquo; means any and all Losses (including the costs of any Remedial Action) arising from or under or resulting
from or based upon (a) a Release or threatened Release of, or exposure to, any Hazardous Material arising or occurring in connection
with the operation or activities of the Business, the Company Property, the assets or properties of the Company or with any act, omission
or conduct of the Company or related to any property, facility, equipment or assets currently or formerly owned, occupied, operated or
leased by the Company or any activities or operations thereof, (b) the transportation, storage, treatment, processing, abatement, remediation,
removal, presence, generation, manufacturing, handling or disposal of Hazardous Materials by or on behalf of the Company or in connection
with the Company Property, or other property, asset, facility, equipment or assets currently or formerly owned, operated, occupied, or
leased by the Company or utilized in the conduct of the Business in violation of Environmental Laws or (C) any violation or alleged violation
of any Environmental Laws or any Liability or alleged Liability under any Environmental Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Environmental
Law</I></B>&rdquo; means any Law as now or hereafter in effect in any way relating to protection of human health and safety, public welfare,
the environment, or natural resources, including those Laws relating to the storage, handling and use of chemicals, hazardous substances
(as that term is defined by CERCLA), hazardous materials or waste materials of any kind, those relating to the generation, processing,
treatment, storage, transport, disposal or other management of chemicals, hazardous substances (as that term is defined by CERCLA), hazardous
materials or waste materials of any kind, those Laws relating to the Release, reporting, discharge, investigation, or remediation of
waste materials, hazardous substances (as that term is defined by CERCLA), hazardous materials or waste materials of any kind, and those
Laws relating to the protection of threatened or endangered species or environmentally sensitive areas. Environmental Law includes the
Comprehensive Environmental Response, Compensation and Liability Act (42 U.S.C. &sect; 9601 <U>et seq.</U>), the Hazardous Materials
Transportation Act (49 U.S.C. App. &sect; 1801 <U>et seq.</U>), the Resource Conservation and Recovery Act (42 U.S.C. &sect; 6901 <U>et
seq.</U>), the Clean Water Act (33 U.S.C. &sect; 1251 <U>et seq.</U>), the Clean Air Act (42 U.S.C. &sect; 7401 <U>et seq.</U>) the Toxic
Substances Control Act (15 U.S.C. &sect; 2601 <U>et seq.</U>), the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. &sect;
136 <U>et seq.</U>), and the Occupational Safety and Health Act (29 U.S.C. &sect; 651 <U>et seq.</U>), and analogous foreign, federal,
state or local Laws, as each has been amended as of the Closing and the regulations promulgated pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>ERISA</I></B>&rdquo;
means the U.S. Employee Retirement Income Security Act of 1974, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>ERISA
Affiliate</I></B>&rdquo; means any trade or business (whether or not incorporated) that is or at any time preceding the date of this
Agreement would have been treated as a &ldquo;single employer&rdquo; with the Company under Code Sections 414(b), (c), (m), or (o).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Escrow
Account</I></B>&rdquo; means the escrow account established by the Escrow Agent pursuant to the terms of the Escrow Agreement for purposes
of holding the Working Capital Escrow Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Escrow
Agent</I></B>&rdquo; means Citibank, N.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Existing
Customer Accounts</I></B>&rdquo; means, collectively, the Existing Customer Accounts set forth on <U>Exhibit C</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Fraud</I></B>&rdquo;
means common law fraud under applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Fundamental
Representations</I></B>&rdquo; means the representations and warranties set forth in <U>Sections </U>2.01 (authorization of agreement),
2.03 (ownership and transfer of the membership interests), <U>2.05</U> (brokers&rsquo; fees and commissions), <U>3.01</U> (organization
and good standing), <U>3.02</U> (authorization and agreement), <U>3.03</U> (conflicts; consents of third parties), <U>3.04</U> (capitalization),
<U>3.09</U> (title to assets; tangible personal property) <U>3.10</U> (real property) <U>3.12</U> (taxes), <U>3.13(a)</U> (compliance
with laws; permits), 3.15 (intellectual property; data security; privacy) and <U>3.18</U> (environmental matters).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>GAAP</I></B>&rdquo;
means generally accepted accounting principles in the United States as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Governmental
Authority</I></B>&rdquo; means any federal, national, state, provincial, territorial, municipal, local or other governmental, quasi-governmental,
regulatory or administrative authority, body, division, bureau, department, agency, ministry, board or commission or other subdivision
thereof or any court, tribunal, administrative hearing body or judicial or arbitral body exercising any executive, legislative, judicial,
regulatory, Tax or administrative function of or pertaining to government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Hazardous
Material</I></B>&rdquo; means any solid, liquid, gas, emission, odor, heat, sound, vibration, radiation, chemical, material, compound,
substance, element, noise, dust, smoke, emission, particulate or any derivative or combination of the foregoing that may impair or adversely
affect the Environment, injure or damage property or plant or animal life or harm, impair or adversely affect the enjoyment of property
or the health of any individual and includes any waste, narcotics, chemicals, asbestos containing material, mold, petroleum compounds,
urea formaldehyde, polychlorinated biphenyls, greenhouse gases, that class of chemicals referred to as per- and polyfluoroalkyl substances,
and any substance, compound or derivative defined, regulated, prohibited, prescribed, limited or prohibited by a Governmental Authority
under any Environmental Laws or otherwise characterized under or pursuant to any Environmental Laws as &ldquo;hazardous&rdquo;, &ldquo;deleterious&rdquo;,
&ldquo;dangerous&rdquo;, &ldquo;waste&rdquo;, &ldquo;toxic&rdquo;, &ldquo;pollutant&rdquo;, &ldquo;contaminant&rdquo;, &ldquo;harmful&rdquo;
or words of similar meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Indebtedness</I></B>&rdquo;
of any Person means, without duplication: (a) the principal, accreted value, accrued and unpaid interest, prepayment and redemption premiums
or penalties (if any), unpaid fees or expenses and other monetary obligations in respect of (i) indebtedness of such Person for money
borrowed and (ii) indebtedness evidenced by notes, debentures, bonds or other similar instruments, the payment of which such Person is
responsible or liable for (including any seller notes, deferred purchase price obligations or earnout obligations issued or entered into
in connection with any acquisition undertaken by such Person); (b) all obligations of such Person issued or assumed as the deferred purchase
price of property or services, all conditional sale obligations of such Person and all obligations of such Person under any title retention
agreement (even though the rights and remedies of seller or lender under such agreement in the event of default are limited to the repossession
or sale of such property) (but excluding, as applicable, trade accounts payable and other accrued current Liabilities to the extent taken
into account in calculation Closing Working Capital, other than the current Liability portion of any indebtedness for borrowed money);
(c) all obligations of such Person under leases required to be capitalized in accordance with GAAP; (d) all obligations of such Person,
contingent or otherwise, for the reimbursement of any obligor on any letter of credit, banker&rsquo;s acceptance or similar credit transaction;
(e) all obligations of such Person under interest rate, currency swap or other hedging transactions (valued at the termination value
thereof); (f) all monies and deposits received in advance; (g); all customer overpayments or credits; (h) all obligations for deferred
compensation arrangements (to the extent not considered a Transaction Expense); (i) all obligations under surety bonds; (j) all obligations
of the type referred to in clauses (a) through (i) of any Persons, the payment of which such Person is responsible or liable for, directly
or indirectly, as obligor, guarantor, surety or otherwise, including guarantees of such obligations; and (k) all obligations of the type
referred to in clauses (a) through (j) of such Person or of any other Person secured by (or for which the holder of such obligations
has an existing right, contingent or otherwise, to be secured by) any Lien on any property or asset of such Person, whether or not such
obligation is assumed by such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Independent
Contractor</I></B>&rdquo; means a Person providing services to the Company on the Closing Date who is not an Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Intellectual
Property Licenses</I></B>&rdquo; means (a) any grant by the Company to another Person of any right relating to or under any Intellectual
Property and (b) any grant by another Person to the Company of any right relating to or under any third Person&rsquo;s Intellectual Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Intellectual
Property</I></B>&rdquo; means all worldwide intellectual property, and all rights, title and interest arising therefrom or in respect
thereof, including the following: (a) all patents and applications therefor (collectively, &ldquo;<B><I>Patents</I></B>&rdquo;); (b)
all trademarks, service marks, trade names, service names, brand names, trade dress, logos and Internet domain names, together with the
goodwill associated with any of the foregoing, and all applications and registrations thereof (collectively, &ldquo;<B><I>Marks</I></B>&rdquo;);
(c) all copyrights, works of authorship and registrations and applications thereof, including Software (collectively, &ldquo;<B><I>Copyrights</I></B>&rdquo;);
(d) all trade secrets and know-how, including any material and manufacturing specifications, drawings, designs, methods, processes and
formulations, in all cases whether patentable or not (collectively, &ldquo;<B><I>Trade Secrets</I></B>&rdquo;); (e) any reissues, continuations
(including continuations-in-part), extensions, renewals, divisionals or amendments of any Patents, Marks, or Copyrights and any other
applications or registrations relying on applicable Patents, Marks, or Copyrights for priority; and (f) any other proprietary, intellectual
or industrial property rights of any kind or nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>IRS</I></B>&rdquo;
means the United States Internal Revenue Service and, to the extent relevant, the U.S. Department of the Treasury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Knowledge</I></B>&rdquo;
means, with respect to any Person that is not an individual, the knowledge after due inquiry of any of such Person&rsquo;s and its Affiliates&rsquo;
directors, managers, executive officers and all other offices and managers having responsibility relating to the applicable matter, or,
in the case of an individual, knowledge of such individual after due inquiry. Notwithstanding the foregoing, references to &ldquo;Knowledge
of Seller&rdquo; in <U>Article III</U> shall include the Knowledge of the Company and the Knowledge of Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Law</I></B>&rdquo;
means any foreign, federal, state, provincial, territorial, or local law (including common law or law in equity), statute, code, ordinance,
rule, regulation, order, by-law, treaty, code, rule, judgment, Order or other requirement applicable to that Person, property, transaction,
event or other matter, whether or not having the force of law, and including all applicable requirements, requests, demands, rules, consents,
approvals, authorizations, guidelines, practices and policies of any Governmental Authority having or purporting to have authority over
that Person, property, transaction, facility, equipment, event or other matter and regarded by such Governmental Authority as requiring
compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Legal
Proceeding</I></B>&rdquo; means any judicial, administrative or arbitral action, suit, mediation, charge, investigation, inquiry, proceeding,
demand, complaint or claim (including any counterclaim) by or before a Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Liability</I></B>&rdquo;
means any debt, Loss, damage, adverse claim, fine, penalty, liability or obligation (whether direct or indirect, known or unknown, asserted
or unasserted, absolute or contingent, accrued or unaccrued, matured or unmatured, determined or determinable, disputed or undisputed,
liquidated or unliquidated, or due or to become due, and whether in contract, tort, strict liability or otherwise), and including all
costs and expenses relating thereto including all fees, disbursements and expenses of legal counsel, experts, engineers and consultants
and costs of investigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Lien</I></B>&rdquo;
means any lien, encumbrance, pledge, mortgage, hypothecation, deed of trust, security interest, claim, lease, charge, option, prior assignment,
claim, lease, sublease, right to possession, charge, option, warrant, right of first refusal, easement, servitude, proxy, voting trust
or agreement, transfer restriction under any equity holder or similar agreement, encumbrance or any other restriction or limitation whatsoever,
which affects, by way of a conflicting ownership interest or otherwise, the right, title or interest in or to any particular property,
including any Contract granting any of the foregoing other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Material
Adverse Effect</I></B>&rdquo; means any result, occurrence, fact, change, event or effect (whether or not constituting a breach of a
representation, warranty or covenant set forth in this Agreement) that, individually or in the aggregate with any such other results,
occurrences, facts, changes, events or effects, (a) had or could reasonably be expected to have an adverse effect on the historical or
near-term or long-term projected business, operations, prospects, assets, liabilities, condition (financial or otherwise) or results
of operations (including EBITDA or cash flow) of the Company or the Business, (b) had or could reasonably be expected to have an adverse
effect on the value of the Company, the Business or the assets or properties of the Company, (c) prevents or materially impairs or delays,
or could reasonably be expected to prevent or materially impair or delay, the ability of the Company to consummate the transactions contemplated
by this Agreement or perform its duties under this Agreement or the Ancillary Agreements, or (d) is or could reasonably be expected to
be materially adverse to the ability of Purchaser to operate the Business immediately after the Closing substantially in the manner as
the Business was operated immediately prior to the Closing. For the avoidance of doubt, the terms &ldquo;<B><I>material,</I></B>&rdquo;
&ldquo;<B><I>materially</I></B>&rdquo; and &ldquo;<B><I>materiality</I></B>&rdquo; as used in this Agreement with an initial lower case
&ldquo;<B><I>m</I></B>&rdquo; shall have their respective customary and ordinary meanings, without regard to the meaning ascribed to
the term Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Material
Certifications</I></B>&rdquo; means all customer and reseller certifications and/or approvals which are material to its business as presently
conducted and as presently intended to be conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Nasdaq</I></B>&rdquo;
means The Nasdaq Stock Market LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Order</I></B>&rdquo;
means any order, injunction, judgment, decree, ruling, decision, direction, award, writ, grant of equitable relief, assessment or arbitration
award of any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Ordinary
Course of Business</I></B>&rdquo; means the ordinary and usual course of normal day-to-day operations of the business of the Company
through the date hereof consistent with past practice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Permits</I></B>&rdquo;
means all permits, licenses, certificates, certifications, accreditations, qualifications, authorizations, approvals, registrations and
similar privileges or rights held or used by the Company and all rights and incidents of interest therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Permitted
Liens</I></B>&rdquo; means (a) statutory Liens for current Taxes, assessments or other governmental charges not yet due and payable,
or the amount or validity of which is being contested in good faith by appropriate proceedings, <U>provided</U>, that an appropriate
reserve has been established therefor in the Financial Statements in accordance with GAAP, (b) mechanics&rsquo;, carriers&rsquo;, workers&rsquo;
and repairers&rsquo; Liens arising or incurred in the ordinary course of business out of an agreement between the Company and the party
filing such Lien that are not material to the business, operations and financial condition of the property so encumbered and that are
not resulting from a breach, default or violation by the Company of any Contract or Law and (c) zoning, entitlement and other land use
and environmental regulations by any Governmental Authority, <U>provided</U>, that such regulations (i) have not been violated, (ii)
do not materially adversely affect the Company&rsquo;s operation of the Business from such lands or the continued use of the real property
to which they relate and (iii) do not affect the marketability of the real property to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Person</I></B>&rdquo;
means any individual, corporation, limited liability company, partnership, firm, joint venture, association, joint-stock company, trust,
unincorporated organization, Governmental Authority or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Plans</I></B>&rdquo;
means (a) all &ldquo;employee benefit plans&rdquo; as defined by Section 3(3) of ERISA, all specified fringe benefit plans as defined
in Section 6039D of the Code and all other incentive compensation, deferred compensation, profit sharing, stock option, stock appreciation
right, stock bonus, stock purchase, employee stock ownership, savings, severance, supplemental unemployment, layoff, salary continuation,
retirement, pension, health, life insurance, dental, disability, accident, group insurance, vacation, holiday, sick leave, fringe benefit
or welfare plans, and any other employee compensation or benefit plan, agreement, policy, practice, commitment, Contract or understanding
(whether qualified or nonqualified, written or unwritten, or subject to ERISA), and any trust, escrow or other agreement related thereto,
which currently is sponsored, established, maintained or contributed to or required to be contributed to by the Company or for which
the Company has any Liability, contingent or otherwise, and (b) all &ldquo;multiemployer plans,&rdquo; as that term is defined in Section
4001 of ERISA and all &ldquo;employee benefit plans&rdquo; (as defined in Section 3(3) of ERISA) that are subject to Title IV of ERISA
or Section 412 of the Code which the Company or any ERISA Affiliate has maintained or contributed to or been required to contribute to
at any time prior to the Closing Date or with respect to which the Company or any ERISA Affiliate has any Liability, contingent or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Privacy
Requirements</I></B>&rdquo; means all federal or state Laws and requirements in Contracts relating to the use, disclosure, storage, maintenance,
transmission, encryption, access to or privacy or security of, &ldquo;personally identifiable information,&rdquo; &ldquo;personal data&rdquo;,
&ldquo;sensitive personal information&rdquo; or &ldquo;personal information&rdquo; or any other information that, whether on its own
or together with any other information, could be used to identify, contact or locate any individual; and the Company&rsquo;s and its
Affiliates&rsquo; internal and external-facing privacy and data protection policies and procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Purchaser
Common Stock</I></B>&rdquo; means the Common Stock, $0.001 par value, of Purchaser (trading on the Nasdaq stock exchange under the trading
symbol SMTI).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Purchaser
Common Stock Price</I></B>&rdquo; means $20.57.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Purchaser
Fundamental Representations</I></B>&rdquo; means the representations and warranties set forth in <U>Sections 4.01</U> (organization of
purchaser), <U>4.02</U> (authorization), <U>4.03(a)</U> (conflicts) and <U>4.05</U> (financial advisors).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Purchaser
SEC Documents</I></B>&rdquo; means each annual and quarterly report and registration statement filed by Purchaser with the SEC since
December 31, 2021, and prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Release</I></B>&rdquo;
means any releasing, spilling, emitting, leaking, pumping, pouring, dumping, emptying, injecting, depositing, disposing, discharging,
dispersing, leaching, spraying, abandoning, throwing, placing, exhausting, emptying, escaping or migrating of a Hazardous Material into,
onto, at, under or from the Environment under any circumstance, and when used as a noun has a like meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Remedial
Action</I></B>&rdquo; means any action, including any expenditures, required by any Environmental Laws or voluntarily undertaken to (a)
inspect, investigate, remediate, mitigate, prevent, restore, monitor, clean up, remove, treat, or in any other way address any Hazardous
Material, (b) prevent the Release or threat of Release, or minimize or mitigate the further Release of any Hazardous Material including
its continuing migration whether surface or subsurface, (c) perform any sampling, studies, inspections, investigations or monitoring
with respect to any Hazardous Material or (d) bring the Company Property, any other property, facility or equipment owned, operated,
occupied or leased by the Company, the operations or activities conducted thereon and the assets or properties of the Company into compliance
with Environmental Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&ldquo;SEC&rdquo;
</I></B>means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Software</I></B>&rdquo;
means all (a) software, computer programs, applications, systems and code, including algorithms, models, methodologies, program interfaces,
source code, object code and executable code, (b) Internet and intranet websites, databases and compilations, including data and collections
of data, whether machine-readable or otherwise, (c) development and design tools, utilities, libraries and compilers, (d) technology
supporting websites, user interfaces, and the contents and audiovisual displays of websites, and (e) media, documentation and other works
of authorship, including forms, user manuals, support, maintenance and training materials, relating to or embodying any of the foregoing
or on which any of the foregoing is recorded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Specified
Inventory</I></B>&rdquo; means, as of the Effective Time, all of the ALLOCYTE&trade; and TEXAGEN&trade; inventory of the Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Target
Working Capital</I></B>&rdquo; means $1,618,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Tax</I></B>&rdquo;
or &ldquo;<B><I>Taxes</I></B>&rdquo; means (i) any federal, state, local, or foreign taxes, charges, fees, imposts, levies or other assessments,
including all income, gross receipts, capital, sales, use, goods and services, harmonized sales, ad valorem, value added, transfer, franchise,
profits, inventory, capital stock, license, withholding, payroll, employment, social security, unemployment, excise, severance, stamp,
occupation, property, escheat and estimated taxes, customs duties, fees, assessments and charges of any kind whatsoever; (ii) any interest,
penalties, fines, additions to tax or additional amounts imposed by any Taxing Authority in connection with any item described in clause
(i); and (iii) any Liability in respect of any items described in clauses (i) and/or (ii) payable by reason of Contract, assumption,
transferee liability, operation of law, Treasury Regulation Section 1.1502-6(a) (or any predecessor or successor thereof or any analogous
or similar provision of Law) or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Tax
Return</I></B>&rdquo; means any return, report or statement required to be filed with respect to any Tax (including any elections, declarations,
schedules or attachments thereto, and any amendment thereof) including any information return, claim for refund, amended return or declaration
of estimated Tax, and including, where permitted or required, combined, consolidated or unitary returns for any group of entities that
includes the Company or any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Taxing
Authority</I></B>&rdquo; means the Internal Revenue Service and any other Governmental Authority responsible for the administration of
any Tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Technology</I></B>&rdquo;
means, collectively, Software, information, programming content and data, designs, source code, formulae, algorithms, procedures, methods,
techniques, ideas, know-how, research and development, technical data, tools, specifications, processes, inventions (whether patentable
or unpatentable and whether or not reduced to practice), apparatus, creations, improvements, works of authorship and other similar materials,
and all recordings, graphs, drawings, reports, analyses, and other writings and registered domain names, website pages and other website
development, and other tangible embodiments of the foregoing, in any form whether or not specifically listed herein, and all related
technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Transaction
Expenses</I></B>&rdquo; means all (whether or not accrued) fees or other payments or obligations owed to third parties by Seller or the
Company (including those fees, expenses, payments and obligations incurred by the Company on behalf of Seller), incurred on or prior
to the Closing date and arising from or in connection with the negotiation, preparation, execution, delivery and performance of this
Agreement, the transactions contemplated hereby, and any due diligence requests or activity related to such transactions, including (a)
financial advisors&rsquo;, attorneys&rsquo;, accountants&rsquo; and other professional fees and expenses, (b) any and all payments arising
from retention, severance, &ldquo;<B><I>stay,</I></B>&rdquo; sale, transaction or sign-on bonuses as well as any deferred compensation
payable to Employees and any other similar payments to Employees and representatives, including the Company&rsquo;s portion of employment
and similar Taxes associated with any such items, and (c) any and all fees, expenses, break costs (including costs calculated based on
difference in swap and current rates) payments or other costs related to the termination of any swap agreements, derivative transactions,
or similar arrangements. For purposes of clarification, Transaction Expenses shall not include any fees or other payments or obligations
owed to third parties by Purchaser or otherwise incurred by Purchaser (including those fees, expenses, payments and obligations incurred
by Purchaser on behalf of the Company), arising from or in connection with the negotiation, preparation, execution, delivery and performance
of this Agreement, the transactions contemplated hereby, and any due diligence requests or activity related to such transactions, including
without limitation, Purchaser&rsquo;s preparation of the Adjustment Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Treasury
Regulations</I></B>&rdquo; means the regulations promulgated under the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Unpaid
Transaction Expenses</I></B>&rdquo; means the amount of Transaction Expenses that remain unpaid as of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Working
Capital Escrow Account</I></B>&rdquo; means the escrow account established by the Escrow Agent pursuant to the terms of the Escrow Agreement
for purposes of holding the Working Capital Escrow Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Working
Capital Escrow Amount</I></B>&rdquo; means $350,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Terms
Defined Elsewhere in this Agreement</U>. For purposes of this Agreement, the following terms have the meanings set forth in the Sections
indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term</U></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
    Cash Payment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustment
    Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    Sheet Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.06(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cap</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.03(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Cash Payment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02(h)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Marks</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Permits</FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13(b)</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Property</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductible</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit
    Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(d)(i)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Time</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Escrow
    Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05(a)(xii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Closing Cash Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Closing Debt Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Closing Statement </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Closing Working Capital </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Unpaid Transaction Expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Amounts</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term</U></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Closing Cash Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Closing Debt Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Closing Working Capital </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final
    Unpaid Transaction Expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.06(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Survival Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.01</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnified
    Parties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Accountant</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Financial Statements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.06(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    and Losses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
    Contracts</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership
    Interests</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occurrence
    Policies</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.06(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
    Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.06(a)(iv)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall
    Cap</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.03(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party
    or Parties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff
    Letters</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05(a)(ii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    Amounts</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Price</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser
    Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.02</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser
    Indemnified Parties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualified
    Plan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property Leases</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    Persons</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    Business</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.01(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.01(a)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    Transaction</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.01</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
    Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
    Indemnified Parties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SNDA
    Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.06(a)(viii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straddle
    Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03(b)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surplus
    Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03(d)(ii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival
    Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.01</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Claim</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03(c)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03(d)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unresolved
    Claims</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.04(b)(ii)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARN
    ACT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24(d)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
OF EXHBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A Defined Terms</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
B Sample Calculation of Closing Working Capital</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
C Existing Customer Accounts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-indent: -49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
OF SCHEDULES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-indent: -49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
1.03(a) Purchase Price Adjustment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
2.02(b) Seller Third Party Consents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
2.05 Seller Brokers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.01 Jurisdictions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.03(a) Conflicts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.03(b) Third Party Consents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.04(a) Capitalization</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.04(b) Rights in Equity</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.04(d) Indebtedness; Obligations for Reimbursement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.07 Absence of Certain Developments</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.08(1) Legal Proceedings</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.08(2) Orders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.10(a) Real Property</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.11(a) Material Contracts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.12(a) Taxes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.14 Financial Advisors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.15(a) Intellectual Property</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.15(b) Ownership of Intellectual Property</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.15(d) Intellectual Property Payments</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.16(a) Accounts Receivable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.16(b) Accounts Payable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.18 Environmental Matters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.19(a)(i) Significant Customers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.19(a)(ii) Significant Customers Terminations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.19(b) Significant Suppliers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.20(a) Employee Benefit Plans</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.21(a)(1) Employee Census</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
3.21(a)(2) Independent Contractors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
4.06 Purchaser Financial Advisors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
6.02(a)(vii) Specially Identified Items of Indemnification</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 48pt; width: 143.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanara
MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORT
WORTH, TX / July 5, 2022 / Sanara MedTech Inc</B>. Based in Fort Worth, Texas, Sanara MedTech Inc. (&ldquo;Sanara,&rdquo; the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic
wound care dedicated to improving patient outcomes, announced today that it closed the acquisition of Scendia Biologics, LLC (&ldquo;Scendia&rdquo;)
on July 1, 2022. Prior to this acquisition, Scendia was a sub-distributor of Sanara&rsquo;s and joint venture partner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zach
Fleming, Sanara&rsquo;s CEO, stated, &ldquo;At Sanara, we are constantly looking to find new products and technologies that can help
us to achieve our goal of improving patient outcomes and lowering overall costs. This acquisition furthers our goal by adding a significant
portfolio of advanced biologic products that are complementary to our current surgical product offering. In addition, we believe the
acquisition will expand our ability to partner with additional health systems to deliver a more comprehensive suite of surgical products.
We also believe that the physicians who currently use our existing surgical products could benefit from the Scendia product portfolio
as they strive to improve patient outcomes and decrease post-acute complications.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction
Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7.4
                                            million base purchase price paid at closing ($1.4 million in cash and $6.0 million in common
                                            stock)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
                                            potential future earnout payments payable on an annual basis in either cash or common stock
                                            at Sanara&rsquo;s election based on sales growth in year one and year two after closing</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scendia&rsquo;s
                                            unaudited full-year 2021 revenue was $8.3 million and unaudited trailing twelve-month revenue
                                            was $11.0 million (as of May 31, 2022). This acquisition is expected to be accretive to Sanara&rsquo;s
                                            EPS in Q3 of 2022 </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
Phillips, Scendia&rsquo;s President and founder, stated, &ldquo;We have had a successful partnership with Sanara for years; both companies
share a goal of improving patient outcomes and lowering costs. Working together, we expect to offer a wider suite of products to more
physicians and patients, helping to ensure the right solution is available when needed. I look forward to being part of the Sanara team
and working together to continue to grow our business in the years to come.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Scendia Biologics, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scendia
Biologics was formed in 2016 and is based in Orlando, Florida. Scendia supplies a range of orthobiologic and soft tissue focused products
used in a wide variety of surgical specialties. Scendia operates a state licensed and FDA registered tissue bank for the storage and
distribution of allograft tissue based products to hospitals, surgery centers and clinicians across the United States. Prior to this
acquisition, Scendia&rsquo;s customers were primarily located in the southeastern United States. Sanara plans to expand Scendia&rsquo;s
geographic footprint and integrate their surgical products into the Company&rsquo;s national strategy. Scendia generates revenue in
8 states at or above $50,000 per year where Sanara does the same. Sanara&rsquo;s management believes that there is an opportunity to
expand Scendia&rsquo;s sales in the additional 18 states where Sanara also generates revenue above that level. Sanara&rsquo;s goal is
to expand its geographic footprint across all 50 states for both its and Scendia&rsquo;s products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes and develops
wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and offers wound
care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the North American
advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX<SUP>&reg;</SUP> Surgical Activated
Collagen<SUP>&reg;</SUP>, FORTIFY TRG<SUP>&trade;</SUP> Tissue Repair Graft and FORTIFY FLOWABLE<SUP>&trade;</SUP> Extracellular Matrix
as well as advanced biologic joint venture products AMPLIFY<SUP>&trade;</SUP> Verified Inductive Bone Matrix, ALLOCYTE<SUP>&trade;</SUP>
Advanced Cellular Bone Matrix, BiFORM<SUP>&reg;</SUP> Bioactive Moldable Matrix and TEXAGEN<SUP>&trade;</SUP> Amniotic Membrane Allograft
to the surgical market. In addition, the following products are sold to the wound care market: <FONT STYLE="background-color: white">BIAK&Omacr;S</FONT><SUP>&trade;</SUP> Antimicrobial
Skin and Wound Cleanser, <FONT STYLE="background-color: white">BIAK&Omacr;S</FONT><SUP>&trade;</SUP> Antimicrobial Wound Gel, <FONT STYLE="background-color: white">BIAK&Omacr;S</FONT><SUP>&trade;</SUP> Antimicrobial Skin and
Wound Irrigation Solution and HYCOL<SUP>&trade;</SUP> Hydrolyzed Collagen. Sanara&rsquo;s pipeline also contains potentially transformative
product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement,
and cell compatible substrates. The Company believes it has the ability to drive its pipeline from concept to preclinical and clinical
development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships with a focus
on products that improve outcomes at a lower overall cost. In addition, Sanara is actively seeking to expand within its six focus areas
of wound and skincare for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal, hydrolyzed collagen,
advanced biologics, negative pressure wound therapy adjunct products, and the oxygen delivery system segment of the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; contemplates,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;preliminary,&rdquo; &ldquo;projects,&rdquo; &ldquo;seeks,&rdquo; &ldquo; &ldquo;should,&rdquo; &ldquo;targets,&rdquo;
&ldquo;will&rdquo; or &ldquo;would,&rdquo; or the negatives of these terms, variations of these terms or other similar expressions. These
forward-looking statements include statements regarding the potential benefits created by the Scendia acquisition, the anticipated impact
of the Scendia acquisition on Sanara&rsquo;s business and future financial and operating results, Sanara&rsquo;s ability to license and
distribute the Scendia products, the development of new products, the regulatory approval process and expansion of the Company&rsquo;s
business in owning and operating the tissue bank. These items involve risks, contingencies and uncertainties such as our ability to integrate
and retain key personnel from Scendia, the extent of product demand, market and customer acceptance, the effect of economic conditions,
competition, pricing, uncertainties associated with the development and process for obtaining regulatory approval for new products, the
ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company&rsquo;s SEC
filings, which could cause the Company&rsquo;s actual operating results, performance or business plans or prospects to differ materially
from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">713-826-0524</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CNichols@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOURCE:
Sanara MedTech Inc</B>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "2 ;8# 2(  A$! Q$!_\0
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M$:E9F^_LTWD(N#&9!;^8-Y3.-VWKC/&>F: VW+%,<@-C%*&.:Y_XI?%#P/\
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M"@8R?:J<*U(XE052T.6[DU9+RWW/&I<4PEA7/D]^]E%.[?GL?NQXU_X*K?\
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M_P YW_!+_P +:1XS_P""GGP?\/:]:)/9S_$RQ-Q!(,K(JS[]I]CMK^L)5VC
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MFGWGFW%YI,$EU9:+<2=2L;R!4<!L_(K%>V#Q7P'^U;_P0]_:HU/X^^)OVB-
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MC"TFHJ+O>/1O16;ZKIW' 8H-&:*Q.TANX7N+22%)&1F4J'7JI(ZU_-/\2/\
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MX-%_^2F_&/\ [ >F_P#HZ6OW&K\.?^#1<C_A9GQCY_Y@6F_^CY*_<:N?B?\
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M\%)?B!X8TWXS^*_!=KX1\73V7A3P[I5T\%L]A'(5MIS%TG\^+9*2P8'S,#
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ME1B$D*;U5LC:S Y&,U#X2\;:5^W/\)/'/P[\5?#CQ+X4LOMUQHDQU*$PRSJ
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M9^*-'T_P#?\ BN2>X@M[B=;D7CAV;=)&FVV^4,!O<#()->I?LC_\$]?V2O\
M@LEXH\1?M6?M1?#_ %;2?&6FZ["GB"3P7JGV'3?$;&,%9)X721HY,* YADCW
MY!/))/1B*-3V<L;C8*5&E[EXNS;=M;76G3U,Z.9858Z&68.<E7JKVEI*Z45?
M2]K>?]6*G[?G_!2_XE_&WQ1X)M-%^!WA[4/ .M>'=+UW1_#_ (R\%V^IKJLE
MQ"KOCSXV^ZY:(&+:V4//.!]]?M>_#SXQ^(/^"=^I>!_V6_!!\)>))?#]B;/P
MOX?\NS>RB#Q/<6<'E;41A'YB (0#C ZUG^ OVRO^">M]\:]%_9%\(C2WUCPQ
M(-*\.JVBAK6UDA7;]G@F8':PV;>",E>I-<U\=/BI_P %(=&_X*%>%_ GPG\$
M-<?"JXDM?[0N!I,<EL\)S]I>6Y(W1.HSM4,.0O#9(KS:DI5)8:G3PT:,J,74
MO-M*HE9K=:M_TQTU3HT\;5J8R>)AB)JE:DKNDY:.S3T2O_P&SE_^")WPV_:O
M^$7PP\77_P"TQ!X@T7P[)<1/X?TSQ;-)'-;%/,^T2B*8[H(S\O4*&QN&>I^P
M+'6O@G^T3X1N]/T[5?#?C+0WF\F^AAFAOK8NIR$<#<N0><'D5I?$GP)H_P 4
M/A[K7PX\033QV6NZ7/87<EJ^V18Y8RC%"0<, QQP>>QZ5YE^Q/\ L6>%/V,/
M">K^&O#WC&^UJ76M06YNKJ\A6,+M4JB*BDXP"<G)))[# 'AYACL/FE2MCJCY
M*S:Y8Q7N^;OTM^+/H<MRW,LD^K951@JN%49*=2<KR3Z+EZI_<CV?3-/L=)L8
M=+TRSCM[>WB6*W@AC"I$BC 50.     *L4U!\U.KP;W/L5%15ET"@T44#&,
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M_*>(L-E^=1I3IXGF4)TKKEG%<SC)2W5EHS[R W+D4^FA1V]*=7S!^F!1110
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MX,UKQ#^S5>O<V/BS39+*?48M5-U&ZC<IVGH""3^->1Q_\$H/BOXT,>E_&_\
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M1P7_ -%5]2? #]G+X9_LU?#I/AE\+-&^R66]I;F:1MTUU.P ::5OXF( 'H
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M %%%% !1110 5'112$^@#[M>:_".ZN9OC3\4K>:XD:.'6M/$,;,2L8.G6Y(
M[<DGCN:**Z*/\*IZ+\XGG8K^-0_Q/_TB9Z6@^3IVH4_SHHK+HST'\0^ANE%%
M1+8H:/NTQB<9HHI_:^X?VD/<<=*=114H044450!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>smti-20220701.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayB+bP9z5Z8GekhvWBzbSlKzyMglF2scSZAmpEWYdID -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:SMTI="http://sanaramedtech.com/20220701" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20220701">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220701_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220701_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>smti-20220701_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>smti-20220701_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20220701.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139655018506688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
    MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
                                            Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20220701.xsd" xlink:type="simple"/>
    <context id="From2022-07-01to2022-07-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-01to2022-07-01">0000714256</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-01to2022-07-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-01to2022-07-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2022-07-01">2022-07-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-01to2022-07-01">SANARA     MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-01to2022-07-01">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-01to2022-07-01">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-01to2022-07-01">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-01to2022-07-01">1200                                             Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-07-01to2022-07-01">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-01to2022-07-01">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-01to2022-07-01">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-01to2022-07-01">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-01to2022-07-01">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-01to2022-07-01">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-07-01to2022-07-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-01to2022-07-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-01to2022-07-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-01to2022-07-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-07-01to2022-07-01">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-01to2022-07-01">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-01to2022-07-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-01to2022-07-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MC$KE5 U3@GII!   3A$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF&USXC80Q]_W4VA\G<[=3!(L\YP",X20'KU+CL:TZ;33%\(6H(DMN;(,R;?O
MRA";2\T:OP#)]O[]TVJ]*WFP4_HYW7!NR$L<R73H;(Q)KAN---CPF*57*N$2
MKJR4CIF!KEXWTD1S%N9&<=3P7+?3B)F0SFB0GYOKT4!E)A*2SS5)LSAF^O6&
M1VHW=*CS=N)1K#?&GFB,!@E;<Y^;WY.YAEZC4 E%S&4JE"2:KX;.F%[?>&UK
MD-_QA^"[]*A-[%"62CW;SBP<.JXEXA$/C)5@\+?E$QY%5@DX_CV(.L4SK>%Q
M^TW]+A\\#&;)4CY1T9,(S6;H]!P2\A7+(O.H=I_Y84 Y8*"B-/\EN_V]K99#
M@BPU*CX8 T$LY/Z?O1P<<630:9XP\ X&7LZ]?U!.><L,&PVTVA%M[P8UV\B'
MFEL#G)!V5GRCX:H .S.:J"W7@X8!*7NB$1S,;O9FW@FS7[/HBKCT@GBNYWUO
MW@"" L,K,+Q<KXEAD+_'R]1HF*A_JHCV"JUJ!1N]UVG" CYT(#Q3KK?<&?WT
M@7;<GQ&^9L'7Q-1'MRK((!8-6;PFO H.-^]=?D$@6@5$"U49 T&84]Q%;%U%
M@=NO6)1RA*-=<+3/<\:<:Z%",I4A@>"K] NNE(=1'D=U@=0IV#JHXE0:85[)
MG8@X><CB975PXQJN2R^;_4ZWA_!T"Y[N.3R/?"UL:(/3'EA<Z2E<QQ\_C!_'
M/Q X[J>WB^GD,YD]3*X0PEY!V#N'< (3JEE$9C+D+^0+?ZUBQ)5<.+JTY;4[
M"%:_P.J?@[5@+V06 IM8B8#EB?STM.**[?ZEY]%^O]]"\*A;)D[W',"9#)1.
ME,[9+HAOX$4@2I.)RL"AX%<55DYWC?KB3PSR*+O3<R#'80@Y,;UX:Y"O<!_Y
M)JO)<$D*!3^/PW,/'PJ^,&2\Y3+#T@\MBP5%<ST^JL5.58X*E_0S ?/6HFAL
ME-6"XOG^/>#$]B H%FHG*^%P.5A_F-SE3]#88(1E*:%X+7A/6,3M7*NMD$%U
M9.":>,R6U87B1>$]VERE!A+37R(Y_3+ABMT.=;'B0LOJ0O'2D$_D&):_IU%P
M@8\]VOV$H92%A>(5X:L*P"OSC9)8I:L1:7N0%)NNBQ&5A83B^?])"V.X!-?$
M<28/Z3JMI,*%ZA8JM"PB%,_YOHI$((R0:W(/ :X%BRIY<)4Z'J\L&AZ>UN>:
M7P;@'@YOV'X]"4LZ6/E^6ZVJYZ]&KY:LK!0>GM;_1S9+TPS(:@%QV5K HQT"
MGJ$7PL":3JT(]3XN/Q&?!QG$6^4RI4;)QJ>2>4+UC0J>+\B/[A4L^DC"--FR
M"*U27ED$/#QK+S0+;>#YK_%2589=C8!_OYAA)&6R]_#$_.8K,GT)-DRN^<E%
M:(W0P]B_'?^&,959WCLKRT]CKM?62[^ @MG8W)$P63VKN.#)2&L<[8[MEX9[
M9I^8DHBO0,B]ZH*NWF_>]QVCDGS#O%0&MM]Y<\,9O 7V!KB^4LJ\=>P>O/B$
M,OH/4$L#!!0    ( (Q*Y52?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM
M;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU
M9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND
M,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&
M@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-
M!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+
MY2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\
MV .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9]
M[/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'D
ML\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y
M+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^
M7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!
M)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z
M!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C
M$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7
M,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T
M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( (Q*Y527BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ C$KE5*K$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    ( (Q*Y50D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " ",2N5499!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @ C$KE5 Y&5]7M    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ C$KE5)E<G",0
M!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " ",2N54#5.">FD$  !.$0  &               @($,"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ C$KE5)^@&_"Q
M @  X@P   T              ( !JPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    " ",2N54EXJ[',     3 @  "P              @ &'#P  7W)E;',O
M+G)E;'-02P$"% ,4    " ",2N54JL0B%C,!   B @  #P
M@ %P$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ C$KE5"0>FZ*M
M^ $  !H              ( !T!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ C$KE5&60>9(9 0  SP,  !,              ( !
MM1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  _Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex2-1.htm</File>
    <File>ex99-1.htm</File>
    <File>smti-20220701.xsd</File>
    <File>smti-20220701_lab.xml</File>
    <File>smti-20220701_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20220701_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20220701_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "smti-20220701.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20220701",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-07-01to2022-07-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sanaramedtech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-07-01to2022-07-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-22-018458-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-018458-xbrl.zip
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MN^"@7J15\,\L^4]3//_QQ4\_OO[I9%XJM82Q_?CU:UB2%S_]LZ1O)P'\DEZ
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M7 6?;%N9F1J5X"D;UZ8R-HN78^Q83!T1W[%Z_ @G TEO8E)X6',&\?I0V;(
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MU+<JXY%7SY[F8+Y;/@4D!E+$DF*SK?VC' @]'[ [+_J*QX_E4#"=J#3BJ2Y
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M,WI1C'V%&??GM3V4?7B7&_&\+N(/8.7E59HHIB"\/^O[8#;,MG9,N\ AO+Y
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M/ZX3!1AP^.H;-KSH2F038%"4;E=K)85(":P.U.V_;B(;@G[18&1HU2M$T31
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MOM']6TT="_@EI5?L<LW)9M_0[3&FYY?CI;D - Q0 OW39KDTB[-1DE!DKO7
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M?2503^X1*JO@ J6B:7&IVBW2]=0H9LE.BSA'E:X,"RF2IY](83BAA!9B*Z^
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M\Z=;H@VT5D+-P"^(H1OV L$9Z5\F#;?W0*B37V*,2I1HU/$G7(6'M=PIIDS
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M#EM.I!<6I)-O6I +H)=//("PXU/2"V"F04/W)UXX0J_ Y8WR[C,U10MWM-8
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M$+P"LX<HP87:XXC%HK/?O5%SSPQ&CQ! "/X >8)I2GX0T7&G,T:64R-$OX^
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M O7184LI3*;J#$QKD%IWHW,-&51#>\8T!S/Y>S*!\FS=ER4PV0_$#UGDSX;
M[(8\!#**;PZ]JFM"K^.1O(2-,_3UN:W>QOEQ);B$93VP!1U]M_7UAA&*-.N4
M\ED<4KL(U\A>S542?] %N+K)] )#Q YK$YY^+X")+V30<.0-4:$0)C<QB988
M2?#)E9SWAL,GEA;3GTW.YS[_\T5,J3]JH;81M=BP<]OV0R14.22X'!298W%4
M;1'9/64D!&@_,S@A+4%!1M+UD/>U2UA##D0+!>!#;S".CLC *=<5+E6$YXD)
M)?A<R &DMI'4/ ;#\R@P2"<)_P\C@K"/20(B/.)V]*:WC?*P S,9%/;[0]%'
M)?JH-4+)N>@,@0M,X.<P<#9)4BW-K%@1 <5\'*AP\1VX+I([!)X%W4T0:BZ*
M"L9QBQ44F8P5E&ZQ<8  AZ*D5CK" <"P2:%Z,KXUTQ1A<T25I6KFF)-] 27&
MVZ7+D/_(BKBI"\R"K/#R)4'0-'<>[&"N:-9,2)6%K8 :(R]H6N2)U;\"0F2
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M4[7JRWY:G\'"\N1:I.^]/H/V\B0?X<;8DW>D4#P=4BB&%(HAA6+5-W>?.O)
M%)&7T9?@+<$^5 />[<IWZ?OBW;Y),_+Q3@)<)>=)W91Y]1).EKFF5,#WR;!N
M'J!+!^OMK"7-GYR4Z!PD?[]+P;@CRJB3^T-HJ%0=8W)"I !AE\.>SA)L@8JQ
MGP NJ:,O',ND('?E@"A3S:@IQ7%=K0["W?861C\0!"QB*!I--Z)5'B##=%N)
M%G6>6K47'+6:Z2'_=K@NGL+.A6GP ]8S2F%'TR)EWW2>)^4B9";INXJ9V3(<
M>U!?QL4L97@\4S^5):A9NVW&7/ $\3@/]TV%Q_;6ZVA>!0;7A1)V&DG:F5 9
M:":*.%H2.%\(U2E6"A5<46)147Z>13,JS_;<ZPY!T$T*2TUH84B%-UVC>JMV
M9ID"Y_GV(.6858CWJ?A1AII>2[--6I?;][LZJ EZVUN.#\LVSS5"R;^N&02M
MQB":0/=*ZIR(@WUH1\?P2U:4;9[D2^@;S(J2U\=>]5][)28"_,LF/-W2<.A
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M'FC+8>+H_\MW*;+JR/XI"$ QJ3AXX]1O+8BBU'K'EN[&15O3-I\)F&!S)U]
M*ZX(XI?TKKXP)67-.7'*ML'6(4VPR*O.)*^0\3!<*BZ'>DMS(ED0Z@]>8K.;
MH\EH2\N2-!_]WK\CG^[9D$\WY-,-^72KKMA_7]:&2TQ?GH"$MIE1?FX&'$@2
MD^>0"GJ#N,XE=F(BG;%!)R-%T.L;!#^NZF@Z"X.X&#<$I5X2W'XF?,Q2F1AR
M8O4$3P#8B5F0,-FV^1;4S[H J60ONRJ+2@#-9X3SGURE!.A/@,)Q@[AX#DVO
ME[CM5" 2<$]1:M2I]%'?X3PKL=1GIRZN"#*9SQV!GQ<N74)/SJ,,W^B6*L%!
MRNX6_@K+K#DPD4X1ES;&ZC[8P#>I9/HC1'7TQ>.2Z@)G_=JJ[#:(OV_#M!9$
MVR7,Z2@94]%R8@6#,K(%PHN#]2+O25H2WZH]()_N:-<+J>MB\J/?=.Z;BG1=
M/:X/KQV+WY6Y<>TXKTV#/V"EN_0=D6!!$K[F-"21@4=.ZE-D"FR9;\[&'7O2
MY/P$.9/.)";_J0/ <\2L'Q%690O25E_"5>0L;0T>Z*,=#C,OFJZI<_;.L/V%
M@\I"VTSB$9+&Q\JW+1!RC@%!F\#D/TU.HU00?2[& U 2E0B,SZ!"$^*_)3"T
MT$=#$U'2/30]X0\B/4$ MG987>HV0?T'PPZ38=P2*_%'<Y8._TR5S/H#<IT+
M?KBXJ,<H^:\<-*;N5IJ8LL96)$R^(P82ES^9, V>JE%I:CCKHK;'@;R;OTN)
ME0>FQ5F.<!1<(:Y2AG'OD4#[R)-ZEM?VUAL"!8\PB1(C2D63L1=^X07RWER;
M P_^XT&XO[]O'/<]\Q3=(BY&\,<7<.DB>)H.$"S6HDKY5'ZQ_[\L(J#@DC#,
M'B56WE(C,9=O89ZI+<_:MR_>L#'55.O<I;X:DF</(^H_\OY^%TT33^-5(' '
MI*:9%9)":W($7;=+RWT$TMC)M<-O&BM*D,9+=:V+,3I1HN!5"OV^2L?0WK.S
M8V4W,MA</K&7PPPF-&%*#1;_>?3G2#],$$^G1K1\_89Q]2=SDM/SZ:C(*L,B
MEDQ!EB,UF)")40T\_IU&%CQ3*"0$*=I@82/>XG0F,?)6?-%#T"%E3DX62P7=
M8G]6X6*[*?ATSB 0;Q@+:SQS$5JR0:7SZ=[!<U CZ>"]FZ**Y^XM/G!1P=60
M(J5M='!&6?!1=R'@$MC>BNSDX\23R/=>YV>]R9)"?HS.;-1V=;7+;D](1P3K
M1ME9EI=B>\O!D46J>],26@V*A(=9$BBTN7Q7C9^;J)0(.%M$PF:GF?(^+;??
MM4'$KG27^D3L\P=B@U1>0%RQ[TG9,F1SYXEP)%ZGL^IE\"DJP2I#$K"C&-0F
M8[/_[O&:85&M4'G??41DF4P2*UQ-FGR6"=$VNGU,D*-%!=J!95$S2[?!5>(
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M!1FDLJ<'P+V/_<OK1? 5G5 ^*9<2W0-2U1*5"3N(/?A#'YC3KZ-PZ^C)\X'
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MNT(FQSMPA)SH5=N"ZDA3 3VDG!)LYL0,/\=8>6B$6:YUKO:;<&G2HC;#^;&
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M]D50'RWF7B@R?PHSYR!<X-*@YP@7CJ128O-DXIRHM, #;6\YB5D( U(VPF*
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MR6M,/G!0-(_@GY@CG:AJ?")H.:-P^=2$:DEV0)=5MI2'U2]^$1D))E;C51#
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M6O8-K6YC;W;A9[8P" T^L@-"Z!4]+A18\C#;1E@'#2G1?D6I%06+;CU;)U>
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MJ>VP.DITOQ9"+LT>V[Q!?Q=M=>&S<_ ^CX0CFE1?I![(BJHIV9]#-@ -CX=
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MIZ3]OJPCS!^R-,ECN3H,LH2<7K @D-.RR.,0*SGJ*]CVH9/S#1>"/,OQTJS
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M-">!)#W7MW=N;Y8C]G6[4K6$N#NY5W!G*K=Z.8<E(1!_@XFQ^%D(WB)'IW\
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M,S>''-86+D;CO![<<BLP1\_V]E^89.UR\)S^MN9CB4DK=V__H;(4!>(<8:U
M:Y@E.%O9/#C%US*2VFF=3"OVWPF\VCCZ?OE7#S\6OZ74Z\7+X/V,5-Z_!&=1
M50^57[][S=,W+:-YH*7]\ +ISZ_>O_X'PF#\^9?+MV=_^_\!4$L#!!0    (
M (Q*Y53>3C['HQ   +E*   *    97@Y.2TQ+FAT;>U<;7/;N!'^KAG]!]1-
M,W<SDBP[+W>Q?9[*;XE;.W9MI;GT2P<B(1$Q1?  TK+NU_?9!4B]YEIWDK1J
MD\G8$D@"NXO=Q;,O],&;_N7%8;-Q\.:T=X+?@OX=],_[%Z>'!]O^-ZYNA\L'
M1U<G'\1M_\/%Z4];0Y,5>V*GFQ>BK\?*B;=J(F[,6&8M/] 2M\KJX18>Q*/7
MCWUN7Q3JH6C+5(^R/1&IK%!V7XRE'>FL79A\3V"*>F!@BL*,>6SK\.#LZFU_
M?KWV4(YU.MW[9RORO4[_JCR!6X=/LX'+]P^V:4)(Y/JS\&+U*"F^.BL'1X>G
M#XD>Z*+9>/6JLW.P?73XF1G[#VT2.*OVZ;.PY*EE,D5WD<-4#3\OZ>>7K\7M
MS?%/6^KAU:OVSM^[W9W.QWRT)7H7_9^VMJI%$D4ZLR>>_TCBG.BX2##%\V>=
MW1<\S1=E^F/I"CV<;NB6?1GJ;V4FK6PV+E7<5U$BSK.H(WI99LHLPES'J7$Z
M&PDS%+>PBEA+<:1-:D8ZPKP7%\>B%_U2:J<+;;)-E<%F[^#9U4V_V7B/GV]P
M^\]B6_RI3*?B14OL=G=W\=5OL9C;86*U(XZD4['0F3@SMA#O\2/!!.I!TGHK
MSW3$=T_3^)?2[/MKK:>6OXDB42)<.3;C7&;3ZE*S$<8GJKX[C)C25B/&5H.E
M"V/?B^_>]FY/>G_9$[>7_?/O6T**W)I['2M+JHC/<1D53L@LAH2C)&.5A.2&
MF,V5V(%(IGPU2JS)=-1L3*#1^"JM$K&*<;T \X41>LPS0\=S66@X?F'*(C(L
M=1GL@&Z,Y12LRD+H0D2P"AH$YW*F_K]A)+7H_.6*S68#3_%N[?C=ZHAKJ\$"
MZ"H2[>9G;]5S3R0N@,M!.]:NL'I0%H;%XC?FJ74TN1?.1Z/!T3W8*L%X+FV1
M*=O91#7?8"/]FXR29N,L56.H66MYFXY/KUK"%:2/K<H2>D6XJR4FT#%L760R
MW),5T)74F#O25RC)4&./,Q#R:8M@G8UD)A*5YLU&Z>@Y$*35O8*J6S$R,!5H
MSZ<-@2=-S03LT5%PKZQ,4U#D"M<1_24]%<,2CD19-YM\,!4RCNE9J"V$K(<P
MOPSP+8?/&9I4&UI?QO>2;6T0;&?&%//@I3#.(480)^V4&*$UHM):(K>V^_ <
M)ATRR1WX+Z; VQ$D.E I\P]"FXUYXB<:G*F'G#BFN>5 I[K@I8+QX)8BJ6?#
M:HF2*4;<U!5JS-*-,3N$!&[')A!M5:(RAU%0J0M%_"Z3ZSKPXMCLU)DY^L X
MN9D\F3H=:9DY,4E,Q3*4H71^%]4#? &)>&5:K%^FD*K*U!"^:VC-F*>LW$DE
MK7HS(!$2N9H*\BY$1>4EU7K5B%5D%0X33.%@1U%9A)TB+PLAN4YP>!MGN9\M
M;/KJ[K)OH2LR(O$W&R>JD#IU&^D\?]/U]WM'%Z?PH!<7U[V3D_.WKW_:ZF[Q
M]]OKWG'U/9!111O=[A_\.H]A-P2!JR$@*.S?/%Z(\ \%F6DE.4Q/"8:#_LGC
MYPJ,=1%$Z8R"J/[)X>>8Z.GO7[W\X=7^OS_?%U:-)S]TGH=<S[_X#^NDY.8'
M[*U*&R7\P>J(7)N.A?3@CASI=T]V.L_K)P"3(^D2]G=/7G:Z"Q?,>$QF]AA*
M7&&BN^]K?28);_=OZ >I].>Q3?^S@[U<NQ5A$!!"T?3M6G^^L/O\9K3_ST;;
MGYC'64IN"NBG!J(9EAS%*&D1E@&PR"DA04<?Y" %#@+*H_]92:!3.@!36*?2
M!$>]]2).\L;J[>]QA,AB&;JK5/$)R_XDIO6=3"&-D3430$(L/@6Q&%?L-_A+
M,0'\'A9$D7<T_^,^X-OY_<T5?$(UZFR(-Z?'66.9R1(Q&,QN6*9IFVUKM[N[
M(RP"IZQ4G"9Y\F/G67U2DPG.GBHL(#&'T1.5WJLVG ),-CS\.%)XI9V=.5#P
M'480XEW*J7@64CO?KPF5\16Q)GR(3T4-*)V$4*H(0=>BMWD<3:?7M^1__O*,
MZ.!$X/^SG_FOCW)NIA( \CHA_<E=G>NK3YIKJYPFV;$6#RF7J>Q*VNB]$HF\
MIQ\Q9PBC2#D'\ZAR%R[1N<]?A/PNI4O)<MR^@$-,.&J7F590-I=0PD4^.CT4
MTD+OC0U)JI&B\Y?3+E[9.6]#J1G,/N&4;IT3F65\#.=.FHVYQ <M$]:&A"B=
M%;)@*G.$"RBIP25)X4Q:5@8F[V'G# \FB<I$IE2LXHXXYS0:"6 B;; ^SYRE
MQ)'/D'@A%4J.FPU:?;+$%#T682LU^1M\IG.?LS&#$B<[9$\F2#.QC/W=8U5E
M0\3&:>GFID-Z VAKL[$^/;^1'F.S_5W8B&:CW@D^16&.8U^3VNWNO&2+APD/
MJD+5E4TQ9%KB+#56Q[)3)S%=F><II;NEL#(;L3.A@I:ID\DTES-#>!_M',QU
M:**2IJU<#J7&_2K>*XE[:;4JI@NI6@?_A4@$/LC-UC:YLG##7)0A?RQ2C2LT
M&:UY=M(#JAAI!\A/Q[Q??2 S=C[L'1"+6#GB&*'9J&LZH:(D4]!OY8QP+XUY
M3YD8E^M"II W4:KL-'0P>)\9 >94+C2RQG%R5[S+& ;=$L5NJ>ZTD!-?/8P@
M.&!GFAX^G],G4![-E0E?5@M>S\'F$B6)\VQYO>!;\Y3((A_N<^XKD'"DB/L\
MP0X.C2FP5C@#\5N-2.ZTE+9K\MZXPS =H2Q9TY_)D+J'I#'!:#K;RY'*PF96
M,%+C7/[1;ZRC$-!048!2X4]>=%O=;E=@]WUDA_/%UH=&;)27LY/P^,N!(TP$
M&T[1:Y7J=W6N'W/0L87-SRDE7V:^_M!LK!=1"#F#R.?J$CLUU0N$<7UAE4W/
M$].08BA=(9EQ *G&;+,TA+Q^?[R:497H1;>B@K2=088.9:IE1NHZR,9YL[7G
M(@C_7;LMSK1*XSUQC?W>QP2_E"J+Z$'1;H=&M8.3\[]69/RSCJ.7-#8P%JBI
M'CM*970G=CHO<D8^.J:0]C&!=9@O,FDJ<P?BJD^S#ITZYEX\@V:1\YIX>&W'
MT2P,G9MZ)L'EV.1@&\)9(Z>!5?*N/5!0*E"3LW#G9??RD]U:UXNB#L/5^M>+
M*\YMX#;MH-^TC57)+T,V%!(*".R+H(24R-@]N!QX^R^$X59;4[X:!/I:K&XP
MLGN/\!+XP>,K2HG^1N!8))#D*!&*.GO@%ML>VU!%G4O9(8S[1#\2^+I3% K6
MD*FN1^, ,[FKFGX8^B%PX^:?&A[0>435\\%4+ 69<X )Q^H<NO(7N#$HYM-M
MON!-DSM54!'>3\,Q+DY?HJ'9X.N>.CN6!:'2J;C7..!ERMT=95HP+L$D]EY3
M\]V]IN"3^AUBD).MPHA9U\<"#(/<:@SVEE"PZ &M4<\%-J;JLICKAV+Y5/ I
MH$RK<@E4%63<6=Z ,.X9FA/_L4I31A8W/Q_<OKL^? KH"SVFC^*V6J(7%?J>
M@&*S<4PG#=#(\LV ^%<W_?.S#Z)_\]I?!%:+5357WU-YXZE\S?B8T79XZNSB
MZCT=(&L>/7W UPATEBE VZ4$[0_<\C#!F*#>JI5&E*4NJDKJO<OK"RRV9HV_
MDG%H3'&>T:V4SSNB*H!?K25Z%Q=7QQ_Z:\AK-GK5\L<5C0N/'FGP>+DB7,11
MTB]TB=WG?(=_@L72/_VY]_KT[1I*>^-,&YS<V-GQ *&3$KTJX&"HQQ"VVCB_
MZTOM-'3'$-MH)FSC\RK)BA@FF=,W/\V>6' ZGW2L1^>]/S^]&@-3[M]6WG -
M'UFAQQJX<X#X#(?$G?8)W_>\['&J8,V4A?IB:X:57JOT2RY2\=5L^.7.K=4C
M[S9NJZ07L?WFP_'5Q9K9WDQC:]+IKZ1>P?16O8K.$9-DH16)\EM2PQ76=3AX
MF(*Z2RA8EZ1RS4;50P07$R,NK^#^&"H2J*-XO(IG'.D;#H/$8'GO0V!J0YV.
M6T%-K&JKG.IV*=;3O\J:+ZJ9P09;(E,0"<T3_%6L!A:'"(54+9^L(Q/W"<U"
MDSFX<N#C/6Y:JZ/"60"F"Y'XSJ?YMJ^86Z H9JGEPBU4D$ND<DYFYE;YDZ'J
M.0U?$,S[DX@#/>PZJ!@KQ6U:O\#MTPJ2N1W!S@N#N-TB0-"6V9@Y7>WFV_^<
M4IR$3$TV:B.T'E=A+ NUSO.ZT*CF#V+N-%WLIZM:NF9I7+A0G\==Z/%;,O<9
M3=[?S%$TBPQI:2@J2<W!!7DL(*E)#(0,Q9ICN<J%\&':FCM86XO'4WT@]1,U
M/Z_PC;TS):A4"B(=FWL)JTQFNA\%W6_-'8B#64XP4R-6;-I9Q[EE3S%%YS*G
M;L:/948M<T&@GD8BWSQ,,6W5 3@-78&0T(AU("26?<L@\ZUQ0&#_IO\C0>]_
M/]E U^=9<%W4M",IJJ 6>*H#M"]";RVGJ=@*-Q*$;W8(T:>N7%?O@(>RVGEK
MA#VGW&S*3BPV(C.%=X^Z(!R.&^%)V5<,905$0GTL5'O:50?U;(WZ_83@N<A*
MQ\ ,N(L]EO=!@X^A?.43>T.JM-D!-97 !5%V<S#E2]>6\2T8C$JK*5LL+F9'
MX0UE+<:$@LD?[+QZ]8*]F5-S]$#B=#()KODQE&PV:'*X>T>%O82 :N *QP+"
M@YQ.MN77+*JSK1ZGTUR-\W3=S54E:W6\3..5=SH4!#Y>-XTO\BV/4KHVBY='
MP>7R$&6$5\8JZ+%"!50"L5&Q0@3&4\ F'%6K"UA#V[CR")UB*X/UQ61>"-5H
M ;-0LYEF[[OH-%U]O66R,$4X[ZJCQH6S@12;-KG%]0=6F.5+]*CA\J,#BQ0@
M0.1D&MQJ[56IV?BTKL.>HK2,%]0-$ 0W\R%.W>9URU7H&G?+&E[ERQ?J!'Q^
MU\H8$\* !;+]?.(9R@\LH<^Z=,J%;M_Q-<1&9E1X\7$UUUN(5C"-J+E.#\S>
M?)G!MU"+6:JMJ'4=\,YS,(_90/G\VQ7^ACFX)G/"4+[H$%5$,P9R ?2NJ3_
MDN?*PV:2\9L1"XS14W.5HLH_:'[#0&?W)KVG6K>[HZ0$FRU01Z1#_H->6;($
MVMGS5-YBZ76&NG[BT;*E%O%,W*DI%32<R3*5>J ;I.1YA^,/<JD@/^ 6GF\%
M8.;Q;Z@/43<+(#+!J_#T<*B\UU.@VB"L(>H]LG3 8H36 8^]-E%7+K\OL\B.
M=,Y %4B_&. N;QEW"83=(%!I!O2HUY;5?:,[5G:80$$M)T[-C,G3+96=YM0X
M $!OE/_BML3<DS\KEBT7J6Y/CV'$W**$V1 \1$EXDR.2I5-KGX&U439IC8%@
MA#$/2"#W42N@K[]A! *@XJ8O*,::VS.(:<L!'RCQKXT8IRIOPZ2WZ%E-KWK4
MOF'A'/L&:[\2V;TT_4V?C\V5=W"W"-=D=: (BM3)!7OMXE=^?'XF5K.0IHJ3
MN>6HD'<@*S,PJ[3",U 8J^XU.UDJES<;RUK@;QFFC)XH;O-N/=(V*L>.'82K
M#D03^9>;(J[AE]G\@4*U2M)F]<"AMW15O,RZ)W-^XXAC_1IX-1NIG'Q3PZ\:
M70'-P,M2<C<KX)+V-C((V>P0ZIC:1A#=OH5A&RI=G,!*HO"><+5#B$12CS W
MCK\?=IZU?]Q]V>Z^V'V^<<0?O#L\#AOS1\?(=:QB>FFW P!TL/WN:ZG;K.B]
M(7([.KR]>G=S?+JWK@KL_ZC!QBG#O]$[LKLOKG*VVSUQ(5WQK97DT:TD7[VQ
MH]+';?K34_YO4=&?K/H'4$L#!!0    ( (Q*Y53YF84O>1X  &;M   +
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M27&-X*!3M=1[(TV/MBP&LUD6?&_(=&LA(S_WJ6D&GU^\PDC0(8PE&(YET;X
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M+0KT*V#>PE:D4ZH\Q96&(W,)50H%6*1-5*TFR%VT"(E%15 *N+JHJWXTBK)
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ME@OCW?D<T8QR,S"*.19MF'(HQ_>D68WV=6^T!5QO 9Z."C&V$CEC;5G*158
MM9@-K(P?A' ,/'EE:MM>^$ A20.OD0AZ$C9?A,AJ@[^J R&(Q!A>*[@\Y6$$
M[7/DS"::8-,I1;'8HT]=&4,!E./'2=I1?@G#C5=Y_7#H."%;C@ 4A-.]#RY_
MAX)+DVTZI;U%D$T6J!L@3UM1K?#=#D,F4EXH:?M U?@:^\C)/GE(3VHHR2W
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M: 6W$.A%;3/(265>:C,4OKMG()JUU2%TR:P,+*$I(@4JMU4]&7(+VHJNE+5
MZ7B!*PAGG?60M9;(+M&;V()Y9)Q-UF>VJ>&AB1H=E;;0?(OE=T8&9"1B&,1F
MM8C'**7P6V"$<NK*$W\R6=3&.]Z EK4V>DIAAE(\T+:/&73D = )U&"BP6T-
MPX"*%!%":AH5^DO:(=3.V(F&FMG4[_6>T@,&E_:FPIQL#'WYV$MJDSMK9 "T
M(P'5&L;0/J;PB<F% 08CJCZ!I.2# 3KR?%O#6(0"1P\V1@UDZ_H/23385 !?
MR.CCU!7*'1+L&6#HO8G!+UVHGF/BXF!?@W7J;07=[Z$1 LZ/*E()PV;/, $F
M5'PD13<5Y3ER BH&>KAKCYD;Z51DLB<HS9=E='$B0X*A8.4;RDMQN;@%O>0]
M,&9/XZ'8;H&<[^+]AH ^FP#W@VO"15>&VD&(2 ]$2#8%!JI'T U; *NR ]\B
MB/>I3J-DRZ.X[=&AOKU615T4LSS.!J/@#QAC6'ODQ:@ AP0$X0^4/J"A,0,D
MM9BN:^0QO(2N5]^'A1L1<A.Y=*HB,[>P1DLC\(D%3=\_\"9]RPQ@ J>2!P$Z
MJEXJ#1@&&?\M;JLKZ0ANKZ=Q(C?B<0F)RP]S1D%08CI$$AIJ:JZ]\>TQMAW#
M4SJ%1@6F&;+':R3\_8N29THR.8;?T\DR8$D4.LIN"<>,5+]CM["><_1JNGA@
MM5:-9&;?D?:>JT%2Y/9S%I4MSG9-88U0"6N$JLK:U:9U--$ 5'K(!4@P'CX5
M(%7%8M<*O=[%NS_%THQ*VI@*Q"TGLBIL9!..IY8>]2UDQ9#T4N102#R+ZV@\
M1@6/%]&6EO6RRWK99;WL&Y2O<]&1Z[E"B5S:D:MIFACG1VU84S4:(U-IJ1@7
M3C&JN/5(-XY'I(,:'9ES>B2IKA/:TE:.9;?BR;5TJO]DD<&$%E9!O9@R5I&2
M%P+FC7*!Z93^'HM)P,Y[X):%?H9$AT=O&2!U%+2QY $UZ1+)Z<(\'1NPGHK*
MAM6BP5$U'7V2Q5/*U4@\I"MC#7A*=TWF\7LJ$!6OX8VV'R4+D\Z@E5?HZDII
M517EHM>-U<%XLG>CL(GS-UC'MQ1HAQ@HZ?E61U7-RAYR]8MKT[QK7V4+N3.R
M?T>'Z)SH0,!B"]YW&/0.3R]L!*<78N65NNB18*1&!%4^6 OA^+:1X)CD2"7,
MM,C 6JP?9EU\U^8B'DU/IW9VIN=>EJF4Q:.J"3T>9D@B:EP*BLB9B2"W@L2P
M&J>5J H9]96)%2Q,"T*!)NIE,]!',E"FU9#,449S":/3T-O/O$<BKO>" IE(
MPY'&@ZED^.Z! ]&W6*2 4T5E@W,SG&EE2SW,$*E"'=MQ]:IX=%$J1?J8TR]3
M0?HM/%-?<Z$"WNE4%/"U\(H/F7Y1_AZV5.5[81PYHJM59,)"YI;?#$E'OZYG
M!"%BUX(Y?'25 #R9<%'P+9GUM;VE'62@H_ 6 ?DN9&7]J2BR9,6EG_0V5@'&
M<CJ5N%G ? >^X#8R8D4?@%ANVAM6BJ.#*YC*ETXGZBG]!K5@A\5HA[5G)J6]
M5'W(N4 0:XD><#1&K&IQ6BI-%T:"27@,$H^ HCH+ZJP3C2]!A*,2:WU,JZF7
M+X:',6$A6,'I205L4:4M %U;1= 80S&N0,)[(J-3816HG(M'%JNTG4IU32C_
M]QO07JA5K+1 *IV[CLQ<TH@RB:2VE[)H0651'_95[F)$*L7+E9+$4NM[Q)).
M;VJY1%Y/+*%Q/CG7+R*6%M^P73%7T:]1ENM"RYWW=-'\<R]OGMUMV;&7BOX,
MP@O#6+BD4R?WY WSB0+_)5"$2RS._;VI\[E"?CX;<3BJ/E^<^\?G@(I2KOB?
M>1+@?"GN1]%(2=?%>SS9H)0MYKI>;Y:H?=XU/&O2L#!)_%Z@V)T[B9<$)=^]
M0R;NSLF1$(/T%Z1OC!!KZ)94/MC9F3V9G\N\34/G;3!<GD2N$2+7Z2.R\D30
M?O47)]UBH?SKTNS,L%C%HP */%F()46QOH_GD'H8C !3>05EM6GJ:FE=3UZW
MY0U&5P>-SV%U=:04>OF2L5<%_S_I5%6?[QB=4$'UQ[1?%T8$:%B%(\_!MO",
MAM/#M\8G2)Y-&3)=V5@=JRUI9H^C&6MYEDJ-D4[I&>51(0U*6'TS$G+"[_<M
M"0?%HQ%!#5&MBOT07N'1=EL5XF 8 >R%V<4(WMHMWX_7XZXOZW&7];C+>MPI
M^G:A;UD'W[M9_W1:N;ALU)HS#;V]O9N[%SOP/W'3V1.5G\F5,-'Z4?VJ Q.]
M (/*8Y520;LL<K0?#ZPR/*0K=6*+=:G5!G]8E</(8A7=0E5W0B<Y'O6]KN,"
M^.;< NO+N.UK>%:H$<(E;/P^RTT ^Y_MSL&-B8%<GBW,Z$(K,+4?/6_X9PO^
MW%S'>>+\]=[?_GUX6)@-6P*Z6( NR7ZA  7-CE]_S)2^PVB8)]#H!,@HL8(U
M$BI&CV!*B&U)<DM ?QE EV2_!/1[ 3T8/N[4S*=.8^8Z@N_G15XK"&YT*;/(
M88Z<&*>,6WMYOB U&[\L%2X,H/A.ZGE% 69:3Z*80$$7X80E%[SA35L80"_P
MUO-%8(-JE[.V@FUTCN"LW>8&<TDR-[R7Y/SC2=-RY$V@GZGPECG4A<L4ZC4%
MZ8!\RS&'2+;YKM>S]N/;WV306>HN,C ''TC]4/YR7=@^N)8OS!#R2D,)ONS'
M_AP<W9B%X\YMY4OWGWS%'-R4OM[>K1^>UX=W?W?$%WZ\>75U?/*G66J4V/H?
MC?\Z7FFCX7PZX)^,K8UOW<K-4<^BFPVG]<T1-UU>*[:.R^:7O^M?3S:<S^SV
M:ZETW.ZVRD=_M0;;=^7\?>G@T]7MI_-_SD[*=_;P2V]GA]8]J^H=B<]GYLUQ
M\]-7>G%\\% HUZZ^%6XN_WO;O#'/[@YZ?QV?'5:+[FFMO^70FK-^UW!HR[TK
M;-7_ZI_^66]L''7R#Y\^&9?-G?O&EXO_'K>Z%]_.&P>'I5JY4RQLK>\4O:'G
M/-"OIQ?TO\.'+:==/CG_X[C[Y^67CQ\52OX?4$L#!!0    ( (Q*Y51R$CSV
M+0,  +H+   1    <VUT:2TR,#(R,#<P,2YX<V2U55ESVC 0?FYG^A]4OW9\
MD>: 0#(Y2H8IM)F0JWGI"'L!363)E62._/I*/KBA0%L_2;O?]^VNM"M7ST<1
M10,0DG!6LWS'LQ"P@(>$]6K60]N^:%\U&A8Z/_OP'NFO^M&V49T #2OHF@=V
M@W7Y*?J&(ZB@&V @L.+B%#UBFA@+KQ,* EWQ**:@0#NR2!5TZ/B?,;+M+70?
M@85</-PU)KI]I6)9<=WA<.@P/L!#+EZE$_!H.\&VPBJ1$S5OY.7?=O06D<&$
M7#YJQ?)X=$>>>\!.DFO,AO()CR\_=6[+;X<O)S?PVA\\7;YUVO3KV[C5H_62
M#-HO%U'\Y>E'V+C.0E9ET(<((WT93-8L4U]>WO# X:+GECS/=Y];S7:*LS)@
M940)>UT%]\OELIMZ"^@2<M01M) ^<(V[@R5,E+67;, 3)A5FP1P^5!/"+/C0
MS9QS4+(2>I1!20$-80$G(7!Z?.!JA\:72@4PD78/XW@"[F+9245SQQQ8"K4,
MU,9%D*W&,<B5T,PU1VBW[AL3K,0,"]TLH8*@;QHSA7K'GJ_'BT($3-6YB*ZA
MBQ.JL_F58$JZ!$(+*2QZH$RGR1@'L(UDT;.8,:Y;6\]7;C&V.":Z=[7A7=5<
M<D5P"O<Z>V06>J@V!# (]XKKU\%")*Q9V=)(:>%4+(0N822-F(^0CVPS,(DI
M42]32M5=!,]()!+"[^PL7<<"I.:E)32U(2?FD#6D -,@H;MQIJFLI.2&XJBF
MAU>,R1UT43I>%=,(-4L2\\!9N:TOH*MMD2)V<4<_=6F.;I0"8J0WC%=Z\HNG
MD0<N)+ (EE26QE^+\!B$(KI;9V8\2YTH0[^="8-,'&DA]U^43'%GUY(U!>A_
MK+5I]&>+S*?$G8Y)OE\<I:HNEPN%V-)@;GH<LV>]R8-4:@/%[.R"9QN3[9?L
M ]\9R7":Z2Y)3$]@MR0*WAY)K'FB5\67Z^!FD;;0MD'7//4;@Z[DN$"5+"Q[
MIS#[8_B+'%*9G9*8N\Y0"==(&%'/]GR[Y*]/YT_,="_W:H* )TR)\2Z-,$LI
M-OO=QO27OMU%%/CL$LQ??M^P>W3!<O!5+5!U,S6]_ U02P,$%     @ C$KE
M5'*4Y-[^"@  @(8  !4   !S;71I+3(P,C(P-S Q7VQA8BYX;6S-G5UOX[@5
MAN\+]#^P[DT+C..)LRV0[&07&4^R,#:;I+%GMNVB6- 2XPB1R8"2$_O?EQ1%
M6:)X)"5%2<[%C$=\#_52?$Q27\>??MQM4O1">)8P>CXZ/OHX0H1&+$[H^GST
M=3&^6,SF\Q'*<DQCG#)*SD>4C7[\X8]_0.+/IS^-Q^@J(6E\AKZP:#RG#^Q[
M=(,WY S]1"CA.&?\>_0-IUNYA5TE*>%HQC;/*<F)*% [/D-_.SK^#J/Q>$"]
MWPB-&?]Z/Z_J?<SSY^QL,GE]?3VB[ 6_,OZ4'45L,ZS"18[S;5;5]G'WL?RC
MPC^E"7TZDW^M<$:0.%XT.]MER?E([K?<[>O)$>/KR?3CQ^/)/W^Y7D2/9(/'
M"97'+2(C'25KL<4=GYZ>3HI2+6TI=RN>ZGV<3+2=JF91FG3H:TZRY"PK[%VS
M".=%M_?N!H$*^;^QEHWEIO'Q='QR?+3+XI$^^,41Y"PE]^0!%<T\R_?/ J4L
MD22,RFV/G#S8S:2<3V3\A)(USDDL=W0J=W3\=[FC/Y>;K_&*I",DE8(/L%VG
MC;K*H(EKLW>$)RR^I.]S;49[LB^^.SS_'QI0CW?>A"7+<?HN\_5(Y[9OR/N.
M^"'._9$6XSQYWY&N1?Y?;.=MRV\^O/;CFLJ-U^)3PR+9Y6("([$V*:OH&(&+
M/1030UEW53N+&O6F<C1GO-UV.3,6=68D.EJSETE,$E'W="H_C.6'HMGB/[_/
MF%@)7*RRG.,HUS45S3@?6<HGIB6IO.#:%^913^-*Q21B8FIZSL>I.HPJ_(&S
MC76W9:N9I?#W=%7%J\,B=@$8;<@XR=B61^1-O5)W"QVETM$F%0JYI")T_'4Q
M^J'0H-^TZC^?)H=:''2T6 )M-X3F2U&CI07-8E?=;#.E>[E>%D0G6PR9?:PE
M2&H<=_"%V'$L=WZ5XK7%OE'NJHNMMG0?-PJ#Z&2;([.7*PV2(E_=_(5D$4^>
MY7*^JQT-F?-.MYAL]7U-$Q8";6,P"36MIX']GJP3.;5("_+\ELB-'<,8H'<]
M]'?:-N<"JS@(:(8X!&>+>A"JHCQQ=$'I%J?WY)GQ+GR:,M?4V$R:L-0U03%B
M,0:BH;1(B3T1\8^M.&,G/-WW0M%2NN8"L&JB8<B"HL/N#02DDOME9,DQS1(Y
M@/5"TI8Z/]T S+9./0Q=4)P YN!3DDKOEY3%(TE3>3\ T_X!Q29V30MLV.2E
MK0R*&- >R$P1@<J0<+"Y?)&K<[%,&MC8FMXG/"W;7?Q4XF 1,AT.I*@(0S+.
M$TFUVQ ]#+64KND!K)K<&+*@B+%[ UE1<E3H_4-R2>-!B%0Z/X 8-NUXE*(
MX6@ZZT-#J'V"<95D$4Z5ERNQ+>MHGD7K&A#0K@E)2Q@4*) [$!85H)DI0KP"
M\R^"^3!<:DH_L+2LVE&I9 &"8GKKPT3JO4 RVW+>< W/.+#4V4W9'K/5_5E
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M]4W7XI/8K#>)OU8X(V++?P%02P,$%     @ C$KE5-P-:!%9!P  WU<  !4
M  !S;71I+3(P,C(P-S Q7W!R92YX;6S-G-]3VS@0Q]]OYOX'7^XYA(3V>E"X
M#J2DDRD%CM#V[EXZBJTD&F0I(\DD^>]/LN,T/RQY>?'" P1G)>WWL[+LM22?
M?UBF/'JF2C,I+EK=H^-61$4L$R:F%ZVOH_;EJ#\<MB)MB$@(EX)>M(1L??CK
MUU\B^W/^6[L=#1CER5GT4<;MH9C(]]$M2>E9](D*JHB1ZGWTC?#,'9$#QJF*
M^C*=<VJH_:)H^"QZ>]1]0Z)V&U#O-RH2J;X^##?USHR9Z[-.9[%8' GY3!92
M/>FC6*:P"D>&F$QO:CM>'J]_BN+GG(FG,_=K3#2-+"^ASY::7;1<N^MF%R='
M4DT[O>/C;N>?+S>C>$93TF;"<8MIJRSE:JDJUST]/>WDWY:F!Y;+L>)E&R>=
MTIU-S?9;%K#?\D2S,YV[=R-C8O*PUS83>2W<?^W2K.T.M;N]]DGW:*F35@D_
M)Z@DIP]T$KF_-GJ;5C411-E )(;&,Q>UCK/H]*7ME=;=O.Q,T<E%2Z>&V29Z
MO>-WQWD#O^\8F=7<]D[-7.=J19V=QN>*:BI,KO?&'M@I0I?&]BF:E!6Y]E_D
MGF'&E5AWFV[4=GTL2VV#]F-AN?:F](?+>,<%[F(A]_26_3HGKFE\-)7/G82R
MCF/@/N0P<A#VGQ]Y0Y=C;12)35D3)V/*\_I_6)L]DTX#7I4D'FV-U4[M6NS[
MM!VY2Q5'4B546=9E743%._$Z[*)KB\Z<*%M1.YXQO@GU1,G41V=-0GH<W09E
MFVB&YJ5M/W$^##B95N/<,P'R[&( K52#1?0CU;%B<\>E!NR.)9!O#Y5OA;:&
M,9?GS@.=,N>O<\5=>*D[&!X7/$6 X$\P1XJ@6J0(7 J1$?Y YU+5@-^U!/)^
M@\F[2AL2YK\SH@Q5? 4A?6 ,A/T6$[9'(1+O1T6$9HX/!/BA-9#X'Z@W'AZ-
M2,A',\JY2^:( /7R*GL@]G>8V/TZ7P'XZV=W?;>7%CC[K2) _'^^%OP':I$B
M<$\5DXF]I"L ^P-C(/533.H>A:B\KT4"I;TQ!><_^+#WY"&A'C =$UYX-+#'
M=!AWA3D4.4K.62L3%?N_E"@P]"UC*'*4-+1&8L/ ^YE2.\X$1Q6_-10Y2@):
M)[)AYM?",+-R3_]OLW3\\\'I+NM#*RACE*33)PJ%;?FD01@WJ1'BNV\)98R2
M:X;$H7#N6SV*\*%(Z/(S785 'YA"2:/DF$%Y**CO%4N)6HU87#]H'-I"8:-D
MEF&!*+0?R7*86%5LPHIIP7KHWB)0]BAI)4@N2@B&(I9J+K<>%_=E9L_'55\F
MP2&]IB T'"CYY@NDHP3E,DDL+KW^<\,$[89"46D.GB/""T! YBO!WGL9]AX<
M.TH>6BOSE6 _>1GV$SAVE%RT5B8F]K[]>*<>Y<(S ^TUAB)'R45K)&("SZ\T
M=^I>R6=6K(ZJHWY0 HH>,44-BT7M\,5%'M+;2TLH;\1TM5H<)N=[J0WA_[%Y
MW9UDM3V4.6+B&A+:] /&(N[NH85O*=&>"90O2JY:*:=II"["BA)_]]VU@ )%
M24"KQ#3,\T:ZN8^9%,'GL8=64*XHF:1/5-,#KUM-K+VG_M;7X!5L*,/JOHR&
M,7Y7S%@/^C)-,[%^1N.9%?.80O&BI']!>0VC'DG.8F:8F'ZQ=XB*$5[-N<H.
M"ADEV?,+:YCPO:(NTM3>=N?KN-QV W4WF?A&WI ]E#A*KE<O%)?\4.N,JI?R
MKR@%C0)*V@<5W?0X0^/,#GNK;F_\Z';,>$:9 RLH:Y24SR>J8;:W\E$1MVMO
MM$K'DONWAU0:0@FC)'@!:0U#WO&C&N^>"10L2F97*0=I3+A>QC,BIM2_>J':
M$@H8)=,+B4,;>Z>@L7?ZPK$7)>/SB4)B6ZP-MV?4W9BS*?'O) L6 .^SP20>
MD-KT_KU\RX_;SZW2W(^!_5"-W6,*!8ZS13(DKVG46<(,30J7!DP0$=N4:K.O
MS9.=UY>"!@!G#R50-,KC_>^4\\]"+L2($BT%38I;_= 3?F\1:!00YQ!KY**$
MX)ODF:6D\H6@RG,.>$RAR!'G#CWR<-9>%HN:-]>>XL4=(>*^$E#PB).(8;%(
MZ],,=3ZS9_J1&++V,,3?5P+*'W%",2P6;?V\ZML+SU2&Y\SW#*&T$9?"5DI#
M@3Q*">=7F6:"ZN#8LF<(A8RXYK52&@KDZY2JJ1W4/BFY,+/UWLX0;$\!*'3$
ME:U!J3CPES_WD1?[WX+D*ZS!;R= Q.X5B?7:C3AV"RF**[E(B/)0#]E#N:-N
MK/0+;9C\G9E1M7W_E#LSM'E;:-%#?2EH%%#25:AHG&OKUD[^X*5UQP[*&S$Q
MK1*&LV<J&W,6#[@DP?OR'3,H7\0LM$(6"MXK(IY4-C?QZE[)F%(W?:(W9QL@
M(0)6  T)8G[Z(A0XCPMDFKK-1#)^&LVL:'V7F?P]IM:_X$.#8#EH:# W<0*$
M(]T%Z9\;O6ARM7J@$ZK<,H5'NC17MJ&G\$T1H#@T/JAO% )CJ C3>>= UXT]
MX-Y46WSC?KFWL=HC_P-02P$"% ,4    " ",2N54]I]8K(SH  !8D 8 "0
M            @ $     97@R+3$N:'1M4$L! A0#%     @ C$KE5-Y./L>C
M$   N4H   H              ( !L^@  &5X.3DM,2YH=&U02P$"% ,4
M" ",2N54^9F%+WD>  !F[0  "P              @ %^^0  9F]R;3@M:RYH
M=&U02P$"% ,4    " ",2N54<A(\]BT#  "Z"P  $0              @ $@
M& $ <VUT:2TR,#(R,#<P,2YX<V102P$"% ,4    " ",2N54<I3DWOX*  "
MA@  %0              @ %\&P$ <VUT:2TR,#(R,#<P,5]L86(N>&UL4$L!
M A0#%     @ C$KE5-P-:!%9!P  WU<  !4              ( !K28! '-M
I=&DM,C R,C W,#%?<')E+GAM;%!+!08     !@ & &T!   Y+@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
